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Abstract 
Antioxidants and myocardial infarction: the EURAMIC study 
PhD thesis, TNO Nutrition and Food Research Institute, Zeist, The Netherlands, 
9 September 1994. 
Alwine F.M. Kardinaal 
This thesis reports the background, design and results of a multi-centre study on the 
relationship between diet-derived antioxidants and the risk of acute myocardial 
infarction (MI) in men. Levels of a-tocopherol and p-carotene in adipose tissue and 
of selenium in toenails were compared between almost 700 patients with first MI 
and a similar number of control subjects, recruited in 8 European countries and 
Israel. The concentration of (3-carotene in adipose tissue, expressed in quintiles of 
the distribution in controls, was inversely associated with the risk of MI (p for trend 
0.001), independently of other risk factors. This association was strongest in current 
cigarette smokers and in subjects with a high proportion of polyunsaturated fatty 
acids in the adipose tissue. The risk of MI was not related to a-tocopherol in 
adipose tissue. In persons with low vitamin E levels, low toenail selenium was 
associated with a 2.5-fold increased risk of MI, compared to high selenium levels. 
An additional study among 85 healthy, non-smoking volunteers, aged 50-70, 
showed only a modest correlation of adipose tissue concentrations with dietary 
intake of a-tocopherol and (3-carotene, assessed by a food frequency questionnaire. 
Randomized controlled trials with varying doses and combinations of antioxidant 
nutrients should clarify whether the observed associations are causal. Until then, 
supplement use is not recommended, but a generous consumption of fruits and 
vegetables may be encouraged. 
The EURAMIC Study was carried out at the following institutes: National 
Public Health Institute, Finland; 0stfold Central Hospital, Norway; University 
of Edinburgh, Scotland; University of Ulster, Northern Ireland; Federal Health 
Office, Germany; University of Zurich, Switzerland; University of Granada, 
University of Malaga, Spain; Hadassah Medical Organization and Hebrew 
University, Israel; Research Centre for Preventive Medicine, Russia; TNO 
Nutrition and Food Research (Coordinating Centre). 
The coordination of the EURAMIC Study was supported by grants from the 
European Union (Medical and Health Research Programme 4 and Europe against 
Cancer). National contributions were funded by the British Heart Foundation, 
Dutch Ministry of Welfare, Public Health and Cultural Affairs, Spanish FIS, 
German Federal Health Office, Norwegian Research Council, Russian Ministry 
of Science, Swiss NRF, and the Yrjo Jahnsson Foundation. 
Financial support of the Netherlands Heart Foundation for the publication of this 
thesis is gratefully acknowledged. Additional financial support was provided by 
Roche Nederland BV, Roche Nicholas BV, Adviesburo Orthomoleculaire 
Voeding BV and TNO Nutrition and Food Research. 
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Introduction 
Although the incidence of coronary heart disease (CHD) is declining in 
countries with a western life-style, including the Netherlands, it still is the 
major cause of death among men and post-menopausal women1'2. Elevated 
serum cholesterol, hypertension and cigarette smoking have been identified as 
the prime risk factors for CHD, but many other clinical and lifestyle factors 
are associated with the risk of CHD. As yet, all these factors do not fully 
explain the variation in CHD risk. Moreover, little is known about the 
biological mechanisms by which specific factors may contribute to the 
expression of coronary heart disease. A major theory postulates that injury of 
the arterial endothelium leads to increased adhesion of monocytes and 
macrophages to the arterial wall3. These cells then migrate between the 
endothelial cells and become large foam cells due to lipid accumulation. The 
resulting fatty streak may progress to more severe lesions. However, it has 
been shown that high serum cholesterol in itself does not lead to foam cell 
formation, because the uptake of low-density lipoproteins (LDL) by cells is 
regulated4. This apparent contradiction is solved by a recent hypothesis, 
stating that cholesterol particles have to be modified, presumably by 
oxidation, to become atherogenic5'6. This hypothesis has led to intensified 
research into the potential protective role of antioxidants in atherogenesis7. 
Antioxidants are present in our daily diet. The main antioxidant 
nutrients are vitamin E (in particular its most active form, a-tocopherol), 
vitamin C and P-carotene, which can be metabolized to vitamin A in the 
body. Selenium is a trace element that is incorporated in the enzyme 
glutathione peroxidase, which also has a major antioxidant function in the 
body. Vitamin C and P-carotene are found primarily in fruits and vegetables, 
vitamin E mainly in vegetable oils. Important sources of selenium are cereals, 
meat and fish. Although evidence has accumulated that these nutrients are 
indeed good antioxidants and may protect LDL-cholesterol against oxidation 
in vitro, there are still few human studies to support their preventive role in 
atherogenesis. Firm evidence for such a role can be obtained from long-term 
intervention studies with antioxidant nutrients and coronary heart disease as 
end-point. Several of these studies are in progress, but definitive results will 
not be published for some time8. In the meantime, relatively short-term 
observational studies may yield information about which antioxidants or 
combination of antioxidants may be most effective. 
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In the EURopean study on Antioxidants, Myocardial Infarction and 
Cancer of the breast, in short the EURAMIC Study, we compared the 
antioxidant status of patients with acute myocardial infarction (MI) with that 
of controls without a history of MI. It was hypothesized that the antioxidant 
status would be lower in patients with acute MI than in control subjects. 
Moreover, we expected to find a combined effect of the antioxidants, 
especially for selenium and a-tocopherol. Because it was not expected that a 
very strong relationship would be found within any particular population, it 
was important to select a study population with a relatively large range of 
antioxidant status. Therefore, the study was conducted according to the same 
protocol in nine countries with varying dietary patterns and the data from 
these countries were pooled in the overall data analysis. Collaborating centres 
were found in Finland, Norway, Russia, Scotland, Germany, Switzerland, 
Spain and Israel. To overcome potential bias in the measurement of diet in 
different countries, the use of tissue concentrations of antioxidants was 
preferred. Since plasma levels represent relatively short-term intake and may 
be affected by acute infarction, other tissues were considered to measure 
exposure to antioxidant nutrients. For selenium, the concentration in toenails 
has been shown to be correlated to long-term dietary intake; for a-tocopherol 
and P-carotene, adipose tissue seemed to be suitable, since both antioxidants 
are fat-soluble and stored primarily in adipose tissue. Available evidence 
indicates a limited availability of the antioxidants from adipose tissue, which 
renders an acute effect of MI on tissue levels unlikely. However, little 
information is available on the relationship of adipose tissue concentrations 
with dietary intake of a-tocopherol and P-carotene. To clarify this 
relationship an additional study has been performed among healthy volunteers 
in the Netherlands. 
Chapter 2 reviews the available evidence for the relation between 
antioxidants and coronary heart disease at the time the EURAMIC Study 
started. Details of the design and hypotheses of the EURAMIC Study are 
discussed in Chapter 3. The results regarding the main hypotheses are 
described in Chapter 4, 5 and 6; these results are based on the pooled data 
from all participating centers. Chapter 7 describes the additional 
methodological study, in which the antioxidant concentration in adipose tissue 
was compared with dietary and supplement intake. For our Dutch 
contribution to the EURAMIC Study, we linked the data on a-tocopherol and 
P-carotene in adipose tissue, as well as on dietary intake of these vitamins, to 
risk of MI. The results of these analyses are discussed in Chapter 8. Finally, 
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some methodological considerations, recent findings in experimental and 
epidemiological studies, and the possible consequences for public health are 
presented in Chapter 9. 
A list of all EURAMIC collaborating centres is included. 
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The protective role of antioxidants and coronary 
artery disease 
Alwine FM Kardinaal, Geert van Poppel, Frans J Kok 
Abstract 
Free radicals may play a role in the development of atherosclerosis primarily by 
oxidizing polyunsaturated fatty acids in lipoproteins, especially low-density 
lipoprotein (LDL). The modified LDL is taken up rapidly by macrophages in the 
arterial wall, forming foam cells. Oxidation reactions are prevented by a 
complex antioxidant defense system, including the vitamins E, C and (3-carotene, 
and the selenium dependent enzyme glutathione peroxidase. Experiments have 
shown that the resistance to oxidation of the LDL is influenced by the 
antioxidant concentration. However, a direct relation between antioxidants and 
cardiovascular disease has not been demonstrated conclusively in 
epidemiological studies. Partly this may be due to methodological shortcomings 
which can be overcome in the future by choosing the relevant parameters of 
antioxidant status and disease outcome in carefully selected populations. 
Introduction 
Free radicals are highly reactive molecules that can readily oxidize and damage 
essential biomolecules, such as lipids and proteins. In recent years, free radicals 
have been implicated in the development of many diseases, including 
atherosclerosis. Free radicals may be of exogenous origin, but also are constantly 
produced as a result of normal biological and metabolic processes. To prevent 
free-radical-induced damage, the human body possesses a number of 
free-radical-scavenging, or antioxidant, defense systems, involving vitamins E 
and C, P-carotene (the precursor of vitamin A), and enzymes such as the 
selenium-dependent protein glutathione peroxidase. 
J Myocard Isch 1992;4:64-78 
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Recent experimental evidence indicates that a disturbed balance between 
free-radical production, or "oxidative stress," and these antioxidant defense 
mechanisms results in damage to biological molecules and lipoproteins and may 
contribute to the development of atherosclerosis. If an unambiguous association 
could be demonstrated among free radicals, antioxidant defense, and the 
incidence of cardiovascular (CV) disease, this would have a profound effect on 
preventive measures. In the following review, we will explain how free radicals 
may contribute to the initiation of atherosclerosis and will explore the possible 
protective role of antioxidants, as suggested by experimental and epidemiologic 
data. 
Free radicals and lipid peroxidation 
Free radicals are molecules or molecular fragments that have an unpaired 
electron. These molecules may have a heightened reactivity that leads to 
abstraction of a hydrogen atom from another molecule, thereby starting a chain 
reaction. The many known exogenous free radicals or radical precursors include 
ozone, nitrous oxides, various carcinogens and mutagens, ionizing radiation, 
cigarette smoke, and halogenated compounds. These stressors increase the 
generation of superoxide anion (0 2 - ) and hydrogen peroxide (H 2 0 2 ). However, 
oxygen free radicals often are of endogenous origin. Many cell redox systems 
produce considerable quantities of the superoxide anion and hydrogen 
peroxide1'3; these molecules are not very reactive but may form the highly 
reactive hydroxyl radical (•OH) in the presence of metal catalysts: 
0 2 ~ + H 2 0 2 —F c + +—> -OH + OH- + 0 2 
The hydroxyl radical reacts with most biological material, such as DNA, 
proteins, and lipids. Polyunsaturated fatty acids are especially vulnerable to this 
reaction. The hydroxyl radical can attack the polyunsaturated fatty acids (L) in 
biological membranes or lipoproteins: 
LH + ^OH —-> L» + H 2 0 
The carbon-centred radical of the fatty acid then takes up an 0 2 molecule and 
forms a peroxyl radical: 
L» + o 2 — > LOO-
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Subsequently, a hydrogen atom from another fatty acid molecule is taken up, 
thereby forming a lipid hydroperoxide, and a new radical: 
LOO* + LH — > LOOH + L« --> chain reaction 
This chain reaction is known as lipid peroxidation4. The hydroperoxide finally 
decomposes to cytotoxic aldehydes, e.g., malonaldehyde or 4-hydroxynonenal. 
Antioxidants: a complex defense system against oxidative stress 
The human body has a complex mechanism for protection against oxidative 
stress. This defense mechanism includes a number of enzymes and non-
enzymatic antioxidant micronutrients (Figure 1). 
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Figure 1. Major antioxidant defense mechanisms within the cell: 
^-carotene • = ^-carotene radical, GSHPx = glutathione peroxidase, H202 = hydrogen 
peroxide, 02 = oxygen, 02- = superoxide anion, -OH = hydroxyl radical, 
PA2 = phospholipase PUFA:H = polyunsaturated fatty acid, PUFA.OH = fatty acid 
hydroxide, PUFA:OOH = fatty acid hydroperoxide, SOD - superoxide dismutase, vitamin 
£• = vitamin E radical. Adapted, with permission, from Duthie et al.2 
Intracellular defenses 
Superoxide dismutase (SOD), glutathione peroxidase (GSHPx), and catalase 
constitute the primary enzymatic antioxidant defenses, which operate 
intracellularly. Zinc, copper and manganese are incorporated into the two types 
of SOD, which neutralizes the superoxide anion. Selenium is a component of 
GSHPx, which plays an important role in the catabolism of hydrogen peroxide 
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and lipid peroxides. Catalase contains iron and removes hydrogen peroxide from 
the cell. 
Extracellular defenses 
Extracellular free radicals must be inactivated by circulating antioxidants, such 
as vitamin E, vitamin C and p-carotene5. In plasma, vitamin C forms the first 
line of defense-this antioxidant is water-soluble and can neutralize free radicals 
as well as singlet oxygen. (Another reactive metabolite of oxygen but not a free 
radical, singlet oxygen contains an electron excited to a higher orbit by energy 
capture. This oxygen metabolite may cause tissue damage.) In membranes and 
lipoproteins, antioxidant protection is provided primarily by the fat-soluble 
vitamin E, especially the a-tocopherol vitamer, and p-carotene. Tocopherols and 
carotenoids are transported in the blood in plasma lipoproteins, predominantly 
LDL and high-density lipoprotein (HDL). 
a-Tocopherol is one of the most efficient chain-breaking antioxidants available. 
Because it can compete for peroxyl radicals much faster than can 
polyunsaturated fatty acids, a small amount of a-tocopherol can protect a large 
amount of polyunsaturated fat. In biological membranes, approximately one 
a-tocopherol molecule is found per 1000 lipid molecules6. a-Tocopherol acts by 
quenching oxygen- or carbon-centred fatty acid radicals of membrane 
phospholipids, and may also inhibit peroxidation by quenching reactive oxygen 
species. The tocopheroxyl radical that is formed by this process is relatively 
unreactive, and tocopherol may be regenerated from this product, for example, 
by vitamin C 6 ' 7. 
P-Carotene is the most efficient naturally produced quencher of singlet 
oxygen and can also function as an antioxidant5. P-Carotene may act as a chain-
breaking antioxidant at low levels of oxygen partial pressure, as found in many 
peripheral tissues8'9. As a chain-breaking antioxidant at high oxygen pressures, 
however, P-carotene is less efficient than vitamin E. 
Oxidative modification of LDL 
The fatty streak, the earliest lesion of atherosclerosis, contains a large number 
of foam cells, primarily macrophages, that are filled with cholesterol derived 
from plasma lipoproteins. Although a high level of low-density lipoprotein 
(LDL) in plasma is recognized as a risk factor for atherosclerosis, a number of 
observations indicate that native LDL,* per se, does not induce the initial stages 
of atherosclerosis. 
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First, native LDL is taken up by the classic LDL receptor, which plays a 
significant role in cholesterol homeostasis. In the presence of high intracellular 
concentrations of cholesterol, however, the activity of this type of receptor is 
curbed-that is, uptake of native LDL is decreased10. Second, lesions rich in 
foam cells develop even in patients who are deficient in functional LDL 
receptors 1 1 1 2. Finally, the incubation of macrophages with even high 
concentrations of native LDL does not result in the formation of foam cells1 1"1 3. 
The scavenger receptor 
All these observations suggested that cholesterol must be taken up via an 
alternative receptor pathway. Goldstein and coworkers14 discovered the receptor 
on monocytes and macrophages. This new receptor, called the "scavenger 
receptor", does not recognize native LDL, but does recognize specific chemically 
or biologically modified forms of LDL. 
All three major cell types in the artery wall - endothelial cells, smooth 
muscle cells, and macrophages - can effect the peroxidation of polyunsaturated 
fatty acids in LDL by releasing oxygen free radicals15"17. Thus modified the LDL 
is recognized by scavenger receptors on macrophages and rapidly taken up (3 
to 10 times faster than is native LDL), forming foam cells (Figure 2). This is the 
main hypothesis explaining the role of free radicals in the initial stages of 
atherosclerosis. 
Circulating . 
Native monocytes N ° J ™ e 
I c»[ r ~ \ ~ \ i « , > t • » \ « = » / 
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Figure 2. Proposed mechanisms by which the oxidation of low-density lipoprotein (LDL) may 
contribute to atherogenesis. Adapted, with permission, from Steinberg et al.n 
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Other atherogenic effects of oxidized LDL 
Other characteristics of oxidized LDL also may contribute to atherosclerosis: 
First, this modified LDL is a chemoattractant that effects the migration of 
circulating monocytes into the intima. When, within the arterial wall, blood 
monocytes have differentiated into tissue macrophages, oxidized LDL also 
inhibits the mobility of these macrophages, which are then retained in the 
arterial wall. Furthermore, oxidized LDL is cytotoxic and may damage 
endothelial cells. This last property may account, at least in part, for the 
progression of relatively benign fatty streaks to more complex lesions composed 
of fibrous plaque1'1 2. In support of this hypothesis, oxidized LDL has actually 
been found in atherosclerotic lesions in humans 1 8 ' 1 9. 
Free radicals also appear to be involved in thrombogenesis. Lipid 
peroxides may stimulate the production of eicosanoids, which are potent 
vasoactive and platelet-reactive substances that play a role in thrombus 
formation1,20. At the same time, lipid peroxidation inhibits prostacyclin 
production, which may result in vasoconstriction and, in turn, hypertension and 
increased platelet aggregation. Moreover, as was mentioned above, free radicals 
and lipid peroxides may have a direct cytotoxic effect on the arterial endothelial 
cells. 
All these different mechanisms are closely interrelated and appear to play 
some role in the development and progression of atherosclerotic lesions. 
However, the oxidized LDL hypothesis seems to be the most promising. 
Do antioxidants prevent the oxidation of LDL? 
If a causal relationship exists between oxidized LDL and atherosclerosis, then 
it would follow that antioxidants protect against atherosclerosis by preventing 
or retarding the oxidative modification of LDL. Because the lipid-soluble 
antioxidant vitamins are transported in plasma via LDL particles, LDL is 
somewhat immune to oxidation in plasma. However, in the process of protecting 
LDL against peroxidation, a-tocopherol, |3-carotene, and other antioxidants 
eventually are consumed. The antioxidant levels present in LDL protect the 
lipoprotein for a relatively short time 1 2 ' 2 1. 
Studies have shown that the resistance of LDL to oxidation, indeed, is 
related to antioxidant levels21"24. In these experiments, LDL was oxidized in 
vitro. Only after investigators depleted levels of a-tocopherol and y-tocopherol, 
(3-carotene and other antioxidants contained in the LDL particle did they see the 
beginnings of LDL degradation, lipid hydroperoxide formation, and rapid uptake 
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of modified LDL by macrophages25 (Figure 3). In two ex vivo studies, 
researchers increased the concentration of tocopherol in LDL by administering 
supplements to the volunteers from whom blood was taken. With the rise in 
tocopherol levels, a significantly increased resistance of the LDL to oxidation 
was demonstrated22'26. 
Most studies on antioxidant protection have focused on a-tocopherol, the 
most potent antioxidant compound. These investigations have revealed 
interindividual differences in the rates of lipid peroxidation that could not be 
entirely explained by variations in LDL-tocopherol concentrations23. Two 
explanations for this phenomenon are most likely: First, in addition to 
a-tocopherol, other antioxidants present in LDL, including y-tocopherol, 
(3-carotene, lycopene, and phytofluene (a recently discovered carotenoid), may 
have important protective effects. Second, different fatty acids vary in their 
sensitivity to oxidative metabolism. Polyunsaturated fatty acids, for example, are 
most vulnerable. Thus, variations in peroxidizable lipids in LDL also may 
determine the lipoprotein's susceptibility to oxidation. Indeed, Esterbauer23 found 
that the fatty acid composition of LDL varied greatly from person to person. 
Figure 3. Relationship between consumption of antioxidants in LDL and the onset of lipid 
peroxidation. Adapted, with permission, from Esterbauer et al.25 
Last, recent publications23'27 indicate that ascorbate (a salt of vitamin C) 
strongly inhibits LDL oxidation in vitro, while simultaneously preserving levels 
of a-tocopherol, v-tocopherol, and ß-carotene in the LDL. 
Minutes 
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Epidemiologic evidence 
Epidemiologic studies focusing on the possible protective effects of antioxidants 
not only must explore the association between absolute levels of single 
antioxidants and cardiovascular disease but also must take into account 
interrelationships among different antioxidants and the effects of known risk 
factors on antioxidant levels. For example, cigarette smokers have lower plasma 
vitamin C and carotene concentrations than do non-smokers28. Epidemiologic 
research into these associations has only just begun, and the results of long-term 
studies are still scant. 
The concentration of antioxidant micronutrients in human tissues depends 
primarily on dietary intake. Antioxidant nutrients for which intake has been 
studied in relation to CV disease include vitamins E and C, P-carotene, and 
selenium. Table 1 lists important dietary sources of these nutrients and their 
recommended dietary allowances29. 
Table 1. Dietary sources of vitamins E and C, ^-carotene, and selenium and the 
recommended dietary allowance (RDA) of each nutrient. 
RDA 
Nutrient Dietary sources Men Women 
Vitamin E Vegetable fats and oils, 
margarine, nuts, fish, meat, 
eggs 
70-80 a-TE f 60-65 a-TE f 
Vitamin C Fresh fruits and vegetables, 
potatoes 
60 mg 60 mg 
ß-carotene Green-yellow and leafy 
vegetables 
1,000 RE* 800 RE* 
Selenium Cereals, meat, fish 70 m 55 fig 
1 mg RRR-a-tocopherol = 1 a-TE (tocopherol equivalent). 
RDA for total vitamin A intake; 1 RE (retinol equivalent) = 1 jxg retinol or 6 fig 
ß-carotene. 
Based on data from National Research Council2 9. 
Intake of foods can be assessed by interview or questionnaire, which may 
introduce a recall bias. The use of food composition tables may also introduce 
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errors, because there are large variations in the nutrient content of some foods. 
Furthermore, dietary intake of nutrients does not provide an accurate indicator 
of bioavailability, as variations in absorption and metabolism are not taken into 
account. Therefore, to study the association between micronutrients and CV 
disease, investigators primarily have used biochemical indicators. 
Biochemical indicators 
The biochemical indicators of nutrient status used in epidemiologic studies often 
are plasma or serum concentrations, which reflect ingestion during the past few 
days to weeks. In theory, the concentration of antioxidant vitamins in plasma 
may only reflect the consumption of specific foods, other constituents of which 
may be responsible for a protective or adverse effect on the risk of CV disease. 
Plasma or serum concentrations of antioxidants may be adequate indicators 
of exposure, if such levels are fairly constant and dietary intake has been stable 
over a longer period. However, if dietary intake has been influenced recently as 
a consequence of disease, it is more appropriate to use a biochemical indicator 
reflecting intake before that change. For lipid-soluble antioxidants such as 
vitamin E, the concentration in subcutaneous adipose tissue is recognized as a 
valuable long-term indicator, whereas levels of a mineral such as selenium can 
be measured reliably in toenails. For other antioxidants, such as vitamin C, a 
long-term indicator is not available30. 
Vitamin E 
Of all the antioxidants, vitamin E has been studied most extensively in relation 
to CV disease. In the Multinational Monitoring Project of Trends and 
Determinants of Cardiovascular Disease, or the World Health Organization 
(WH0)/M0NICA study, plasma levels of antioxidants were compared among 
different groups of apparently healthy men from regions with a six-fold 
difference in age-standardized ischemic heart disease (IHD) mortality; each 
group consisted of about 100 men between the ages of 40 and 49. Gey and 
coworkers31 reported results for 16 different populations. For most of the 
vitamins studied, these investigators found an inverse correlation between 
plasma antioxidant levels and IHD mortality; this relationship was strongest for 
vitamin E, independent of plasma lipid levels (Figure 4). These data should be 
interpreted cautiously, however. Since antioxidant exposure and IHD incidence 
were assessed at the same point in time, no conclusions can be drawn about the 
time course of this association and no adjustment can be made for possible 
confounding factors. 
22 Chapter 2 
0 21.8 25.0 28.8 
Median of Ipid-standardized vitamin E levels, uM/L 
Figure 4. Relationship between plasma vitamin E levels and mortality due to ischemic heart 
disease (IHD), as determined in the Optional Vitamin Study, World Health Organization 
(WHO)IMONICA project. Adapted, with permission, from Gey et al.31 
In a more recent study, Riemersma and colleagues32 found an inverse 
relationship, which was independent of smoking behaviour, between plasma 
levels of vitamin E and angina pectoris. Their results indicated that individuals 
whose plasma vitamin E levels were in the lowest quintile had almost a 
threefold greater risk of angina than did those whose plasma vitamin E 
measurements were in the highest quintile. As in the MONICA study, vitamin 
intake and disease in the study by Riemersma et al. were measured at the same 
time. Another limitation of the latter investigation was the method of recruitment 
of cases, which was based on self-reported symptoms. Again, no inferences 
about a possible cause-and-effect relationship between antioxidant intake and 
angina pectoris can therefore be made from these data. 
The effect of vitamin E intake on CV disease also has been examined in 
prospective cohort studies, in which antioxidant exposure was measured at a 
given point in time before the diagnosis of disease. In the three prospective 
studies reported to date33"35, the mean baseline plasma vitamin E levels among 
patients who died from IHD during follow-up were not significantly lower than 
levels among controls. 
In a prospective study from the Netherlands, Kok et al. 3 4 compared serum 
vitamin E levels in 84 individuals who died of CV disease during a 9-year 
follow-up period with levels in 168 matched controls; in both groups, the serum 
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samples were obtained at the baseline evaluation. Although the researchers 
observed no significant associations between serum vitamin E levels and CV 
mortality, the results may have been biased by loss of vitamin E during 
prolonged storage of the serum. 
In a similar Finnish study that entailed a 5-year follow-up period33, lengthy 
storage of serum also may have influenced the results. Furthermore, in this 
study, vitamin E levels were not adjusted for plasma cholesterol; such an 
adjustment may be appropriate in view of the strong association between these 
two measurements. In both the Dutch and Finnish studies, vitamin E levels were 
within normal ranges. Therefore, the possibility that marginal levels of vitamin 
E may influence CV risk cannot be excluded. 
Several small-scale intervention studies have failed to demonstrate an effect 
of vitamin E on symptoms of angina pectoris36. Long-term intervention studies 
specifically designed to evaluate the effects of lipid-soluble antioxidants on CV 
disease have not yet been reported. 
Vitamin C 
In the United Kingdom, IHD mortality is high in areas where residents have 
relatively low vitamin C consumption37. The previously mentioned MONICA 
study also revealed a moderately strong inverse correlation between plasma 
vitamin C and IHD mortality31. In a prospective study from Basel35, IHD 
mortality was 60% higher in individuals who had low plasma vitamin C levels 
than in those who had higher vitamin C levels; however, due to the small 
number of cases, this mortality difference did not reach statistical significance. 
No long-term studies of vitamin C as an intervention for CV disease have been 
reported. 
(3-Carotene 
Few epidemiologic studies have addressed the possible protective role of 
(3-carotene against CV disease. Nevertheless, the consumption of fresh fruits and 
vegetables containing P-carotene has been shown to be inversely correlated with 
mortality due to coronary disease (CAD) and with the risk of acute myocardial 
infarction (MI)3 8-3 9. The results of cross-sectional or prospective studies 
evaluating the association between plasma levels of |3-carotene (or any other 
biological indicator) and CAD have yet not been published40. Some early data 
suggest, however, that |3-carotene supplementation may reduce morbidity and 
mortality due to CV disease. A preliminary analysis of data from the US 
Physicians' Health Study showed a 44% reduction in major coronary events 
among physicians with angina pectoris who took 50 mg of (3-carotene on 
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alternate days . This analysis was carried out in a relatively small subgroup, 
and, hence, the results do not suffice as evidence for a protective effect of 
P-carotene. 
Selenium 
Selenium, a cofactor of glutathione peroxidase, has been widely investigated for 
its effect on CV disease. After several cross-sectional studies were performed 
in the early 1970s, the first case-control study on serum selenium concentration 
and risk of cardiovascular disease was published in 19824 2. This study revealed 
that the risk of CAD mortality in individuals with low serum selenium 
concentrations (<, 45 fig/1) was more than twice as high as in those with higher 
serum selenium levels (> 45 fig/l). 
In the decade that followed, several other studies focusing on the 
association between selenium and CAD were published43"48. As Table 2 shows, 
the findings from different studies are conflicting. In fact, the number of studies 
showing a statistically significant inverse relationship between serum selenium 
concentrations and CV disease is as large as the number showing no association. 
Table 2. Epidemiologic evidence for a relationship between serum or plasma selenium 
concentration and cardiovascular disease. 
Relative risk 
Reference Patients Controls 
(95% CI) 
Salonen et al. 4 2 51.8 ± 14.2 55.3 ± 14.2 2.2 (1.2-4.0) 
Miettinen et al.4 3 71.6 ± 13.8 72.9 ± 14.4+ -
Salonen et al. 3 3 62 68 1.3 (0.3-7.0) 
Virtamo et al. 4 4 - _* 1.6 (1.1-2.3) 
Kok et al. 3 4 125.1 ± 3.1 126.5 ± 2.2 1.6 (0.8-3.2) 
Ringstad et al.4 5 1.57 ± 0.21 1.61 ± Q.2f 1.0 (0.4-2.3) 
Kok et al. 4 6 100.8 ± 3.0 106.8 ± 2.6 f -
Beaglehole et al. 4 7 82.8 ± 2.9 87.9 ± 1.8 1.6 (1.1-2.2) 
Kok et al. 4 8 95.1 ± 2.0 108.8 ± 29.3 § -
p > 0.05. 
Cohort analysis, not a case-control analysis; selenium levels for total cohort were analyzed 
and relative risk calculated for individuals with selenium levels s 45 /<g/l vs > 45 fig/l. 
in /onol/I. 
p s 0.05. 
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Experimental observations suggest that selenium intake must be below a 
threshold level before a relationship between selenium status and CV risk 
becomes evident. Selenium supplementation increases the activity of glutathione 
peroxidase in platelets of selenium-deficient humans, and this increase levels off 
when a plasma selenium concentration of about 100 to 135 ^g/1 is achieved49. 
The earliest investigation of selenium and CV disease in Finland was conducted 
when the average dietary intake of selenium was still very low 4 2. In later years, 
the soil in Finland was seeded with selenium, and intake has, therefore, 
increased. 
It may be argued that, in case-control studies, low serum selenium 
concentrations are difficult to interpret, because the serum measurement may be 
affected by the disease and, on the other hand, a single serum measurement may 
not reflect the selenium status over years. As mentioned above, an alternative 
to calculating selenium levels in plasma is to measure levels of the antioxidant 
in toenails, which reflects long-term intake. Kok and colleagues found 
significantly lower toenail selenium levels in patients who had suffered an MI 
than in healthy population controls46. This finding indicates that low selenium 
levels were present before the infarction, which may be of etiologic relevance. 
Directions for future research 
Animal and in vitro experiments, for the most part, have investigated the 
influence of oxidative stress on the LDL particle and the preventive effect of 
antioxidant compounds. In contrast, epidemiologic studies have focused on the 
relationship between plasma antioxidant levels and CV disease, the eventual 
endpoints of oxidative stress. The populations in which most of these 
epidemiologic studies have been performed have had a high intake of vitamins 
and minerals, but positive results have been found in some populations with a 
relatively low intake of antioxidants. Still, the sum of these studies has failed to 
produce conclusive evidence of a protective effect of any single antioxidant 
nutrient. 
Considering the complex relationships among the various antioxidant 
nutrients, a more sophisticated research approach might be more successful. 
Future studies should be aimed at identifying subgroups that may be at increased 
risk of CV disease due to factors such as low vitamin intake or to high 
exogenous oxidative stress, such as might be caused by cigarette smoking. 
Experimental studies have shown a synergistic effect of certain antioxidants; this 
possible synergy should be studied in epidemiologic studies as well. 
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In addition to antioxidant status, epidemiologic studies should assess intake 
of polyunsaturated fatty acids (PUFAs). For example, Kok et al. 4 8 recently 
evaluated the combined association of blood levels of a-tocopherol, PUFAs, and 
selenium with coronary atherosclerosis. These investigators found a significantly 
lower ratio of plasma selenium to plasma PUFAs in patients with atherosclerosis 
who had relatively low a-tocopherol levels but not in those who had high a-
tocopherol levels. This potential interrelationship among plasma PUFAs, 
selenium, and a-tocopherol needs to be studied further. 
Moreover, recent findings suggest that increased consumption of 
monounsaturated fatty acids (MUFAs) may decrease the susceptibility of LDL 
to oxidation and uptake by macrophages50. MUFAs seem to have a 
cholesterol-lowering effect equivalent to that of PUFAs but do not decrease 
HDL levels 5 1 5 2. In view of the susceptibility of PUFAs to peroxidation, a diet 
that is rich in MUFAs may afford greater protection than a diet high in PUFAs. 
Epidemiological studies need not be limited to addressing the direct 
association between antioxidant status and risk of CV morbidity and mortality. 
Observational studies in humans could serve to elucidate earlier steps in the 
LDL oxidation hypothesis. For example, in vivo demonstrations of this 
inhibition of LDL oxidation by antioxidants (which, up to now, has been studied 
primarily in vitro) and of the subsequent retardation or regression of 
atherosclerosis would provide strong confirmation of this hypothesis. 
Measurement of the resistance of LDL to oxidation and levels of lipid 
peroxides may prove to be valuable parameters in future epidemiologic studies. 
Mobarhan et al. 5 3 showed that the level of circulating lipid peroxides in healthy 
subjects can be reduced by p-carotene supplementation. Stringer54 reported a 
significantly higher plasma lipid peroxide concentration in patients hospitalized 
for occlusive arterial disease than in control patients hospitalized for other 
conditions. In relation to CV disease, however, the significance of lipid peroxide 
concentrations in plasma is not clear. High lipid peroxide levels may be an 
indicator of the disease, but they may be a result rather than a cause. 
Furthermore, the relevant process of LDL oxidation most likely takes place in 
the subendothelial space in the arterial wall, rather than in plasma. The oxidative 
stress in the subendothelium may be quite different from that in plasma. 
Therefore, the resistance of the LDL particle to oxidative stress may be more 
relevant to CV disease than are levels of peroxidation products in plasma. 
However, other mechanisms, such as thrombogenesis may also play a 
pathological role in which plasma lipid peroxides could be involved. Clearly, 
additional research is needed to clarify these issues. 
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Conclusions 
A large amount of experimental evidence shows that the oxidation of LDL in 
the intima of the arterial wall may play an important role in the initial phase of 
atherosclerosis. In vitro studies indicate that oxidation can be inhibited by 
various antioxidant agents, of which vitamin E seems to be the most effective. 
Whether dietary antioxidant intake actually influences the course of 
atherosclerosis and the incidence of CV events has not been proven in 
epidemiologic studies, however. 
The inconsistency between the results of in vitro studies and the findings 
of epidemiologic investigations may be attributed, at least in part, to 
methodological weaknesses in the study designs. Relatively small studies in 
homogeneous populations suffer from too little variation in the intake of relevant 
nutrients. Misclassification of exposure or disease status also may be a source 
of bias. Therefore, it is essential to use an adequate method of diagnosis and a 
relevant indicator of nutrient intake. 
Of course, researchers must also control for known CV risk factors such as 
smoking, high plasma cholesterol levels, and hypertension. And finally, since the 
body's antioxidant defense is a complex system in which the function of 
different antioxidants is closely interwoven, the combined effect of nutrient 
antioxidants should be studied. 
Fortunately, analytical tools for the measurement of nutrient biologic 
markers in epidemiologic studies are now available. The use of these biologic 
markers in methodologically sound studies will permit the comprehensive 
evaluation of the antioxidant hypothesis in human populations. 
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Abstract 
Epidemiological studies have not given sufficient evidence yet for the role of 
antioxidant nutrients in the prevention of cardiovascular disease. As regards 
cancer, an inverse association between p~carotene intake and specific types of 
cancer, especially lung cancer, has been shown. For other cancer sites and 
other antioxidants, the association is less clear. The EURAMIC Study, an EC 
Concerted Action, is a case-control study conducted in 10 countries, in which 
the combined effect of vitamin E, p-carotene and selenium, in relation to 
fatty acid intake, will be examined. The disease endpoints are acute 
myocardial infarction and early stage breast cancer. The broad range of 
antioxidant intake, the use of biomarkers of exposure, and the analysis of 
pooled data will allow an estimate of the strength of the putative beneficial 
effect. In this paper the background and design of the study will be 
introduced. 
Introduction 
In recent years the deleterious effects of free radicals of exogenous and 
endogenous origin in the human body have been implicated in the 
development of age-related disorders, such as cardiovascular and malignant 
disease1,2. Free radicals initiate chain reactions that may eventually lead to 
adverse effects including the formation of toxic lipid peroxides and genomic 
Eur J Clin Nutr 1993;47:S64-S72 
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alterations. To prevent free-radical damage, the human body possesses a 
number of free-radical-scavenging or antioxidant defense systems, including 
the vitamins E and C, p-carotene, and enzymes such as selenium-dependent 
glutathione peroxidase3'4. The potential preventive role of antioxidants in the 
development of cardiovascular disease (CVD) and malignant diseases has 
been the subject of a number of epidemiological studies. Cross-cultural 
comparisons have shown correlations between lower serum vitamin E levels 
and higher age-standardized CVD mortality5. Three prospective studies6"8 
showed no correlation between plasma vitamin E levels and CVD mortality, 
whereas in a recent study Riemersma et al.9 found an inverse relationship 
between plasma vitamin E levels and angina pectoris. Few studies have 
addressed the role of P-carotene status in CVD prevention10. Consumption of 
fresh fruits and vegetables has been shown to be inversely correlated with 
mortality from coronary heart disease and acute myocardial infarction11 ,12. 
The inverse relation found between plasma carotene levels and angina 
pectoris9 disappeared when the confounding influence of cigarette smoking 
was taken into account. Preliminary findings from the Physicians' Health 
Study, a large intervention trial with p-carotene, suggest that patients with a 
history of stable angina pectoris who received P-carotene had a significantly 
reduced risk of further cardiovascular events13. Regarding selenium, 
observational data on its possible protective effect on CVD are also 
conflicting. An early case-control study in Finland showed a significant 
higher risk for CVD mortality in persons with low serum selenium levels1 4. 
In some later studies these results were repeated1 5 , 1 6, while in others no 
association was found6 , 8'1 6. 
Regarding cancer, the antioxidant nutrient that has been studied most is 
P-carotene. Since Peto et al. 1 8 hypothesized that carotenoids may reduce 
cancer rates, a large number of epidemiological studies has addressed this 
topic. The association between intake of fruits and vegetables rich in 
carotenoids, or plasma carotene levels, and a decreased risk of cancer appears 
to be most consistent for lung cancer and stomach cancer7 ,19"22 and less 
consistent for cancers of the breast and prostate23"28. Serum or plasma vitamin 
E levels in relation to cancer have been studied in several prospective 
investigations23,27"31. Wald et al. 2 3 observed a significant inverse association 
between plasma vitamin E levels and subsequent risk of breast cancer. 
Comstock et al. 2 8 reported a protective association of pre-diagnostic serum 
vitamin E levels with lung cancer, but with none of the other sites studied. 
Early epidemiological studies 3 2 , 3 3 suggested that dietary selenium compounds 
might protect against cancer at several sites. In general, studies on selenium 
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and total cancer risk have shown slightly lower selenium levels in cases than 
in controls, suggesting an inverse association8,36"38. 
A lack of association in some studies may be attributed, at least in part, 
to methodological weaknesses. Most studies have focused on the effect of 
single antioxidants. However, since the body's antioxidant defense is a 
complex system in which the function of different antioxidants may be 
closely intertwined, it is the combined effect of nutrient antioxidants that is of 
interest. It is difficult to obtain accurate information of dietary vitamin intake 
in epidemiological studies. Intake of foods can be assessed by interview or 
questionnaire, but may be recalled differentially between cases and controls. 
The use of food composition tables may also introduce errors, because of 
large variations in nutrient content of some foods. Furthermore, when 
measuring intake, individual variation in absorption and metabolism is not 
taken into account. Therefore, relevant biochemical indicators of intake are 
often preferred. These indicators are often plasma or serum concentrations, 
which mostly reflect intake during the past few days or weeks. If levels are 
fairly constant and intake has been stable over a longer period of time, these 
plasma/serum concentrations may be adequate indicators of exposure. 
However, if dietary intake has been influenced recently as a consequence of 
disease, it is more appropriate to use a biochemical indicator reflecting intake 
before that change. In summary, for CVD the associations with antioxidant 
nutrients found in several, but certainly not all studies, warrant further 
observational studies to be followed by human intervention studies. Results 
from cancer studies indicate that |3-carotene may affect carcinogenesis, but 
not necessarily at all cancer sites. The study described in this paper was 
designed to address the association between vitamin E, p-carotene and 
selenium status prior to disease occurrence and well-defined endpoints of 
cardiovascular and malignant disease. The field work of this multi-centre 
study was conducted (during the 1990-1992 period) in nine European 
countries and in Israel, and is known as the EURopean Study on 
Antioxidants, Myocardial Infarction and Cancer of the Breast (EURAMIC). 
Research questions 
The specific hypothesis that is to be tested in the EURAMIC study relates to 
levels of the fat-soluble antioxidant nutrients and selenium in tissues with a 
low turn-over, as biomarkers of the intake of these nutrients, integrated over 
a longer period of time. The hypothesis, formulated in such a way that it 
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applies to both disease endpoints, is as follows: The concentration of 
a-tocopherol and |3-carotene in adipose tissue, and of selenium in toenails, is 
lower in cases as compared to healthy population controls. As 
polyunsaturated fatty acids are an important substrate for free radical 
peroxidation, and the intake of linoleic acid is positively associated with the 
intake of vitamin E, the vitamin status relative to fatty acid composition will 
also be compared. Moreover, the study design allows to evaluate the shape of 
the antioxidant-disease relationship, which is postulated to be non-linear, i.e. 
the increased risk may only be observed at the lowest antioxidant 
concentrations. Lastly, the synergistic effect of the different antioxidants, in 
particular a-tocopherol and selenium, on disease will be analysed. The 
putative protective effect of P-carotene may be particularly important at low 
a-tocopherol/selenium status or in smokers experiencing high oxidant stress. 
Study design 
The study design selected is a set of equally sized population-based case-
control studies, conducted in nine European countries and Israel, thus 
including subjects with a large variation in antioxidant intake and background 
disease risk. The disease endpoints of first acute myocardial infarction in men 
and early stage-breast cancer in women have been chosen. These early stage, 
first occurrences protect against artefactual results due to secondary changes 
in life-style and exposure status. Moreover, both diseases are major 
contributors to morbidity and mortality in industrialized countries. The 
concentration of fat-soluble vitamins in adipose tissue and selenium in 
toenails is used as an indication of long-term dietary intake of these antioxi-
dants. A common protocol, including identical case definition, standardized 
sampling and handling procedures and centralized laboratory analyses, is 
being used. 
Subjects 
Each of the participating study centres agreed to enrol 100 cases and an equal 
number of controls for the myocardial infarction and/or the breast cancer part 
of EURAMIC. Cases for the cardiovascular endpoint are defined as male 
subjects aged under 70 years, with diagnosis of first acute myocardial 
infarction (ICD-code 410), confirmed by specific abnormalities on the ECG, 
with elevated enzyme levels, who are admitted to hospital within 24 hours 
after beginning of symptoms. Breast cancer cases are defined as female 
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subjects aged 50-75 years, with first diagnosis of breast cancer (ICD-code 
174), histologically classified as ductal carcinoma, with primary tumors less 
than 5 cm, axillary lymphe nodes stage ss N3, without any clinical indication 
of distant metastases at discharge. Cases are recruited from the Coronary 
Care Units and Surgical Units of participating hospitals. Informed consent is 
obtained in accordance with the ethical standards of the responsible 
committees on human experimentation. Controls are drawn to represent the 
exposure levels in the population giving rise to cases. The actual way in 
which controls are recruited differs between participating centres (Table 1). 
However, sufficient care is taken that differential exposure-related selection 
between cases and controls is being avoided. The sampling of controls is 
frequency-matched for age (5-year interval). The inclusion criteria applying to 
both cases and controls are listed in Table 2. 
Table 1. Source populations for control recruitment. 
Centre study population 
AMI BC 
Berlin AMI BC population register 
Coleraine BC via general practitioners 
Edinburgh AMI Health Board Register 
Granada AMI BC hospital controls 
Helsinki AMI population register 
Jerusalem AMI population register 
Malaga AMI BC hospital controls 
Moscow AMI hospital controls 
Sarpsborg AMI blooddonors 
Zeist AMI BC via general practitioner of case 
Zurich AMI BC population register 
Biomarkers of exposure 
Contrary to most studies so far, in which short or intermediate-term 
biomarkers (plasma concentration mainly) of antioxidant status have been 
determined, in this study biomarkers of long-term status were chosen. These 
biomarkers are believed to be an integrated measure of exposure over months 
rather than days. Tangney et al. 3 9 showed that large intraindividual day-to-day 
variations in diet and plasma vitamin E and |3-carotene can constitute an 
important source of error in classifying subjects according to exposure. 
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Several independent measurements are required to distinguish even large 
differences between individuals. About 90% of vitamin E is contained in 
adipose tissue40. Schäfer & Overvad41 showed that adipose tissue vitamin E is 
strongly associated with dietary intake (r = 0.76); these data support the use 
of adipose tissue vitamin E as a long-term measure of nutrition status. 
Table 2. Inclusion criteria for cases and controls. 
Acute Myocardial Infarction Breast Cancer 
men women 
< 70 year 50-74 year 
postmenopausal 
no anamnesis of previous MI no anamnesis of previous BC 
Belonging to the indigenous population of the country 
and speaking the national language 
During the past year no changes in the use of dietary 
supplements containing either one or more 
of the studied antioxidants 
No new/altered dietary prescription by GP in the past year 
No weight loss over 5 kg in the past year 
No anamnesis with treatment for alcohol or drug abuse 
No major diagnosed psychiatric disorder 
No institutionalization 
For P-carotene the relation between diet and adipose tissue concentration has 
not yet been studied. However, it is known that adipose tissue and liver are 
the quantitatively most important sites of deposition of carotenoids, and the 
relative concentrations of the different carotenoids in adipose tissue are quite 
similar to those in plasma. It may be postulated that adipose tissue carotenoid 
levels reflect long-term intake, as has been shown for fatty acid 
composition42. Another reason not to use plasma levels is that the acute 
myocardial infarction event will influence antioxidant plasma levels43, thereby 
precluding the feasibility of control comparison. Selenium exposure will be 
determined as the concentration in toenail clippings, which can time-integrate 
dietary exposure over intervals ranging from several weeks to 12 months44. 
The sampling procedures have been standardized. Toenail clippings from all 
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toes (giving an integrated measure of exposure to selenium), after cleaning 
and removing nail polish, are collected within eight weeks of diagnosis or 
surgery. This will be done either in hospital, or by the subjects themselves at 
home. The nails are stored in a small plastic bag at room temperature. 
Subcutaneous adipose tissue (20-50 mg) is taken from the buttock by needle 
aspiration as described elsewhere45. The adipose sample will be taken within 
four days after diagnosis for myocardial infarction, and within one week after 
surgery for breast cancer. Samples are immediately put on dry ice or in liquid 
nitrogen, and subsequently stored at -40°C or -80°C. To assist in acquiring 
the appropriate skills for sampling, and to assure standardized procedures, a 
videotape showing the technique was distributed to all participating centres. 
Background variables 
Information on socio-economic status, familial history, smoking habits, 
alcohol intake, and anthropometric measures is collected for all subjects. In 
addition, information on angina pectoris, diabetes, blood pressure, serum total 
and HDL cholesterol and triglycerides in both AMI patients and their controls 
is required. Time of diagnosis of diabetes and onset of angina are also taken 
into account, to control for information bias due to differential diagnosis for 
cases and controls. These data are assessed by questionnaire; cholesterol 
levels are determined in serum, prepared from a blood sample taken as soon 
as possible after hospital admission, but no later than 24 hours after start of 
symptoms. For the breast cancer study, age at menarche, age at pregnancies, 
parity, use of oral contraceptives, age at menopause and type of menopause 
are assessed. Finally, the fatty acid composition of adipose tissue will also be 
determined. The intake of vitamin E is positively associated with the intake 
of linoleic acid, while linoleic acid in adipose tissue is inversely related to the 
risk of MI 4 6. Thus linoleic acid intake is a potential confounder of the 
association between vitamin E and the disease endpoints. Furthermore, 
Schäfer & Overvad41 showed that the content of n-3 fatty acids in adipose 
tissue influences adipose tissue vitamin E negatively. 
Laboratory analysis 
Crucial for the quality of the data is central analysis for the determination of 
the antioxidant vitamins and fatty acid composition in adipose, for selenium 
in toenails and cholesterol in serum. Concentrations of ß-carotene, lycopene 
and single tocopherols in adipose tissue will be determined by reverse-phase 
HPLC 4 7 , 4 8. Quality control is assured by analysing reference samples in each 
run and evaluating the within and between run analytical variation. Equal 
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numbers of samples from cases and controls will be analysed in each run. 
Storage and transport conditions will be monitored by analysis of pooled 
adipose tissue samples with known vitamin content, stored with the actual 
samples in each participating centre. The concentration of the vitamins is 
expressed on the basis of fatty acids, which are assessed by GLC 4 9 ' 5 0 in an 
aliquot of the same extract. Toenail selenium is determined by Neutron 
Activation Analysis at the Interfaculty Reactor Institute in Delft, 
Netherlands51. References for quality control will be included in the analysis. 
Enzymatic methods are used for the determination of serum cholesterol and 
triglyceride levels at the National Public Health Institute in Helsinki 
(Finland). HDL-cholesterol is assayed after precipitation of VLDL and LDL 
by dextran sulphate and MgC12. 
Data analysis 
In a study population of 100 cases and an equal number of controls, the 
power (at a = 0.05, two-sided) to detect a twofold increased relative odds 
when comparing the lowest and highest quartile of exposure will be about 
40% only, while a threefold increased risk can be detected with a power of 
73% (Table 3;5 2). Thus, while moderate associations can be detected by 
individual centres, pooling of data from all study centres provides sufficient 
power to detect weaker associations (Table 3) and an opportunity to take 
multiple variables into account. These power calculations are based on 
comparisons of subjects in the extreme quartiles of antioxidant status within a 
single population. These estimations of the power may be too conservative, if 
a trend over all quartiles may be demonstrated. On the other hand, the 
estimate may be too optimistic, since covariates and potential confounders 
and effect modifiers have not been taken into account. 
Table 3. Power of a case-control study in relation to study size and strength of 
association. 
Power to detect 
# cases # controls OR = 1.5 OR = 2 OR = 3 
100 100 17% 40% 73% 
200 200 29% 68% 95% 
600 600 69% 99% -100% 
1000 1000 89% 99% -100% 
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Each participating centre will analyse its own dataset. A pooled analysis, 
stratifying not only by confounders and interaction terms, but also by centre, 
will be performed by the coordinating centre. Mean levels of antioxidants 
among cases and controls will be compared for both disease endpoints. Risk 
analyses will be performed by calculating the relative odds of the disease 
endpoints for different categories and combinations of the antioxidants, using 
stratified analysis to identify potential confounders and/or effect modifiers. A 
model of relative risk will be constructed taking into account factors shown 
to confound the potential relationship between antioxidant status and disease 
outcome in the study population, using multiple logistic regression analysis. 
Heterogeneity of associations between study centres will be assessed and 
related to the differential prevalence of other disease risk factors between 
countries. 
Discussion 
Much of the recent experimental interest in antioxidants and cardiovascular 
disease has been focused on their role in the prevention of LDL oxidation 
and subsequent formation of foam cells and fatty streaks, early stages of 
atherosclerosis53. However, there is evidence that free radicals could also 
induce thrombogenesis, and that antioxidant vitamins may be beneficial54"56. 
Lipid peroxides may stimulate the production of thromboxane, which has a 
potent vasoactive and platelet aggregation stimulatory activity2 ,57. On the 
other hand, prostacyclin production is inhibited58, which may result in 
unopposed activity of thromboxane and thus increased vasoconstriction, 
platelet aggregation and thrombus formation. These mechanisms may be 
important in later stages of atherosclerosis and in ischaemic heart disease. 
Antioxidant vitamins thus may act at the early as well as the late stages of 
CVD. The endpoint chosen in this study, acute myocardial infarction, allows 
a clear definition of cases and controls and minimizes the effect of lifestyle 
changes due to a longer history of cardiac complaints. It should be clear that 
this design does not enable to distinguish the effects on atherogenesis and 
thrombogenesis. 
Breast cancer, the endpoint chosen for malignant disease, is a 
diet-related type of cancer; attention has been focused on the role of dietary 
fat. Since antioxidant nutrients, especially P-carotene, have been shown to 
affect cancers at other sites (e.g. lung cancer), it is of particular interest to 
study these nutrients in relation to breast cancer, the major cause of death in 
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women in industrialized countries. It should be realised, however, that only 
effects in the later stages of the malignancy may be detected. Because only 
recently diagnosed cases will be included, secondary changes in life-style and 
exposure status will be avoided as much as possible. 
A multi-centre study, carried out in different countries, has unique 
advantages. We can expect a larger range of exposure to antioxidant vitamins 
and selenium, because of major differences in food consumption. By pooling 
the data from participating centres, smaller samples per centre still allow to 
detect weak associations with sufficient statistical power. This increases the 
cost-effectiveness of the local studies. Simultaneous data collection in many 
centres also makes it possible to recruit the required number of cases and 
controls in a relatively short period. The problem of reliable assessment of 
nutrient intake has been avoided by the use of biomarkers, which also takes 
into account the biological variability in absorption and metabolism. 
Systematic variation in data collection and biomarker analysis between 
centres could severely limit the results of a multi-centre study. Therefore, 
considerable effort was directed to the standardisation of clinical and 
analytical procedures. 
Prospective studies, in which the individual exposure to antioxidant 
nutrients can be related to disease incidence, will provide valuable 
information in due time59"61. However, since relatively large populations are 
needed and the induction time of the diseases of interest is relatively long, 
these studies take years to complete and are very costly. The EURAMic Study 
will provide data on the combined effect of tocopherols, carotenoids and 
selenium on manifestations of cardiovascular disease and cancer, within a 
relatively short period of time. It may present valuable information for the 
design of future intervention studies and support evaluations of dietary 
guidelines. 
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Abstract 
Laboratory and epidemiological studies suggest that the antioxidants, vitamin E 
and |3-carotene, protect against coronary heart disease. In a European multi-
centre case-control study a-tocopherol and p-carotene concentrations were 
measured in adipose tissue samples collected in 1991-1992 from 683 people 
with acute myocardial infarction and 727 controls. 
Mean adipose tissue P-carotene concentration was 0.35 jug/g in cases and 
0.42 jug/g in controls, with age-adjusted and centre-adjusted mean difference 
0.07 jug/g (95% confidence interval [CI] 0.04-0.10). Mean a-tocopherol 
concentrations were 193 /ug/g and 192 ftg/g for cases and controls, respectively. 
The age- and centre-adjusted odds ratio for risk of myocardial infarction in the 
lowest quintile of p-carotene as compared with the highest was 2.62 (95% CI 
1.79-3.83). Additional control for body mass index and smoking reduced the 
odds ratio to 1.78 (95% CI 1.17-2.71); other established risk factors did not 
substantially alter this ratio. The increased risk was mainly confined to current 
smokers: the multivariate odds ratio in the lowest p-carotene quintile in smokers 
was 2.39 (95% CI 1.35-4.25), whereas it was 1.07 for people who had never 
smoked. A low a-tocopherol concentration was not associated with risk of 
myocardial infarction. 
Our results support the hypothesis that high p-carotene concentrations within 
the normal range reduce the risk of a first myocardial infarction. The findings 
for a-tocopherol are compatible with previous observations of reduced risk 
among vitamin E supplement users only. The consumption of p-carotene-rich 
Lancet 1993;342:1379-1384 
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foods such as carrots and green-leaf vegetables may reduce the risk of 
myocardial infarction. 
Introduction 
Oxidation of low-density lipoprotein (LDL) particles may play a part in the 
formation of foam cells, atherosclerotic lesions, and coronary heart disease 
(CHD)1 , 2. Evidence first came from pharmacological studies in animals, in which 
large amounts of antioxidants such as probucol, butylated hydroxytoluene3, or 
a-tocopherol inhibited lesion formation or caused the regression of 
atherosclerotic plaques4. 
The importance of antioxidant vitamins is the possible protection they 
provide against CHD. The most important antioxidant vitamins are a-tocopherol 
(the most active and most abundant form of vitamin E) and B-carotene (pro-
vitamin A). Large prospective diet studies have recently shown decreased risk 
of CHD at high intakes of vitamin E in men5 and in women6. In Scotland, 
plasma vitamin E was found to be lower in newly-diagnosed angina than in 
controls7. However, prospective studies of the association between low 
a-tocopherol and CHD do not support causation8,9. An inverse association of 
6-carotene intake with CHD risk among current and former smokers has been 
observed5, and serum B-carotene concentrations were found prospectively to be 
inversely associated with myocardial infarction10 and ischaemic heart disease 
mortality11. Moreover, preliminary findings in patients with stable angina 
suggests that B-carotene supplements may reduce the risk of cardiovascular 
complications12. 
We studied the relation between a-tocopherol, B-carotene, and first acute 
myocardial infarction (MI) in a multi-centre case-control study in men aged 
35-70. In order to obtain a time-integrated measure, antioxidant vitamin 
concentrations were measured in adipose tissue. 
Methods 
Design and subjects 
Ten centres collaborated (Table 1). The study^ design has been described 
elsewhere13. Eligible subjects were men < 70 years, native residents, speaking 
the predominant or official local language, and without previously-reported MI. 
They had to have stable dietary patterns in the past year: no changes in the use 
of dietary supplements containing a-tocopherol, B-carotene, or selenium; no new 
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or altered dietary prescription or advice from a physician, except changes to 
low-sodium or energy-restricted diets; and no weight loss > 5 kg in the past 
year. 
Cases were subjects recruited from the coronary care unit of participating 
hospitals with a first acute MI (ICD-code 410) - confirmed by specific 
abnormalities on the electrocardiogram (ECG) and elevated enzyme levels - and 
admitted within 24 hours of symptoms. 
Subjects without a history of MI were recruited as controls from the 
population in the catchment area, frequency-matched for age according to 5-year 
intervals. Whenever possible, random samples from local population registries 
were used (Finland, Israel, Germany, Scotland, Switzerland). In some centres 
(Russia, Spain) population registries could not be used because of incomplete 
coverage or legal restrictions, so hospital controls were selected, with diseases 
not known to be associated with antioxidant status (renal colic, non-infectious 
prostatism, acute appendicitis, non-infectious ear disease, hernia, volvulus, rectal 
or anal disease except cancer, hemorrhoids, or chronic infection). Where it was 
thought that low response rates from population based samples would spoil the 
internal validity, controls were selected from the catchment area via a random 
sample by the patient's general practitioner (Netherlands) or by inviting friends 
and relatives of the case (Norway). In the Netherlands, Spain, and Russia, 
methods of subject recruitment were combined. Table 1 shows response rates of 
patients and controls between centres. Informed consent was obtained in 
accordance with the ethical standards of the responsible committees. 
Subjects on antioxidant supplements or prescribed diets for more than one 
year were included. Subjects with a history of treatment for alcohol or drug 
abuse, psychiatric disorders that would interfere with their ability to give 
informed consent, and institutionalized subjects were excluded. 
Information on smoking habits, blood pressure, angina pectoris, and diabetes 
was collected for all subjects by standard questionnaires14. Socio-economic 
status, family history, and alcohol intake were assessed through locally-
developed questionnaires. 
Adipose tissue and blood sampling 
Subcutaneous adipose tissue was taken from the buttock by needle aspiration15. 
To standardise sampling, a videotape showing the technique was distributed to 
all centres. In cases, the adipose sample was taken within seven days of hospital 
admission. Samples were kept in the plastic adaptor, immediately placed on dry 
ice or in liquid nitrogen, and stored at -70°C. On average 29 mg (SD 16) 
material was obtained containing 19 mg (11) fatty acids. 
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Table 1. Population response rate and method of control recruitment. 
Centre Cases Controls Method of control 
(response %) (response %) recruitment1' 
Finland (Helsinki) 62 (97) 61 (51) PR 
Germany (Berlin) 77 (82) 97 (73) PR 
Israel (Jerusalem) 59 (60) 60 (53) PR 
Netherlands (Zeist) 72 (75) 63 (50) GP, PR 
Norway (Sarpsborg) 101 (96) 102 (98) FR 
Russia (Moscow) 100 (97) 100 (79) GP, H 
Scotland (Edinburgh) 58 (98) 43 (61) PR 
Spain (Granada) 57 (45) 54 (67) H 
Spain (Malaga) 100 (89) 102 (77) H, GP 
Switzerland (Zurich) 57 (93) 74 (26) PR 
PR = population register; GP = general practitioners; H = hospital controls; FR = friends, 
relatives. 
Vitamin concentrations were not associated with the time between infarction and 
biopsy (Pearson r < 0.05) or with storage time before analysis (r = 0.02 for 
P-carotene, r = -0.04 for a-tocopherol). 
A non-fasting blood sample was drawn not later than 24 hours after onset 
of symptoms. Time between onset of symptoms and blood sampling was 
recorded. Pool samples were stored with study samples. In cases, cholesterol 
concentrations were inversely related to time from onset of symptoms (5.8 
mmol/1 at 2 hours, 5.2 mmol/1 at 20 hours), probably due to the effect of the 
acute MI on serum cholesterol. 
Laboratory procedures 
Biological samples (except those from Scotland) were analyzed in a central 
laboratory. During the study, samples were transported to the coordinating centre 
on dry ice, at -56°C. Pilot studies showed this did not influence vitamin 
concentrations. To monitor transport and storage conditions, pool samples were 
included in shipments and processed in a similar manner. Samples from cases 
and controls were analyzed blind and simultaneously. 
P-Carotene and a-tocopherol in adipose tissue were determined concurrently 
by reverse-phase high performance liquid chromatography16 and 
spectrophotometric detection. The sample was saponified and quantitatively split 
for vitamin and fatty acid determination. The coefficients of variation for the 
analysis of P-carotene and a-tocopherol were 6.7% and 6.9% (at mean values 
of 2.13 figlg and 84.1 figlg in the quality control samples, respectively). 
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Detection limits were 0.02 fi%l% for B-carotene and 2 ^g/g for a-tocopherol, at 
mean sample weight. Samples from Scotland were analysed in a separate 
laboratory. 16 samples were analysed in both laboratories; the median (25-75% 
range) of a-tocopherol and B-carotene levels were not significantly different by 
paired t-test: 88 (47-137) vs 89 (52-126) and 0.49 (0.21-0.92) vs 0.30 (0.13-
0.39) jMg/g, respectively. 
Concentrations of the vitamins were calculated on the basis of fatty acid 
concentration, which was assessed by gas-liquid chromatography17 in an aliquot 
of the same extract as B-carotene and a-tocopherol, adding nonadecanoic acid 
as an internal standard to the sample before saponification. Vitamin 
concentrations were expressed in fiqjg total fatty acids. 
Serum total and HDL cholesterol were determined enzymatically at the 
National Public Health Institute in Helsinki (Finland). 
Data analysis 
Needle biopsy and questionnaire data were available for 1499 eligible 
subjects. Vitamin results were unavailable for 34 subjects (no adipose tissue 
found). 55 samples with very high (> 130%) or very low (< 30%) fat (weight 
of total fatty acids/total biopsy weight), indicating measurement errors in very 
small samples, were excluded. 
Crude means for major risk factors and potential confounders were 
calculated; linear and logistic regression were used to obtain age- and 
centre-adjusted differences. Mean concentrations of antioxidants in the different 
centres were calculated, and the mean differences and 95% confidence intervals 
(CI), adjusted for age and centre, were estimated by linear regression. 
a-Tocopherol and B-carotene concentrations were log-transformed. Potential 
confounders and/or effect modifiers were identified with stratified analysis. For 
multivariate analysis, multiple logistic regression was used with maximum 
likelihood estimation of the regression coefficients and their standard errors. 
Relative risks were estimated as odds ratios for the lowest quintile as compared 
with the highest, based on the distribution among controls. Tests for trend were 
done by assigning each subject the median value for the category and modelling 
this value as a continuous variable. The fitted model included age, centre, 
smoking, and body mass index (BMI). Cigarette smoking was modelled in 
detail, given its strong association with acute MI in the data and its association 
with B-carotene. Smoking categories included never smokers, ex-smokers, 
pipe/cigar smokers, and current cigarette smokers-the last category further 
divided in subjects smoking < 6, 6-10, 11-20, and > 20 cigarettes per day. 
Finally, interactions between centre and exposure variables and effect 
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modification for smoking categories were examined. Data analysis was repeated 
without the Scottish samples, and because results were similar, these data were 
included in all analyses. 
Results 
Risk factors 
Risk factors for CHD in MI cases and controls are shown in Table 2 and 3. 
Age, serum cholesterol, history of hypertension, smoking, angina pectoris, 
diabetes mellitus, family history for CHD, and BMI differed significantly. The 
lower concentrations of cholesterol in cases almost certainly reflects the 
cholesterol-lowering effect of the MI. Therefore, cholesterol was not further 
considered in the analyses. 
Table 3. Risk factors for myocardial infarction in the EURAMIC Study. 
Risk factor Crude means 
cases 
n = 683 
controls 
n = 727 
Age and centre adjusted 
difference (95% CI) 
Age 54.7 53.3 1.5 (0.6 - 2 .4) 
Serum total cholesterol 5.4 5.6 -0.16 (-0.28 - -0.03) 
(mmol/1) 
History of hypertension (%) 26 17 12 (7 - 17) 
Smoking 
- % current 56 33 29 (24 - 34) 
smokers 
- cigarettes/day 25 18 8 ( 6 - 1 0 ) 
(among smokers) 
Angina pectoris (%) 14 5 6 ( 4 - 7 ) 
Diabetes mellitus (%) 8 4 2.5 (1.5 - 4.0) 
Family history of CHD (%) 57 43 13 (8 - 19) 
Alcohol use (%) 80 82 -1 (-4 - 3) 
BMI (kg/m2) 26.5 26.0 0.5 (0.1 - 0.9) 
Inter-centre variation 
Mean adipose tissue concentrations of a-tocopherol and 6-carotene varied 
between centres (Table 4): Switzerland had the highest a-tocopherol (305 /ug/g) 
and 6-carotene (0.59 fig/g); lowest were found in Israel for a-tocopherol (112 
fig/g) and in Spain for 6-carotene (0.18 ftg/g). 
Table 2. Distribution of cardiovascular risk factors by disease status and study centre: EURAMIC Study. 
study centre Age Total cholesterol Hypertension Current smoking Diabetes (%f Body mass 
(mmol/1) (%) (%) index (kg/m2) 
cases contr cases contr cases contr cases contr cases contr cases contr 
Finland (Helsinki) 52.8 53.7 5.1 5.8 23 10 65 25 13 3 27.1 26.7 
Germany (Berlin) 56.9 52.8 5.5 6.0 34 23 51 38 15 6 26.8 25.6 
Israel (Jerusalem) 54.8 54.0 4.9 5.2 22 10 51 36 10 9 26.0 26.1 
Netherlands (Zeist) 53.5 52.0 5.7 5.7 15 11 53 41 5 2 26.1 25.3 
Norway (Sarpsborg) 55.3 55.5 5.8 6.3 29 13 58 23 7 1 26.0 25.0 
Russia (Moscow) 54.0 47.8 5.6 5.1 37 38 60 39 3 2 26.2 26.0 
Scotland (Edinburgh) 54.6 55.0 6.8' 6.5' 7 5 48 26 0 § 0 s 26.8 26.2 
Spain (Granada) 54.5 55.0 5.2 5.2 31 9 77 52 8 0 26.1 26.3 
Spain (Malaga) 54.6 55.2 5.3 5.2 25 16 74 33 10 6 27.6 27.3 
Switzerland (Zurich) 56.3 53.5 5.6 5.5 33 18 38 21 8 4 26.4 25.9 
Diagnosed at least 6 months before myocardial infarction. 
Contr.: control subjects. 
Samples were not analyzed in central laboratory. 
Subjects with diabetes were excluded in this centre. 
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The overall mean concentrations for cases and controls (adjusted for age and 
centre, transformed back from the log values) were 193 figlg and 192 ^g/g 
respectively for a-tocopherol and 0.35 and 0.42 respectively for 6-carotene. 
Concentrations of a-tocopherol and 6-carotene were correlated (r = 0.24 in cases 
and 0.37 in controls). 
Table 4. Mean adipose tissue concentrations of a-tocopherol and ^-carotene, by study 
centre. 
Number of a-tocopherolt P-carotene+ 
cases controls cases controls cases controls 
Finland (Helsinki) 60 60 217 165 0.46 0.53 
Germany (Berlin) 67 96 195 204 0.46 0.45 
Israel (Jerusalem) 51 59 173 112 0.32 0.29 
Netherlands (Zeist) 60 54 201 194 0.42 0.58 
Norway (Sarpsborg) 96 95 145 188 0.37 0.58 
Russia (Moscow) 92 95 210 240 0.45 0.56 
Scotland (Edinburgh)* 58 42 135 181 0.37 0.49 
Spain (Granada) 52 54 192 194 0.23 0.31 
Spain (Malaga) 95 100 202 166 0.18 0.19 
Switzerland (Zurich) 52 72 290 305 0.44 0.59 
Overall mean11 193 192 0.35 0.42 
Mean difference11 (95% CI) 1 (-12 - 14) -0.07 (-0.10~0.04) 
Calculated from log. transformed values, in ^g/gram fatty acids. 
Samples were not analyzed in central laboratory. 
Adjusted for age and centre. 
Vitamins and risk factors 
We examined the relation between adipose tissue vitamin concentrations and 
CHD risk factors in the controls. For 6-carotene, negative associations were 
observed for the number of cigarettes smoked per day (r = -0.15, p < 0.05) and 
for BMI (r = -0.35, p < 0.001). Subjects with a positive family history of CHD 
had significantly higher 6-carotene (p = 0.009). p-carotene was not associated 
with serum total cholesterol (r = 0.010, p = 0.8), but positively associated with 
HDL cholesterol (r = 0.275, p < 0.001). 
a-Tocopherol concentration was also negatively associated with BMI 
(r = -0.12, p = 0.001) and with number of cigarettes smoked per day (r = -0.13, 
p = 0.053). There were no significant correlations with age, serum cholesterol, 
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alcohol use, angina pectoris, diabetes, history of hypertension, or family history 
of CHD. 
Vitamins and MI 
To assess the risk of MI for low vitamin concentrations, a logistic regression 
model was fitted, including age, centre, smoking, and BMI. The odds ratios for 
MI, relative to the highest quintile of the distribution of adipose tissue vitamin 
concentrations in controls, are shown in Table 5. 
Table 5. Odds ratio of acute myocardial infarction, according to quintiles of adipose 
tissue a-tocopherol and ^-carotene. 
Number of Age & centre Multivariate1' 
adjusted 
Quintiles (Mg/g)median cases controls OR 95% CI OR 95% CI 
a-tocopherol 
1 < 127 (103) 136 145 0.92 (0.65-1.33) 0.83 (0.57-1.21) 
2 127-175 (149) 132 146 0.93 (0.66-1.31) 0.88 (0.61-1.28) 
3 175-229 (198) 136 145 0.99 (0.70-1.39) 1.01 (0.70-1.46) 
4 229-303 (253) 144 145 1.07 (0.76-1.49) 1.12 (0.78-1.60) 
5 > 303 (385) 135 146 1.00 1.00 
X2 trend (p-value) 0.35 (0.55) 1.21 (0.27) 
Continuous OR* 1.00 (0.78-1.27) 0.88 (0.67-1.13) 
|3-carotene 
1 < 0.21 (0.15) 177 145 2.62 (1.79-3.83) 1.78 (1.17-2.71) 
2 0.21-0.37 (0.30) 184 146 2.48 (1.73-3.55) 1.79 (1.21-2.64) 
3 0.37-0.53 (0.45) 124 145 1.66 (1.15-2.41) 1.40 (0.94-2.10) 
4 0.53-0.82 (0.65) 119 145 1.49 (1.03-2.16) 1.27 (0.85-1.88) 
5 > 0.82 (1.11) 79 146 1.00 1.00 
X2 trend (p-value) 32.56 (< 0.0001) 10.72 (0.001) 
Continuous OR* 1.99 (1.50-2.65) 1.48 (1.09-2.03) 
f Adjusted for age, centre, smoking, and BMI. 
$ Odds ratio of MI at 10th percentile level of antioxidant, compared to 90th percentile level. 
For a-tocopherol no association with MI was observed. The age- and 
centre-adjusted odds ratio (OR) in the lowest quintile of the 6-carotene 
distribution was 2.62 (95% CI 1.79-3.83, p for trend < 0.0001). After additional 
adjustment for smoking and BMI, the OR was 1.78 (95% CI 1.17-2.71; p for 
trend = 0.001). Adjustment for other CHD risk factors (including HDL 
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cholesterol) had only marginal effects on the estimate of the odds ratios. 
Including 6-carotene concentration as a continuous variable, the OR for a 
contrast of the 10% point of distribution of 6-carotene compared to the 90% 
point, was 1.48 (1.09-2.03). This OR ranged from 0.57 (0.21-1.59) in Israel to 
5.07 (1.81-14.23) in Norway; in 7 of the 10 centres, there was an increased risk 
of MI at low 6-carotene concentrations. 
The odds ratios for MI at quintiles of 6-carotene, (Table 5) were 
recalculated for different subgroups of centres, according to type of control 
selection. When centres with hospital controls (Spain, Granada, and Malaga; 
Russia) or centres using mixed methods of control recruitment (Netherlands; 
Spain, Malaga; Russia) were excluded, odds ratios were similar. When type of 
control selection was included in the logistic regression model the interaction 
terms for these models were not statistically significant. 
Table 6. Odds ratiof of myocardial infarction, according to quintiles of adipose tissue 
^-carotene and smoking category. 
Quintile* Never smokers Ex-smokers Cigarette smokers 
(n = 83/200)11 (n = 116/187) (n = 435/272) 
OR (95% CI) OR (95% CI) OR (95% CI) 
1 1.07 (0.44-2.57) 1.81 (0.81-4.06) 2.39 (1.35-4.25) 
2 1.55 (0.67-3.58) 1.62 (0.74-3.55) 2.40 (1.38-4.17) 
3 0.87 (0.40-1.90) 1.10 (0.50-2.43) 1.75 (0.97-3.17) 
4 0.79 (0.36-1.70) 0.76 (0.32-1.84) 2.30 -, 4.15) 
5 1.00 1.00 1.00 
Continuous OR§ 0.98 (0.52-1.87) 1.42 (0.77-2.61) 1.67 (1.12-2.49) 
Adjusted for age, centre, BMI. 
Quintile cutpoints as in table 5. 
Number of cases/controls. 
OR of MI at 10th percentile level compared to 90th percentile level of P-carotene. 
The lower relative risk after adjustment is largely due to the effect of 
smoking. Mean 6-carotene concentrations in smokers differ between categories 
of smoking. In subjects who never smoked, 6-carotene was significantly higher 
(0.49 fig/g) than in ex-smokers (0.41 fig/g) or heavy current smokers (0.37 jug/g). 
The interaction between smoking behaviour and 6-carotene status was analyzed. 
The odds ratio of MI, at quintiles of the 6-carotene distribution compared to the 
highest, is given for different categories of smoking behaviour (Table 6). In 
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current smokers the risk for MI is higher at low B-carotene concentrations 
(OR 2.39; 95% CI 1.35-4.25). For ex-smokers the increased risk is smaller 
(OR 1.81) and non significant. Never-smokers seem to have no elevated risk of 
MI at low B-carotene status (OR 1.07). The Figure gives the risk of MI in the 
quintiles of the B-carotene distribution, but also takes into account the higher 
risk by smoking (OR for former smokers as compared to never smokers was 
1.22, whereas it was 2.34 for current smokers, in the highest B-carotene 
quintile). 
Inclusion of a-tocopherol as a continuous covariable in the multivariate 
model strengthened the inverse association with MI for B-carotene; the OR in 
the lowest quintile was 1.99 (1.29-3.07). The association between p-carotene and 
MI was also examined multivariately in tertiles of a-tocopherol. The continuous 
OR for B-carotene (10% point vs 90% of distribution) at the lowest a-tocopherol 
tertile was 1.09 (95% CI 0.67-1.77); at the highest tocopherol tertile the OR for 
P-carotene was 2.28 (1.36-3.84). The risk at a-tocopherol concentrations in 
between was 1.86 (1.05-3.28). 
o.o 
Q1 (low) Q3 Q4 Q5 (high) 
Quintile for adipose tissue B-carotene 
* never smokers • ex-smokers • current smokers 
' The risk in the highest B-carotene quintile, in the category never smokers, has been taken 
as single reference value. 
Figure 1. Odds ratio1 of MI, according to quintiles of ji-carotene and smoking category. 
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Discussion 
Our results, based on adipose tissue concentrations in 1410 subjects, are 
consistent with the suggested protective effect of high P-carotene concentrations 
against acute MI, whereas high - but within the normal range - a-tocopherol 
concentrations were not protective. Increased risk of MI at low adipose tissue 
p-carotene levels, was most pronounced in current smokers. This is consistent 
with data indicating higher oxidative stress due to smoking2 6'2 7, which may 
require relatively higher antioxidant concentrations for adequate protection. 
a-Tocopherol seemed to modify the effect of P-carotene; at high tocopherol 
levels, the inverse association of P-carotene with MI was strongest. 
Control recruitment 
This study, in 9 countries with substantially different diets, used several methods 
of control recruitment. Five centres used random samples of population 
registries, and others hospital controls for whom the diagnosis, according to 
current knowledge, was not related to antioxidant status. If, however, a control 
disease was related to antioxidants, it is most likely to have reduced anti-
oxidants, and thus diminish the risk estimates for MI. To minimize potential bias 
if any one disease was related to exposure, controls were chosen with a variety 
of diseases. The use of friend or relative controls may lead to overmatching on 
lifestyle exposures; but this would also result in a decreased estimation of 
association between antioxidants and MI. Exclusion of centres using hospital 
controls or mixed methods of control recruitment did not affect the strength of 
association. Moreover, risk factors - cigarette smoking, hypertension and 
diabetes - were consistently more prevalent in acute MI cases than controls, 
which provides support for the overall validity of the case-control comparison. 
Sample analysis 
Standardized procedures were applied in each centre for the collection of 
questionnaire data and biological materials. Freezer problems were reported in 
two centres. In Israel (Jerusalem) the temperature increased to -17°C once, and 
one shipment from Spain, Granada reached the central laboratory thawed. 
However, to prevent differential misclassification of exposure, samples from 
cases and controls were stored in the same freezer and shipped in the same 
container. Moreover, the adipose tissue pool samples that were stored and 
shipped with the study samples had vitamin concentrations similar to other pool 
samples. 
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Vitamin and diet 
Adipose tissue vitamin concentrations were chosen to represent long-term 
antioxidant status. Adipose tissue and liver are the most important sites of 
deposition of carotenoids; the relative concentration of different carotenoids in 
adipose tissue is similar to that in plasma, and an effect of high dose 
supplementation on adipose tissue concentrations has been observed19. For 
a-tocopherol, almost 90% of the body pool is concentrated in adipose tissue20. 
In a small experiment, adipose tissue a-tocopherol concentration showed a 
correlation both with dietary intake (r = 0.56) and plasma concentrations 
(r = 0.59) of a-tocopherol21. This suggests that adipose tissue B-carotene and 
a-tocopherol concentrations probably reflect long-term dietary intake. 
Variation between centres 
Concentrations varied between centres, as expected. Notable are the lower 
concentrations, especially of B-carotene, in Jerusalem and both Spanish centres, 
which is not in agreement with plasma concentrations reported for several 
European countries22. Furthermore, the relative odds of MI at low B-carotene 
status was not the same in different centres. The highest OR was found in 
Norway, and the lowest in Israel. Centres with low mean B-carotene levels seem 
to have the lowest relative risk (Jerusalem, Malaga). Although within-centre 
sample sizes were relatively small and chance effects could play a part, these 
findings might be explained by smoking, drinking, or dietary intake affecting 
antioxidant requirements, and resulting in altered adipose tissue antioxidant 
concentrations. Similarly, the unexpected finding of a stronger association 
between B-carotene and MI at high a-tocopherol concentrations might also be 
attributed to these country-specific exposure characteristics rather than to 
a-tocopherol as such. 
Previous studies 
Recent reports from prospective studies5'6 support the protective role of food 
antioxidants. Women in the highest quintile of vitamin E intake had a relative 
risk of CHD of 0.66 (95% CI 0.50-0.87), after adjustment for age and smoking6; 
a benefit mainly found in users of vitamin E supplements (moderately high 
levels of dietary intake were not associated with a significant reduction in risk). 
Results were similar for vitamin E intake in men5; supplement users had a 
multivariate relative risk of 0.64 (95% CI 0.49-0.83), In Scotland7 a significant 
relation between plasma vitamin E and angina pectoris was observed in a 
case-control study. Although an inverse association has been reported between 
plasma cholesterol-standardized vitamin E concentrations and age-specific CHD 
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mortality in 16 European countries2 2 , 2 3, Gey et a l . n did not find an association 
of plasma vitamin E with the risk, of cardiovascular disease in a 12-year 
follow-up study. Two nested case-control studies in the Netherlands and 
Finland8,9, also found no association between baseline vitamin E in frozen serum 
samples and cardiovascular disease mortality. The lack of association between 
a-tocopherol and risk of MI in the present study is compatible with the finding 
that such an association may be present only in supplement users5 , 6. 
The part played by carotene was also addressed in the US Health 
Professionals Study6. Carotene intake was not associated with a lower risk of 
CHD among those who never smoked, but among current smokers and former 
smokers, the relative risk in the highest quintile was decreased (current: OR 0.30 
(0.11-0.82); former: OR 0.60 (0.38-0.94)). In a prospective cohort study24, the 
age- and sex-adjusted relative risk of CHD at the highest quintile of intake of 
B-carotene-rich fruits and vegetables was 0.54 (95% CI 0.34-0.87; 
p trend = 0.044). Recently, it has been shown that low concentrations of plasma 
6-carotene and a-carotene (< 0.23 jumol/l) are associated with a significantly 
higher relative risk of CHD mortality, after adjustment for age and classical risk 
factors, as well as other antioxidant variables (RR 1.53, 95% CI 1.07-2.20)11. 
Street et al. 1 0 reported a protective association of 6-carotene with myocardial 
infarction. Preliminary results from a B-carotene intervention study1 2 showed a 
significant reduction of vascular events in the intervention group. Our findings 
for 6-carotene are therefore also consistent with the available evidence, 
including those testing for effect modification by smoking. Although this type 
of study does not provide direct proof of a cause and effect relationship, the 
results are supported by experimental evidence. 
Protective actions of antioxidants 
Oral supplements with a-tocopherol protect low-density lipoproteins against 
oxidation in vitro2 5; although for 6-carotene comparable studies have yielded 
conflicting results2 5'2 6. It is, however, possible that 6-carotene is the more 
important in vivo. 6-Carotene is an efficient quencher of singlet oxygen and a 
radical trapping antioxidant27, and differs from the chain-breaking antioxidant 
a-tocopherol, in being more effective at low 0 2 pressure, as may be found in the 
tissues28. Short-term, high-dose B-carotene supplements have been reported to 
lead to an increase in serum high-density lipoproteins, which affects 
cardiovascular risk. In this study we also found an association between 
B-carotene in adipose tissue and serum HDL-cholesterol, but it did not explain 
the association with MI. B-Carotene may have other biological functions, 
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possibly related to its pro-vitamin A activity, or perhaps via the immune 
system30, which affect atherogenesis or thrombosis. 
Our finding of an inverse association of adipose tissue ß-carotene, derived 
from normal dietary intake, with acute MI, supports the hypothesis that 
antioxidants protect against CHD. The lack of association for a-tocopherol raises 
interest in possible alternative mechanisms for ß-carotene. The results suggest 
that the consumption of ß-carotene-rich foods, such as carrots and green leafy 
vegetables, may reduce the risk of myocardial infarction in men. 
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Letter to the Editor 
Sir-The EURAMIC study (Dec 4, p 1379) attempts to shed light on a potential 
protective role for antioxidant vitamins against myocardial infarction (MI). The 
study draws on cases and controls sampled in several populations with varying 
adipose tissue concentrations of 6-carotene and a-tocopherol. The results are 
therefore potentially important. Unfortunately, the argument falls short of 
precision in places. 
The cases were recruited from coronary care units up to 24 hours after 
onset of symptoms of ML In view of the consistently high out-of-hospital case-
fatality rate for MI 1 the EURAMIC study was of survivors rather than of all cases 
of Ml. Unless an identical pathogenesis and no relation between vitamin status 
and early prognosis after acute MI are assumed, this point should have been 
explicitly addressed. The selection of controls seems to be a weakness too. Some 
of the control groups in EURAMIC deviate considerably in their vitamin 
concentrations and in established risk factors from standardised international 
population estimates2'3; this leads to striking differences between cases and 
controls. The vitamin quintiles may be based on controls who are unusually 
healthy selections from the populations studied, and this may have resulted in 
overestimations of vitamin-associated MI risks. The most prominent finding is 
a strong inverse relation of 6-carotene with MI risk, which is modified by 
smoking, the effect being strongest in current smokers. No further analyses are 
presented on the impact of the number of cigarettes smoked. It may be that 
some of this presumed effect of 6-carotene in current smokers is due to residual 
confounding. There was a strong inverse relation between 6-carotene and 
smoking in this and other4 studies; current smokers with low vitamin 
concentrations are expected to be predominantly heavy smokers, whereas light 
smokers are likely to have the higher vitamin concentrations. Likewise, the 
observed lesser risk gradient in ex-smokers could be accounted for by 
misclassifications (e.g., still smoking occasionally), or short time periods since 
quitting, and thus could also be related to numbers of cigarettes smoked. 
Hans-Werner Hense, Angela Doring 
CVD Epidemiology Unit, GSF-Forschungszentrum, Institut fur Epidemiologic, 
D-85758 Munich-Neuherberg, Germany. 
1 Lowel H, Dobson A, Keil U, et al. Coronary heart disease case fatality in four countries: 
a community study. Circulation 1993;88:2524-2531. 
2 Gey FK, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E 
and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin 
Lancet 1994;343:595-596 (letter to the editor) 
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Nutr 1991;53:326-334. 
3 Keil U, Kuulasma KWHO MONICA Project: risk factors. Int JEpidemiol 1989;18:S46-
S55. 
4 Margetts BM, Jackson AA. Interactions between people's diet and their smoking habits: 
the dietary and nutritional survey of British adults. BMJ 1993;307:1381-1384. 
Authors' reply 
Sir-The cases were survivors of acute MI and direct conclusions should be 
restricted to this group. Might survival be related to the antioxidants under 
study? The significance of free radicals in the process of myocardial injury and 
necrosis of reperfused tissue is recognised and treatment with antioxidants may 
slow down or inhibit these processes1. That would suggest that fatal cases have 
similar or perhaps lower levels of antioxidants than the survivors, so including 
them might have led to stronger associations with low antioxidants status. 
Theoretically, if vitamin E were an important determinant of case fatality, this 
could partly explain the lack of association between vitamin E and MI in our 
study. 
Hense and Döring also ask about selection toward healthier controls, and 
they cite the plasma vitamin concentrations and prevalence of coronary heart 
disease risk factors from the MONICA study2. However, adipose tissue vitamin 
concentrations differ from plasma levels in units, range, and order of magnitude. 
We know of no standard international population estimates for adipose tissue 
levels and cannot tell whether the means in our controls are high or low. The 
ranking of countries according to adipose tissue vitamin levels may differ from 
that for plasma concentrations3. We did discuss the relatively low values in 
Spain and Israel, but lower than expected antioxidant levels do not suggest the 
selection of healthier subjects. 
The prevalence of smoking and hypertension and mean values for body 
mass index (BMI) and serum total cholesterol might be compared between our 
study population and specific MONICA centres. Unfortunately, Norway, the 
Netherlands, the south of Spain, and Israel, countries that contribute half of the 
EURAMIC population, are not represented in MONICA, and for the remaining 
countries regional differences within countries may be as large as between-
country differences, as shown in the MONICA report1. Anyway, we see only 
minor differences for BMI; the prevalence of smoking shows larger differences 
(e.g., for Moscow 46% in MONICA and 39% in our controls). Within-country 
means for EURAMIC are based on only 70 cases and 70 controls per centre, on 
average. The 95% confidence intervals (about ± 10%) are bigger than in MONICA 
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and values from the MONICA study tend to fall well within these intervals. 
Moreover, our population was studied in 1991-1992 whereas most of the 
MONICA data were collected between 1982 and 1986; a real decrease in smoking 
among men may explain lower prevalence figures among EURAMIC controls. A 
direct comparison of the prevalence of risk factors in MONICA and EURAMIC is 
not valid; nor would it support the view that our controls were biased by the 
inclusion of healthier individuals. 
The issue of residual confounding by number of cigarettes smoked in the 
association between B-carotene and MI is important. In our statistical model to 
test whether the association between B-carotene and MI was dependent on 
smoking status, we did not include the number of cigarettes smoked since this 
is a redundant variable for never-smokers. However, we did account for some 
misclassification in ex-smokers by limiting this category to those who had 
stopped smoking at least 2 years before inclusion in the study. We have now 
done separate calculations for smokers and ex-smokers, with adjustment for 
number of cigarettes and maximum number of cigarettes smoked daily before 
stopping smoking, respectively. The 'continuous' odds ratio (OR) is reported 
here, because this is less susceptible to irrelevant fluctuations by small numbers 
in the smoking categories than ORs in quintiles. Among ex-smokers, the OR for 
MI at low versus high B-carotene (10th vs 90th percentile) reported in the paper 
was 1.42 (95% CI 0.77-2.61); the same model, applied to ex-smokers only, gives 
an OR of 1.65 (0.73-3.74). Additional adjustment for number of cigarettes 
changes the OR to 1.61 (0.71-3.66), a 2% decrease. Among current smokers, the 
respective ORs are 1.67 (1.12-2.49), 2.02 (1.23-3.32), and 1.66 (1.00-2.80) (18% 
decrease). These results indicate that some of the increased risk at low 
B-carotene was still due to smoking, but an independent association of 
B-carotene and MI remains. 
Alwine FM Kardinaal, Pieter van ' t Veer, Frans J Kok, for the EURAMIC Study 
Group. 
Epidemiology Section, TNO Nutrition and Food Research and Department of 
Epidemiology and Public Health, Agricultural University. 
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for clinical trial? Ann Intern Med 1989;111:918-931. 
2 Keil U, Kuulasma K. WHO MONICA Project: risk factors. Int J Epidemiol 
1989;18:S46-S55. 
3 Gey FK, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E 
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Interaction between low selenium and vitamin E 
status and risk of acute myocardial infarction: 
the EURAMIC study 
Alwine FM Kardinaal, Frans J Kok, Lenore Kohlmeier, Jose M Martin-
Moreno, Jetmund Ringstad, Jorge Gomez-Aracena, Vladimir P Mazaev, 
Michael Thamm, Blaise C Martin, Antti Aro, Jeremy D Kark, Miguel 
Delgado-Rodriguez, Rudolph A Riemersma, Pieter van 't Veer, Jussi K 
Huttunen 
Abstract 
To examine the association between selenium status and risk of acute 
myocardial infarction and interactions with vitamin E status, a multi-centre 
case-control study was conducted in ten centres from Europe and Israel. 
Selenium in toenails and vitamin E in adipose tissue were assessed for 683 
non-fatal cases with first acute myocardial infarction (MI) and 729 controls 
under 70 years of age. Mean toenail selenium content was 0.575 ^g/g for 
cases and 0.599 piglg for controls (p < 0.05). After multivariate adjustment, 
the odds ratio for MI in the lowest quintile of selenium as compared to the 
highest was 1.55 (95% confidence interval (CI) 0.89-2.70, p for trend 0.12). 
Adipose tissue vitamin E was not associated with risk of MI (odds ratio (OR) 
0.94, 95% CI 0.62-1.41). The relation between selenium and MI was most 
pronounced at low vitamin E levels (OR at the lowest selenium quintile: 
2.62, 95% CI 1.16-5.89, p for trend 0.02). At medium vitamin E levels, the 
OR was 1.88 (95% CI 0.83-4.27), whereas no increased risk was observed at 
high vitamin E levels. An overall comparison of the risk of MI at combined 
low levels of selenium and vitamin E relative to combined high levels of 
both, showed no significantly increased OR. These results suggest that 
selenium may play a role in the etiology of myocardial infarction especially 
when vitamin E status is low. 
Submitted 
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Introduction 
Selenium is part of the enzyme glutathione peroxidase (GSHPx), which plays 
an important role in the body's antioxidant defense against the deleterious 
actions of free radicals and lipid peroxides. Evidence is accumulating that 
oxidation of low density lipoprotein particles and cytotoxic effects of lipid 
peroxides enhance the formation of foam cells and atherosclerotic lesions1'2. 
The question whether low selenium status predisposes to cardiovascular 
disease has been addressed in a number of studies in the past decade3"10. In 
several prospective3"5 and case-control6 studies, low serum selenium levels 
were associated with increased risk of coronary heart disease (CHD). 
However, in other studies, especially in populations with an intermediate 
selenium status, this association could not be confirmed7"10. 
Antioxidant defense is achieved by additive or synergistic action of 
enzymes and antioxidant nutrients1 1'1 2. Selenium and vitamin E in particular 
seem to have overlapping and partly compensative functions13"17. GSHPx is 
more effective as a free radical scavenger in the cytoplasm, while vitamin E 
prevents lipid peroxidation by breaking the oxidation chain reaction, primarily 
in biomembranes. However, vitamin E can protect against many of the 
symptoms of selenium deficiency and vice versa12. Therefore, it is 
conceivable that low selenium status is associated with risk of CHD 
especially at low vitamin E status. This notion is supported by a study in 
rabbits, in which the administration of both selenium and vitamin E markedly 
reduced atherosclerotic plaque formation induced by a high-fat diet, but an 
intensified effect was observed at the combination of both1 8. 
We have studied the association between selenium, separately and in 
combination with vitamin E levels, and acute myocardial infarction in a 
multi-centre case-control study. The large variation in selenium intake in 
these centres permits evaluation of a dose-response relation. Selenium and 
vitamin E levels were represented by long-term biomarkers of intake, not 
affected by the acute event of the disease: selenium was measured in toenail 
clippings19"21 and vitamin E in subcutaneous adipose tissue22. 
Methods 
Design and subjects 
A total of 683 cases and 729 controls were recruited in 8 European countries 
and Israel, according to the same eligibility criteria. Table 1 shows the 
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numbers of cases and controls that were enrolled and the response rates in 
the different centres. The study design has been described elsewhere23'24. 
Briefly, eligible subjects were men under 70 years of age, without previously 
reported myocardial infarction, with stable dietary patterns in the past year. 
Cases were subjects diagnosed with a first acute myocardial infarction (MI) 
(ICD-code 410) - confirmed by specific abnormalities on the ECG and 
elevated enzyme levels2 5 - and admitted within 24 hours of manifesting 
symptoms. They were recruited from the coronary care unit of participating 
hospitals. 
Subjects without a history of myocardial infarction were eligible as 
controls, and were recruited from the population in the catchment area, 
frequency-matched for age according to 5-year intervals. If possible, random 
samples from local population registries were used (Finland, Israel, Germany, 
Scotland, Switzerland). In some centres (Russia, Spain) population registries 
could not be used due to incomplete coverage or legal restrictions. 
Table 1. Population response rate and method of control recruitment. 
Centre Cases Controls Method of 
No. (response %*) No. (response %) control 
recruitment* 
Finland (Helsinki) 57 (97) 62 (51) PR 
Germany (Berlin) 75 (82) 97 (73) PR 
Israel (Jerusalem) 57 (60) 59 (53) PR 
Netherlands (Zeist) 63 (75) 57 (50) GP,PR 
Norway (Sarpsborg) 96 (96) 101 (98) FR 
Russia (Moscow) 92 (97) 99 (79) GP,H 
Scotland (Edinburgh) 41 (98) 32 (61) PR 
Spain (Granada) 55 (45) 53 (67) H 
Spain (Malaga) 94 (89) 100 (77) H,GP 
Switzerland (Zurich) 57 (93) 74 (26) PR 
Percentage of cases and controls who consented to participate, from those who were 
eligible and invited to participate. 
PR = population register; GP = general practitioners; H = hospital controls; FR = friends, 
relatives. 
Therefore, hospital controls were selected, with diseases that were not known 
to be associated with antioxidant status - e.g., renal colic, non-infectious 
prostatism, acute appendicitis, non-infectious otic pathology, hernia, volvulus, 
rectal/anal pathology (except cancer, hemorrhoids, chronic infections). Where 
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it was anticipated that low response rates from population-based samples 
would compromise internal validity, controls were selected from the 
catchment area via a random sample by the patient's general practitioner 
(Netherlands) or by inviting friends and relatives of the case (Norway). In 
three centres (Netherlands, Spain, Russia) several methods of subject 
recruitment were employed. Informed consent was obtained in accordance 
with the ethical standards of the responsible committees on human 
experimentation. 
Information on smoking habits, blood pressure, angina pectoris, and 
diabetes was collected for all subjects by standard questionnaires26. 
Socio-economic status, family history, and alcohol intake were assessed 
through locally developed questionnaires. 
A non-fasting blood sample was drawn not later than 24 h after onset of 
symptoms. Serum total and HDL cholesterol levels were determined 
enzymatically (Boehringer Mannheim Kit) at the National Public Health 
Institute in Helsinki (Finland). In cases, cholesterol concentrations were 
inversely related to time from onset of symptoms (Pearson r = -0.18, 
p < 0.001), which may be due to the effect of acute MI on serum cholesterol. 
Selenium in toenails 
Toenail clippings were collected, within 8 weeks of inclusion in the study, 
and stored in small plastic bags at room temperature. Nails were cleaned 
before clipping. The selenium content of the toenails was assessed by 
instrumental neutron activation analysis of the metastable-selenium-77 isotope 
(Interfaculty Reactor Institute (IRI), Delft University, Netherlands)27. Samples 
were irradiated for 17 seconds, in a thermal flux of 1.2xl01 3 neutrons.s-1.cmf2. 
After a decay time of 20 seconds, gamma radiation of 7 7 m Se was measured 
for 60 seconds. Mean level of selenium (n = 87) in certified bovine liver 
reference material (NBS-1577A) was 0.761 ± 0.043 ppm, against a certified 
value of 0.804 ± 0.036 ppm. Reproducibility of measurement was evaluated 
by repeated analysis of 19 samples; the coefficient of variation was 5%. 
Vitamin E in adipose tissue 
Subcutaneous adipose tissue was taken from the buttock by needle 
aspiration28. In cases, the adipose sample was taken within seven days of 
hospital admission. Samples were stored at -70°C; handling of the samples 
has been described previously24. In short, samples were analyzed in a central 
laboratory. Concentrations of vitamin E (determined as a-tocopherol, the 
major active form of vitamin E) in adipose tissue were determined by 
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reverse-phase HPLC 2 9 and spectrophotometric detection. The coefficient of 
variation for the analysis of vitamin E was 7% (at mean values of 84 pglg in 
the quality control samples). Detection limit was 2 fxglg for vitamin E, at 
mean sample weight (29 mg). 
The concentration of vitamin E was calculated on the basis of fatty acid 
content of the sample, which was assessed by GLC 3 0 in an aliquot of the 
same extract as vitamin E, adding nonadecanoic acid (C19:0) as an internal 
standard to the sample before saponification. Vitamin E concentration was 
expressed in pig/g of total fatty acids. 
Data analysis 
Questionnaire and selenium results were available for 1421 eligible subjects 
(Table 1). In 9 samples (4 cases, 5 controls), selenium values were found to 
be below the detection level; these were excluded from data-analysis. In 
analyses including data on vitamin E, another 34 subjects (30 cases, 4 
controls) were excluded because no biopsy material was obtained and 51 
subjects (27 cases and 24 controls) because the amount of fat collected was 
extremely small (below 5 mg), resulting in unreliable measurement of 
vitamin E. 
Crude means for major risk factors and potential confounders among 
cases and controls were calculated and significance testing of the difference 
in means was performed with Student's t-test and chi-square analyses. Mean 
levels of selenium (along with the standard deviations) among cases and 
controls in the different centres were computed, and the mean difference and 
95 percent confidence intervals (CI), adjusted for age and centre, were 
estimated by linear regression. Selenium and vitamin E values were log-
transformed in all calculations; retransformed values are presented in the 
tables. Relation between selenium and vitamin E was assessed by calculating 
the Pearson correlation coefficient. Potential confounders and/or effect 
modifiers were identified with stratified analysis. Smoking categories 
included never smokers, ex-smokers, pipe/cigar smokers, and current cigarette 
smokers; the last category was further divided into subjects smoking < 6, 
6-10, 11-20, and > 20 cigarettes per day. For multivariate analysis, multiple 
logistic regression was used with maximum likelihood estimation of the 
regression coefficients and their standard errors. Odds ratios were calculated 
for the lowest quintile as compared to the highest, based on the distribution 
among controls. Tests for trend were performed by assigning each subject the 
median value for the category and treating this value as a continuous variable 
in the model3 1. Interaction between selenium and vitamin E was evaluated 
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using a model including dummy variables for each combination of the 
categorical variables (Table 7). The same approach was used for the potential 
interaction of selenium and smoking status, the latter divided in three 
categories: subjects who never smoked, ex-smokers (who have stopped 
smoking for at least two years) and current smokers. All analyses were 
performed with the BMDP statistical software package. 
Results 
The prevalence of CHD risk factors in MI cases and controls is given in 
Table 2. Significant crude differences are observed for age, history of 
hypertension, smoking, angina pectoris, diabetes mellitus, family history of 
CHD and body mass index (BMI). The lower cholesterol concentration in 
cases may well be caused by the acute effect of the infarction. 
Table 2. Risk factors for myocardial infarction in cases and controls. 
Risk factor Cases (n = 683) Controls (n = 729) 
Means (SD) Means (SD) 
Age (years) 54.7 (8.9) 53.2 (9.2) * 
Serum cholesterol (mmol/1) 5.5 (1.1) 5.6 (1.1) 
History of hypertension (%) 26 18 ** 
Current smokers (%) 58 33 ** 
No. of cigarettes/day 25 (15) 18 (12) ** 
(among smokers) 
Angina pectoris (%) 14 5 
Diabetes mellitus (%) 8 4 ** 
Family history of CHD (%) 58 46 ** 
Alcohol use (%) 80 83 
Body mass index (kg/m2) 26.5 (3.9) 25.9 (3.4) * 
* p < 0.01; ** p < 0.001. 
Mean selenium concentrations in toenails for cases and controls in the 
different centres are shown in Table 3. The age- and centre-adjusted overall 
mean is 0.575 [ig/g in cases and 0.599 /tg/g in controls (p < 0.05). The 
relation of selenium concentration with CHD risk factors was examined in 
controls (Table 4). Subjects who currently smoked cigarettes had significantly 
lower selenium levels than non-smokers (0.555 fig/g and 0.621 fig/g, 
respectively). Other classical risk factors (including total, HDL and LDL 
cholesterol) were not associated with selenium concentration. 
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Table 3. Mean toenail selenium concentrations* by centre and disease status. 
Centre Number of Selenium concentrations 
cases controls cases controls 
Germany (Berlin) 75 96 0.424 (0.103) 0.460 (0.076) 
Netherlands (Zeist) 62 56 0.466 (0.091) 0.479 (0.113) 
Spain (Granada) 54 52 0.488 (0.076) 0.515 (0.105) 
Spain (Malaga) 94 100 0.506 (0.097) 0.532 (0.107) 
Scotland (Edinburgh) 41 32 0.507 (0.090) 0.553 (0.114) 
Switzerland (Zurich) 57 74 0.561 (0.121) 0.616 (0.214) 
Russia (Moscow) 91 98 0.630 (0.178) 0.643 (0.162) 
Norway (Sarpsborg) 96 100 0.671 (0.258) 0.652 (0.115) 
Finland (Helsinki) 57 62 0.798 (0.158) 0.833 (0.124) 
Israel (Jerusalem) 56 59 0.845 (0.198) 0.866 (0.142) 
Overall mean* 683 729 0.575 0.599 
Mean difference* (95% CI) 0.024 (0.012-
0.037) 
figlg, retransformed loge-values. 
Age- and centre-adjusted. 
Table 4. Selenium concentration* in controls by CHD risk factor. 
Risk factor Present Age- & centre-adjusted 
Yes No difference 95% CI 
Current smoking 0.555 0.621 0.052 ( 0.034 - 0.068) 
History of hypertension 0.582 0.602 0.009 (-0.015 - 0.032) 
Angina pectoris 0.578 0.593 0.026 (-0.022 - 0.071) 
Diabetes 0.580 0.598 0.016 (-0.026 - 0.056) 
Alcohol use 0.597 0.580 -0.000 (-0.025 - 0.024) 
Family history of CHD 0.623 0.579 -0.012 (-0.030 - 0.007) 
Body mass index > 25.6 0.591 0.603 0.004 (-0.013 - 0.021) 
//g/g, retransformed logc-values. 
Vitamin E was not associated with selenium (r = -0.04, p = 0.25). Smokers 
and non-smokers had similar levels of vitamin E (189 /xglg and 196 /A,glg 
respectively, p = 0.46). 
To evaluate confounding by CHD risk factors, stepwise logistic 
regression was used. Age and centre were included in all models. Of the 
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classical risk factors (Table 2), only the addition of smoking significantly 
altered the odds ratio (OR) for MI. The age- and centre-adjusted OR in the 
lowest selenium quintile was 3.19 (95% CI 1.96-5.21, p for trend < 0.001). 
After additional adjustment for smoking (in 7 categories), the OR in the 
lowest quintile was 1.61 (95% CI 0.95-2.73, p for trend 0.07). Inclusion of all 
major risk factors (except serum cholesterol, because of dubious values in 
cases) in the logistic model only slightly further changed the estimates of the 
ORs: in the lowest quintile the OR was 1.55 (95% CI 0.89-2.70, Table 5). 
Subsequently, vitamin E was included in the model, but showed no 
confounding effect. Selenium was also included in the model as a continuous 
variable (Table 5); the adjusted OR of MI at the 10 t h percentile of selenium, 
compared to the 90 t h percentile, was 1.15 (95% CI 0.76-1.74). 
Table 5. Odds ratio of acute myocardial infarction, according to quintiles of toenail 
selenium. 
Quintiles Cases Controls Age- & centre MultivariateT 
adjusted 
Selenium (ag/g) n = 683 n = 729 OR 95% CI OR 95% CI 
Ql < 0.467 181 148 3.19 (1.96-5.21) 1.55 (0.89-2.70) 
Q2 0.467-0.548 156 143 2.42 (1.52-3.85) 1.50 (0.89-2.52) 
Q3 0.549-0.633 109 147 1.49 (0.95-2.33) 0.99 (0.60-1.64) 
Q4 0.634-0.755 130 145 1.55 (1.04-2.32) 1.27 (0.81-1.98) 
Q5 > 0.755 107 146 1.00 1.00 
X2 trend (p-value) 23.55 (< 0.001) 2.48 (0.12) 
Continuous OR* 2.00 (1.38-2.92) 1.15 (0.76-1.74) 
Adjusted for age, centre, smoking, BMI, diabetes, history of hypertension and family 
history of CHD. 
OR of MI at 10" percentage level (0.432 uglg) of selenium compared to 90 l h percentage 
(0.862 fig/g) level. 
To see whether the inverse association of selenium and MI was consistent 
among individual centres, the continuous OR was estimated for each centre 
separately. In 8 out of the 10 centres, adjusted ORs exceeded one, but had 
very wide confidence intervals including one. When centres using hospital 
controls (Russia, Spain) were excluded from the analysis, multivariate odds 
ratios from the lowest to the highest quintile were 2.19-1.78-1.25-1.61-1.00. 
Smoking was the most important confounder of the association between 
selenium and MI; selenium levels were shown to be lower in current cigarette 
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smokers than in non-smokers (Table 4). Therefore, we examined the potential 
interaction of smoking behaviour and selenium status. Increased odds ratios 
for the lowest vs highest quintile of selenium were observed in ex-smokers 
(OR 2.35, 95% CI 1.04-5.34) and in current smokers (OR 1.70, 95% CI 
0.89-3.25), respectively, but not in subjects who have never smoked 
(OR 0.98). However, the interaction between the three smoking categories 
and selenium (as a continuous variable in the model) was not significant 
(p = 0.23). Moreover, additional adjustment for the number of cigarettes 
smoked daily, in the category current smokers, resulted in a considerable 
decrease of ORs in the selenium quintiles (-30% in the lowest quintile). 
Therefore, the varying associations between selenium and MI among never, 
ex- and current smokers are most likely due to residual confounding by 
smoking. 
Table 6. Odds ratio of acute myocardial infarction, according to quintiles of adipose 
vitamin E. 
Quintiles Cases Controls Multivariatef 
Vitamin E (ug/g) n = 626 n = 701 OR 95% CI 
Ql <127 122 143 0.94 (0.62-1.41) 
Q2 127-175 134 140 0.98 (0.66-1.45) 
Q3 175-229 126 142 1.08 (0.73-1.61) 
Q4 229-303 127 139 1.25 (0.86-1.83) 
Q5 > 303 117 137 1.00 
X2 trend (p-value) 
Continuous OR* 
0.20 (0.65) 
0.92 (0.70-1.22) 
+ Adjusted for age, centre, smoking, BMI, diabetes, history of hypertension and family 
history of CHD. 
$ OR of MI at 10lh percentage level (105 ug/g) of vitamin E compared to 90 lh percentage 
(387 fig/g) level. 
No association was observed between vitamin E and risk of MI when 
confounding was taken into account (Table 6). To test the a priori hypothesis 
that an inverse association of selenium and MI would be most pronounced at 
low levels of vitamin E, the risk of MI for quintiles of selenium was 
estimated at different levels (textiles) of vitamin E (Table 7), by including all 
combinations of selenium quintiles and vitamin E tertiles in the logistic 
model. The OR at the lowest selenium quintile was 0.86 (95% CI 0.39-1.92) 
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in subjects with relatively high vitamin E status (highest tertile); 1.88 (95% 
CI 0.83-4.27) at intermediate vitamin E status; and 2.62 (95% CI 1.16-5.89) 
at low vitamin E status. A significant linear trend was observed at the lowest 
vitamin E level. However, this apparent interaction between selenium and 
vitamin E was not statistically significant when both were included as 
continuous variables in the logistic regression model (p = 0.72). 
The largest increase in risk would be expected in the combined low 
selenium/low vitamin E category, when compared to the high selenium/high 
vitamin E category. To see whether this was true, the OR of MI at different 
combinations of vitamin E and selenium levels was calculated, with high 
selenium and high vitamin E as single reference category (Fig. 1). 
Surprisingly, there was an unexpected positive, although non-significant 
association between vitamin E and MI at all but the lowest selenium level. In 
the highest selenium quintile, the OR for MI at low compared to high vitamin 
E level was 0.50 (95% CI 0.23-1.05). Therefore, OR in the combined low 
selenium and low vitamin E level was only 1.29 (95% CI 0.58-2.92). The 
three-way interaction between selenium, vitamin E and smoking, was not 
evaluated, as the number of subjects was not sufficient for reliable risk 
estimates. Considering the lack of association between smoking and vitamin 
E, it is not likely that the interaction between selenium and vitamin E could 
be explained by differences in smoking status. 
Table 7. Odds ratio* of MI at quintiles of selenium, and at tertiles of adipose tissue 
vitamin E. 
Vitamin E 
Selenium Low Medium High 
OR (95%CI) OR (95%CI) OR (95%CI) 
Ql low 2.62 (1.16-5.89) 1.88 (0.83-4.27) 0.86 (0.39-1.92) 
Q2 1.97 (0.89-4.38) 1.58 (0.71-3.54) 1.19 (0.54-2.59) 
0 3 1.38 (0.61-3.17) 1.07 (0.48-2.36) 0.84 (0.40-1.80) 
Q4 1.54 (0.74-3.19) 1.36 (0.64-2.87) 1.00 (0.48-2.09) 
Q5 high 1.00 1.00 1.00 
X2 trend (p-value) 5.42 (0.02) 2.23 (0.14) 0.02 (0.88) 
Adjusted for age, centre, smoking, BMI, diabetes, history of hypertension and family 
history of CHD. 
Quintile cutpoints as in Table 5. 
Tertile cutpoints: 161 and 244 uglg. 
Selenium, Vitamin E and MI 75 
OR 
1.4 
0 . 4 - 1 1 1 1 
01 (low) Q2 03 Q4 Q5 (high) 
Quintile for toenail selenium 
vitamin E 
• high A medium " low 
a Odds ratio adjusted for age, centre, smoking, BMI, diabetes, history of hypertension, family 
history of CHD. 
b Single reference category: high selenium/high vitamin (OR = 1.0). 
c Quintile cutpoints as in Table 5. 
d Tertile cutpoints as in Table 6. 
Figure 1. Risk of MI" by jointh distribution of toenail selenium0 and adipose tissue 
vitamin Ed 
Discussion 
In this multi-centre case-control study we observed an inverse relation 
between toenail selenium levels and risk of acute myocardial infarction, 
dependent on vitamin E status. Selenium by itself was inversely associated 
with MI, although not significant, whereas vitamin E showed no association 
with MI at all. However, the adjusted odds ratio at low selenium was 
increased by a factor 2.6 compared to high selenium status, in subjects with 
low adipose tissue vitamin E. When compared to the category with high 
levels of both selenium and vitamin E, there was no increased risk of MI at 
the combined low selenium and low vitamin E levels. 
To avoid changes in selenium status due to previous disease, the cases in 
this study were subjects presenting acute, first-time myocardial infarction. 
When subjects with a history of angina pectoris, who might have changed 
their diet previously, were excluded from data-analysis, the ORs increased 
somewhat in all quintiles of the selenium distribution. 
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Data collection was restricted to survivors of acute ML It is conceivable 
that survival is associated with antioxidant status, independent of the role of 
antioxidants in the pathogenesis of MI. Indeed, the potential significance of 
free radical production in the process of myocardial injury and necrosis of 
reperfused tissue is recognized32 and treatment with antioxidants may be a 
way to slow down or inhibit these processes. This would imply that fatal 
cases of MI may have lower levels of antioxidants than the survivors. 
Therefore, including them would have increased the difference with the 
control population and perhaps have led to stronger associations with low 
selenium status. If vitamin E were an important determinant of case fatality, 
this could partly explain the lack of association between vitamin E and MI in 
our study. 
As the selection of controls is an important issue in the interpretation of 
the results, we evaluated whether source of controls might have affected our 
estimates. The classical risk factors - cigarette smoking, hypertension and 
diabetes - were consistently more prevalent in acute MI cases than controls. 
In our study, five centres used random samples of population registries. In 
some centres, population registries were inadequate or impossible to use 
because of legal restrictions (Russia, Spain). Hospital controls were used, for 
whom the diagnosis, according to current knowledge, did not affect and was 
not influenced by antioxidant status. To minimize potential bias if any one 
disease turns out to be related to exposure, controls were chosen from a 
variety of disease categories. If, however, a control disease would have been 
related to antioxidant status, it would most likely reduce antioxidant levels, 
and thus diminish the risk estimates for ML Indeed, exclusion of centres 
using hospital controls or mixed methods of control recruitment increased the 
strength of association considerably. However, this is not necessarily caused 
by selection bias, but may also be due to centre-specific factors, interacting 
with the relation between selenium and MI. The use of friend/relative 
controls (in Norway) may lead to overmatching on lifestyle (including diet) 
exposures. This would also result in a decreased estimate of association 
between selenium and MI. 
Toenail selenium represents an integrated measure of dietary intake over 
a period of 6-12 months21, which will not be affected by the acute event of 
infarction. Major dietary sources are meat and cereal products. Apart from 
the diet, also smoking habits, gender and possibly age are predictors of 
toenail selenium levels 2 0 , 3 3. Rich in vitamin E are vegetable oils, nuts and 
green leafy vegetables. About 90% of the body's vitamin E is stored in 
adipose tissue. 
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Evidence for an association between serum selenium and risk of CHD 
has not been conclusive so far. Two cohort studies3 ,5 have found an inverse 
association. Virtamo et al.3 reported an increased risk of CHD at serum 
selenium levels below 45 jig/l, which is extremely low. The more recent 
study by Suadicani et al.5 shows a RR of ischemic heart disease of 1.70 (95% 
CI 1.14-2.53) at levels below 1 /miol/l (± 79 fig/l). These studies confirmed 
an earlier report of an inverse association between serum selenium and CHD4. 
Several nested case-control studies have found no association between serum 
selenium and CHD7"10, but this may be due to relatively small numbers of 
cases. Toenail selenium levels of MI cases were found to be significantly 
lower than in controls in a study in the Netherlands34; the multivariate OR for 
MI at the lowest toenail selenium level compared to the highest was 4.5 
(95% CI 1.3-15.7). A more recent case-control study from New Zealand6 
reported an increased risk of MI at low selenium levels which was confined 
to smokers. In the light of our findings, this might be due to insufficient 
adjustment for smoking behavior. In a prospective study, Kok et al.8 reported 
no interaction between serum selenium and serum vitamin E and risk of 
cardiovascular death. However, in a case-control study35, plasma selenium 
(relative to polyunsaturated fatty acids) was significantly lower in patients 
with severe as opposed to mild atherosclerosis, but only at low plasma 
vitamin E status. No other epidemiological studies have addressed this 
possible interactive effect. In rabbits, an enhanced effect of selenium and 
vitamin E administered simultaneously was observed, on induced 
hyperlipidemia and atherosclerotic lesions18. 
The best characterized function of selenium is that as a constituent of the 
enzyme glutathione peroxidase (GSHPx), which catalyzes the removal of 
hydrogen peroxide and lipid peroxides. Lipid peroxidation may involve 
modification of LDL cholesterol within the arterial wall, damage of cell 
membranes, and activation of cyclooxygenase, leading to increased 
thromboxane synthesis and platelet aggregation1 , 3 6 , 3 7. The exact function of 
selenium, in GSHPx or seleno-proteins, in relation to other nutrients with 
antioxidant properties, has not yet been elucidated13 ,14. Experimental studies 
have provided evidence for overlapping, though not identical roles for 
selenium and vitamin E 1 4 ' 1 6 , 1 7 , especially in their effect on the arachidonic 
acid cascade. The results of the present study are in line with such an antioxi-
dant function for selenium. Theoretically, selenium status may be an indicator 
of other dietary or lifestyle factors that affect risk of MI; such a confounding 
effect is not likely to have caused our results, since the major factors known 
to be associated with risk of MI and selenium status have been adjusted for 
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in the data analysis. 
The biological relevance of adipose tissue vitamin E needs further 
evaluation. It may be an indicator of dietary intake, but may also reflect the 
status after vitamin E has been used in defense against oxidative stress. The 
low levels of adipose tissue vitamin E that have been observed for Jerusalem, 
where intake of polyunsaturated fats is high and concomitant intake of 
vitamin E is expected to be high as well, support the latter view. In that case, 
lower vitamin E status in controls compared to cases could represent more 
effective antioxidant defense through vitamin E in the stage before storage in 
adipose tissue takes place. 
In conclusion, our results suggest a protective role for selenium in the 
etiology of myocardial infarction, in men with low vitamin E status. 
Additional information about a possible causal relationship should be 
provided by preventive trials, to support the clinical relevance of this finding. 
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Association between antioxidants and acute 
myocardial infarction depends on poly-
unsaturated fatty acid status: the EURAMIC study 
Alwine FM Kardinaal, Antti Aro, Jeremy D Kark, Rudolph A Riemersma, 
Pieter van 't Veer, Jorge Gomez-Aracena, Lenore Kohlmeier, Jetmund 
Ringstad, Blaise C Martin, Vladimir P Mazaev, Miguel Delgado-Rodriguez, 
Michael Thamm, Jussi K Huttunen, Jose M Martin-Moreno, Frans J Kok 
Abstract 
Dietary antioxidants may play a role in the prevention of coronary heart 
disease, by inhibiting free radical-induced lipid peroxidation. Experiments 
indicate that dietary polyunsaturated fatty acids (PUFA) should also be 
considered, as they are susceptible to peroxidation. 
The combined association between diet-derived antioxidants and PUFA 
with acute myocardial infarction (MI) was investigated in a multi-centre case-
control study in eight European countries and Israel, including 674 patients 
and 725 control subjects. Fatty acid composition, a-tocopherol and B-carotene 
were determined in adipose tissue, selenium in toenails, as time-integrated 
measures of intake. For a-tocopherol no association with MI was observed at 
any level of PUFA. The overall odds ratio (OR) for low (10-percentile) 
versus high (90-percentile) B-carotene, adjusted for age, centre, smoking and 
body mass index was 1.98 (95% CI 1.39-2.82). The strength of this inverse 
association with MI was dependent on PUFA levels (tertiles): at low PUFA, 
the OR for low versus high B-carotene was 1.79 (95% CI 0.98-3.25), at 
medium PUFA the OR was 1.76 (95% CI 1.00-3.11) and at high PUFA 3.47 
(95% CI 1.93-6.24). For selenium increased risk was observed only at the 
lowest PUFA tortile (OR 2.49, 95% CI 1.22-5.09). This interaction between 
selenium and PUFA was not significant and may at least partly be explained 
by a higher proportion of smokers at the low PUFA level. 
These findings support the hypothesis that B-carotene plays a role in the 
protection of PUFA against oxidation, and subsequently in the protection 
Submitted 
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against myocardial infarction. No evidence was found that a-tocopherol or 
selenium may protect against MI at any level of PUFA intake. 
Introduction 
Experimental as well as epidemiological studies have accumulated evidence 
that antioxidants may play a part in the prevention of cardiovascular disease1. 
Micronutrients such as vitamin E, 6-carotene and selenium may protect the 
LDL cholesterol particle against oxidation in the vascular subendothelium2 
and thereby prevent the enhanced uptake of cholesterol by macrophages, 
leading to the formation of foam cells3. In vitro studies have shown that the 
resistance of LDL against oxidation is dependent not only on antioxidant 
levels4'5, but also on its fatty acid composition. Increasing the ratio of oleic to 
linoleic acid in LDL by dietary intervention reduces the uptake of the LDL 
by macrophages in vitro6'7. 
Several studies8"11 have shown an inverse association of dietary antioxi-
dant intake or plasma or serum concentrations with risk of cardiovascular 
disease. However, other studies12"15 did not find such an association. This lack 
of association may be attributed to relatively high levels of antioxidants in 
these populations or to deterioration of vitamin E during prolonged storage. It 
is also possible, that the balance between antioxidants and polyunsaturates is 
the more important factor. Kok et al. 1 6 have reported lower selenium to 
polyunsaturated fatty acid ratios in patients with severe versus mild 
atherosclerosis. 
Here we present the results of a case-control study on the combined 
association of antioxidants and polyunsaturated fatty acids with the risk of 
acute myocardial infarction in nine different countries, with varying dietary 
habits. Concentrations of a-tocopherol, 6-carotene and fatty acids in 
subcutaneous adipose tissue and selenium in toenails were compared between 
674 cases with acute myocardial infarction and 725 controls without a history 
of infarction. 
Methods 
Design and subjects 
Eligible subjects in this study, conducted in 1991-1992, were men under 70 
years of age, from ten study centres in nine countries. They were native 
residents of respective countries, with stable dietary patterns in the past year 
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i.e., no changes in the use of dietary supplements containing a-tocopherol, 
6-carotene, or selenium; no new or altered dietary prescription or advice for 
health reasons and no weight loss over 5 kg in the past year. Cases were 
subjects diagnosed with a first acute myocardial infarction (MI) (ICD-code 
410) - confirmed by specific abnormalities on the ECG and elevated enzyme 
levels - and admitted within 24 hours of manifesting symptoms. They were 
recruited from the coronary care unit of participating hospitals. 
Controls were subjects without history of myocardial infarction and 
frequency-matched for age according to 5-year intervals. The controls were 
recruited from the population in the catchment area, from population registers 
or other appropriate sources. In some centres, hospital controls were selected, 
with diseases that were not known to be associated with antioxidant status 
(renal colic, non-infectious prostatism, acute appendicitis, non-infectious otic 
pathology, hernia, volvulus, rectal/anal pathology (except cancer, 
haemorrhoids, chronic infections)). Where it was thought that low response 
rates from population based samples would affect the internal validity, 
controls were selected from the catchment area via a random sample by the 
patient's general practitioner (Netherlands) or by inviting friends and relatives 
of the case (Norway). 
Excluded from both groups were subjects with a history of treatment for 
alcohol or drug abuse, those diagnosed with major psychiatric disorders that 
would interfere with their ability to give informed consent, and 
institutionalized subjects. Informed consent was obtained from all subjects 
and the study protocol was approved the institutional committees on human 
experimentation. The study design has been reported in detail elsewhere17. 
Biochemical analyses 
Subcutaneous adipose tissue was taken from the buttock by needle 
aspiration18. In cases, the adipose sample was taken within seven days of 
hospital admission. Samples were stored at -70°C; handling of the samples 
has been described previously. In short, samples were analyzed in a central 
laboratory. Concentrations of a-tocopherol and 6-carotene in adipose tissue 
were determined by reverse-phase HPLC 1 9 and spectro-photometric detection. 
The coefficient of variation for the analysis of 6-carotene and a-tocopherol 
was 7% (at mean values of 2.1 /ug/g and 84 jug/g in the quality control 
samples, respectively). Detection limits were 0.02 jug/g for 6-carotene and 
2 fig/g for a-tocopherol, at mean sample weight (29 mg). Vitamin 
concentration was expressed in tug/g of total fatty acids. 
The fatty acids were assayed centrally at the National Public Health 
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Institute, Helsinki, Finland. The saponified sample was acidified with HC1 
and the free fatty acids were extracted with hexane and methylated with 
acidic methanol. Fatty acid composition was determined by a gas 
chromatograph (HNU Nordion Oy, Finland, HRCG 412) with a 60 m long 
SP-2380 column, I.D. 0.32 mm, phase layer 0.20 jum with split injector and 
helium as carrier gas. Fatty acid peaks from C12:0 (fatty acid with 12 carbon 
atoms:0 double bonds) to C22:6 were identified by an SC-workstation 
(Sunicom Oy, Finland) in a temperature-programmed run. Polyunsaturated 
fatty acids (PUFA) include linoleic acid (C18:2), alpha-linolenic acid (C18:3) 
and arachidonic acid (C20:4); monounsaturated fatty acids (MUFA) are 
C14:l, palmitoleic acid (C16:l), oleic acid (C18:l) and eicosaenoic acid 
(C20:l); saturated fatty acids (SFA) include lauric acid (C12:0), myristic acid 
(C14:0), palmitic acid (C16:0) and stearic acid (C18:0). All fatty acids are 
expressed as proportion of total fatty acids. Minor fatty acids are not included 
in these aggregated categories; therefore, proportions of PUFA, MUFA and 
SFA do not add up to 100%. 
Serum total cholesterol levels were determined enzymatically (Kits of 
Boehringer-Mannheim GmbH, Mannheim, Germany) in Helsinki (Finland), 
HDL cholesterol after precipitation with dextran sulphate and magnesium 
chloride. LDL cholesterol was calculated by the Friedewald formula. In cases, 
cholesterol concentrations were inversely related to time from onset of 
symptoms (Pearson r = -0.18, p < 0.001), which may be due to the effect of 
acute MI on serum cholesterol. 
Toenail clippings were collected, within 8 weeks of inclusion in the 
study, and stored in small plastic bags at room temperature. Nails were 
cleaned before clipping. The selenium content of the toenails was assessed by 
instrumental neutron activation analysis of the metastable-selenium-77 isotope 
(Interfaculty Reactor Institute (IRI), Delft University, Netherlands)20. Samples 
were irradiated for 17 seconds, in a thermal flux of 1.2xl01 3 neutrons.s'.cm"2. 
After a decay time of 20 seconds, gamma radiation of 7 7 m Se was measured 
for 60 seconds. Mean level of selenium (n = 87) in certified bovine liver 
reference material (NBS-1577A) was 0.76 ± 0.04 ppm, against a certified 
value of 0.80 ± 0.04 ppm. Reproducibility of measurement was evaluated by 
repeated analysis of 19 samples; the coefficient of variation was 5%. 
Data analysis 
Questionnaire data were available for 1499 eligible subjects. Vitamin results 
were unavailable (no adipose tissue in adaptor) for 34 subjects (30 cases, 
4 controls). Extreme values, caused by measurement error due to very small 
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sample size, were excluded (n = 38 cases, 28 controls), leaving 674 cases and 
725 controls for data analysis. With respect to selenium, for 79 out of 1499 
subjects no toenail samples had been collected (55 cases and 24 controls); 
another 9 subjects (4 cases, 5 controls) had values below the detection level, 
handled as missing values as well. Of the remaining subjects, 28 cases and 
4 controls had provided no biopsy, leaving 655 cases and 724 controls for the 
data analysis of selenium in combination with fatty acid composition. 
Crude means for major risk factors and potential confounders were 
computed; the difference between cases and controls was tested with 
Student's t-test and chi-square analysis. Mean centre-adjusted levels of 
antioxidants and fatty acids (as proportion of total fatty acids) were calculated 
for cases and controls. As the distribution of PUFA and MUFA was skewed, 
the loge-transformed values were used. Potential confounders of the 
association between the antioxidants and MI were identified with stratified 
analysis. Pearson correlations between antioxidants and fatty acids were 
calculated. The odds ratio of MI was estimated for the lOth-percentile (plO) 
level of the antioxidants, relative to the 90th-percentile (p90) level, based on 
the distribution among controls, by multiple logistic regression, with 
maximum likelihood estimation of the regression coefficients. This 
"continuous" odds ratio was preferred to calculating odds ratios in quintiles of 
the antioxidant distribution to avoid irrelevant fluctuations of odds ratios 
which may occur due to small numbers when examining interactions. The 
fitted model included age, centre, smoking, and body mass index (BMI), for 
the relationship with a-tocopherol and B-carotene; the model for selenium 
and MI included only age, centre and smoking. Smoking categories included 
never smokers, ex-smokers, pipe/cigar smokers, and current cigarette 
smokers, the last category further divided in subjects smoking less than 6, 
6-10, 11-20, and more than 20 cigarettes per day. The significance of the 
interaction of antioxidants and fatty acid composition was tested (with the 
loglikelihood-ratio test) by including an interaction term of the continuous, 
loge-transformed variables in the logistic regression model. Subsequently, risk 
of MI of the plO compared to the p90 level of the antioxidants was estimated 
at tertiles of PUFA, MUFA and SFA (in nine separate models, for each 
combination of the three antioxidants and the three types of fatty acids). 
Results 
The prevalence of risk factors of CHD among cases and controls is 
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summarized in Table 1. Age, serum total and HDL cholesterol, history of 
hypertension, smoking, angina pectoris, diabetes mellitus, family history for 
CHD, socio-economic status and BMI differed significantly between the 
groups. The reduced concentrations of serum cholesterol in cases may reflect 
the cholesterol-lowering effect of the acute event. 
Table 1. Prevalence of risk factors for cardiovascular disease among MI cases and 
controls. 
Mean (SD) 
Cases Controls 
n = 674 n=725 
Age 54.7 (9.0) 53.4 (9.1) ** 
Total serum cholesterol 5.4 (1.1) 5.6 (1.1) * 
LDL cholesterol 3.7 (1.0) 3.7 (1.0) n.s. 
HDL cholesterol 0.95 (0.3) 1.04 (0.4) *** 
Current smokers (%) 59 33 *** 
Cigarettes/day (among smokers) 25 (15) 18 (12) *** 
History of hypertension (%) 26 17 *** 
Family history of CHD (%) 58 45 ** * 
Diabetes (%) 7.6 3.6 ** 
Angina pectoris (%) 14 5 *** 
Alcohol use (%) 79 82 n.s. 
Low social class (%) 25 20 #* 
BMI 26.5 (3.8) 26.0 (3.5) * 
p < 0.05; ** p < 0.01; *** p < 0.001. 
Mean centre-adjusted values for the antioxidants and the fatty acids are 
shown in Table 2 for cases and controls. B-Carotene and selenium 
concentrations are significantly lower in cases as compared to controls. Mean 
proportions of the saturated fatty acids (SFA) myristic acid (C14:0) and 
stearic acid (C18:0) are 6% and 7% lower in cases, respectively; 
monounsaturated fatty acids (MUFA), in particular palmitoleic acid (C16:l) 
and C18:l (n-7) are higher in cases (both 6%), whereas polyunsaturated fatty 
acids (PUFA) are similar for cases and controls. 
We examined the relationship between antioxidant concentrations and 
CHD risk factors in the controls. For B-carotene, negative associations were 
observed for the number of cigarettes smoked per day (r = -0.17, p < 0.05) 
and for BMI (r = -0.36, p < 0.001). 
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Table 2. Centre-adjusted means of antioxidants (figlg) and fatty acids (% of total fatty 
acids) in adipose tissue by disease status. 
Cases Controls Difference 95% CI 
a-tocopherol 192 193 -1 (-14 - 13) 
(3-carotene 0.34 0.42 -0.08 (-0.11 - -0.05) 
selenium (in toenails) 0.575 0.600 -0.025 (-0.038 - -0.012) 
saturated fatty acids+ 28.4 29.0 -0.6 (-1.0 - -0.3) 
CI 2:0 0.32 0.36 -0.04 (0.06 - -0.03) 
CI 4:0 2.71 2.89 -0.18 (-0.24 - -0.11) 
CI 6:0 21.5 21.6 -0.1 (-0.4 - 0.1) 
CI 8:0 3.86 4.16 -0.30 (-0.40 - -0.19) 
monounsaturated fatty acids+ 52.7 52.1 0.6 (0.1 - 1.0) 
CI 4:1 0.36 0.37 -0.01 (-0.02 - 0.01) 
C16:l n-7 5.86 5.53 0.33 (0.16 - 0.50) 
C18:l n-9 43.8 43.7 0.1 (-0.2 - 0.5) 
CI 8:1 n-7 2.25 2.13 0.12 (0.07 - 0.17) 
C20:l n-9 0.68 0.69 -0.01 (-0.02 - 0.01) 
polyunsaturated fatty acidsf 14.2 14.2 0.0 (-0.3 - 0.4) 
CI 8:2 n-6 13.0 12.9 0.1 (-0.2 - 0.5) 
CI 8:3 n-3 0.77 0.80 -0.03 (0.05 - 0.00) 
C20:4 n-6 0.42 0.41 0.01 (0.00 - 0.02) 
Proportions do not add up to 100%, due to exclusion of some minor fatty acids. 
Subjects with a positive family history of CHD and subjects with higher 
socio-economic status had significantly higher (3-carotene levels (p < 0.001). 
a-Tocopherol concentration was also negatively associated with BMI 
(r = -0.12, p < 0.001) and number of cigarettes smoked per day (r = -0.13, 
p = 0.06) and positively with socio-economic status (p < 0.05). There were 
no significant correlations with other risk factors. With respect to selenium, 
subjects who currently smoked cigarettes or had a negative family history of 
CHD, had significantly lower levels than non-smokers (p < 0.001). Other 
classical risk factors were not associated with selenium concentration. The 
association between antioxidants and proportion of fatty acids in adipose 
tissue is shown in Table 3. 
To evaluate whether an association between antioxidants and MI 
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depends on the fatty acid composition of the adipose tissue, we tested the 
significance of the interaction for each of the fatty acid categories (PUFA, 
MUFA and SFA) with each antioxidant (P-carotene, a-tocopherol and 
selenium). 
Table 3. Correlation between antioxidant concentrations and proportion of fatty acids in 
adipose tissue (Pearson r). 
Fatty acids a-tocopherol P-carotene toenail seleni-
um 
SFA 0.10 * 0.32 ** 0.12 ** 
MUFA -0.04 -0.21 ** -0.41 ** 
PUFA 0.03 -0.05 0.30 ** 
* p < 0.01; ** p < 0.001. 
These parameters were included in a logistic regression model as continuous 
variables, with adjustment for age, centre, smoking and BMI (i.e. nine 
separate models for all possible interactions). A significant interaction was 
observed for a-tocopherol and SFA (x2 = 6.68, p < 0.01). The interactions for 
R-carotene and PUFA (x2 = 3.20, p = 0.07) and for selenium and SFA 
(X2 = 3.51, p = 0.06) were borderline significant. Subsequently, the 
multivariate risk of MI at low (lOth-percentile value) versus high (90th-
percentile value) antioxidant concentrations was calculated, overall and for 
tertiles of PUFA, MUFA and SFA (Table 4). For 6-carotene the association 
with MI appeared to be dependent on fatty acid composition. At all levels of 
PUFA an increased risk for low P-carotene as compared to high P-carotene 
was observed. The highest odds ratios were seen at the highest PUFA level 
(OR for low vs high P-carotene: 3.47, 95% CI 1.93-6.24) and at the lowest 
MUFA and SFA levels. Since PUFA, MUFA and SFA are expressed as 
proportions of total fatty acids, this interrelation is to be expected. Similar 
calculations were done for tertiles of the ratio between monounsaturated and 
polyunsaturated fatty acids (m/p-ratio). The OR for MI at low versus high 
P-carotene at low, medium and high m/p-ratio was 2.86 (95% CI 1.61-5.11), 
2.76 and 1.38, respectively. For a-tocopherol, a significant positive 
association with MI was observed at the low SFA level, and a (non-
significant) negative association at the high SFA level. This relationship was 
not reflected in the associations at different levels of PUFA or MUFA. For 
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selenium, an inverse association with MI was seen at low PUFA (OR 2.95, 
95% CI 1.22-5.09) and high SFA levels (OR 1.75, 95% CI 0.89-3.42). 
The association between B-carotene and MI at different levels of PUFA 
was recomputed, excluding persons with angina pectoris; the same trend was 
observed (ORs were 1.46, 2.03 and 3.20 for low, medium and high PUFA 
tertiles, respectively). To evaluate the contribution of centres with very high 
PUFA (Israel) or MUFA (Spain) levels to the observed interaction between 
PUFA and B-carotene, ORs were also computed with exclusion of these 
centres, which did not considerably change the estimates (results not shown). 
Table 4. Risk of myocardial infarction at low (10-percentile) compared to high (90-
percentile) levels of antioxidants, at different fatty acid levels. 
P-carotene a-tocopherol Selenium 
OR f (95% CI) OR* (95% CI) OR11 (95% CI) 
Overall 1.98 (1.39-2.82) 0.87 (0.67-1.12) 1.12 (0.75-1.68) 
Polyunsaturated fatty acids§ 
Low 1.79 (0.98-3.25) 0.77 (0.47-1.25) 2.49 (1.22-5.09) 
Medium 1.76 (1.00-3.11) 1.23 (0.79-1.89) 0.76 (0.41-1.41) 
High 3.47 (1.93-6.24) 0.95 (0.61-1.48) 1.11 (0.61-2.06) 
Monounsaturated fatty acids* 
Low 2.68 (1.49-4.84) 1.07 (0.68-1.69) 1.00 (0.54-1.83) 
Medium 1.89 (1.02-3.47) 1.12 (0.71-1.77) 0.99 (0.54-1.85) 
High 1.66 (0.94-2.96) 0.68 (0.45-1.02) 1.21 (0.63-2.31) 
Saturated fatty acids6' 
Low 2.51 (1.39-4.56) 0.63 (0.41-0.96) 0.84 (0.46-1.53) 
Medium 1.63 (0.87-3.03) 0.89 (0.60-1.33) 0.97 (0.55-1.73) 
High 2.15 (1.19-3.90) 1.44 (0.86-2.42) 1.75 (0.89-3.42) 
10-percentile: 0.15 (iglg, 90-percentile: 1.11 figlg. Adjusted for age, centre, smoking and 
BMI. 
* 10-percentile: 103 /xg/g, 90-percentile: 385 fxg/g. Adjusted for age, centre, smoking and BMI. 
' 10-percentile: 0.431 /zg/g, 90-percentile: 0.861 /zg/g. Adjusted for age, centre and smoking. 
8 Outpoints for tertiles: 12.32 %, 15.60 %. 
# Outpoints for tertiles: 50.27 %, 54.53 %. 
fe Outpoints for tertiles: 26.86 %, 30.53 %. 
The association of proportion of PUFA with risk of MI, without 
accounting for antioxidant levels, was examined in a logistic regression 
model including tertiles of PUFA, with adjustment for age, centre, smoking 
and BMI. A positive association was observed, with an OR of 1.26 (95% CI 
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0.92-1.71) in the middle tertile as compared to the lowest, and 1.76 (95% CI 
1.24-2.50) for the highest tertile. 
The most important predictor of MI in all multivariate models was 
smoking. The odds ratios for the smoking categories, in the model estimating 
coefficients for the interaction between B-carotene and PUFA, increased from 
1.72 (95% CI 1.20-2.45) in ex-smokers and 1.74 (95% CI 0.86-3.51) in 
subjects smoking less than 6 cigarettes per day, to 9.63 (95% CI 6.03-15.4) 
in subjects smoking over 20 cigarettes daily, compared to those who had 
never smoked. Smoking was also associated with PUFA; the mean proportion 
of PUFA was 14.4% in non-smokers and 13.7% in smokers (p = 0.06). To 
test whether the interaction between selenium and PUFA was perhaps the 
reflection of an interaction with smoking, we compared the fit of a no-
interaction model with the fit of a model with the selenium-PUFA interaction 
(both as continuous variables) and with a model including the selenium-
smoking interaction (smoking in 7 categories). The relative improvement with 
the smoking interaction was larger (x 2 = 12.30 [6 degrees of freedom], 
p = 0.06) than with the PUFA interaction (x 2 = 1-64 [1 degree of freedom], 
p = 0.20). A similar approach was used for B-carotene: improvement of the 
model with the B-carotene-PUFA interaction was, as said before, borderline 
significant (x 2 = 3.20, p = 0.07); an interaction of B-carotene and smoking 
did not improve the model (x 2 = 2.30, p = 0.89). 
Discussion 
In this multi-centre case-control study, the strongest association of low 
adipose tissue B-carotene with increased risk of MI was observed at 
simultaneous high proportion of PUFA in adipose tissue. Due to the 
mathematical relation that exists between proportions of different types of 
fatty acids, opposite results were seen for levels of MUFA and SFA. Since 
the correlation between adipose tissue levels and dietary intake is best for 
PUFA2 1, levels of MUFA and SFA may be considered derived values, not 
directly related to intake. For a-tocopherol no association with MI was 
observed, at neither of the PUFA levels. An inverse association of selenium 
with MI was observed at low PUFA and high SFA levels, which may be 
attributed to the larger proportion of smokers in the low PUFA category. 
To avoid changes in antioxidant status due to previous disease, the cases 
in this study were subjects presenting acute, first-time myocardial infarction. 
Excluding subjects with a history of angina pectoris, who might have 
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changed their diet previously, did not change the overall trend for the 
6-carotene-PUFA interaction. Hospital controls, or friends and relatives, in 
some of the participating centres, might not have represented the distribution 
of the antioxidant status in the population from which the cases had 
originated, although due care was taken to avoid such a bias. If, however, a 
control disease would have been related to antioxidant status, it is most likely 
to reduce the antioxidant status, and thus diminish the risk estimates for MI. 
The use of friend/relative controls may lead to overmatching on lifestyle 
(including diet) exposures. This would also result in a decreased estimate of 
association between antioxidants and MI, thus a conservative bias. The 
classical risk factors - cigarette smoking, hypertension and diabetes - were 
consistently more prevalent in acute MI cases than controls. 
Smoking habits and BMI were found to be confounders of the 
relationship between 6-carotene and MI, and smoking habits alone for 
selenium and MI; therefore, we adjusted for these factors in the multivariate 
analysis. At low PUFA levels we observed an inverse association of selenium 
and MI. As smoking is also associated with PUFA status (lower PUFA in 
smokers compared to non-smokers), the interaction between selenium and 
PUFA may also be explained by an interaction between selenium and 
smoking, although we cannot say to what extent. For 6-carotene, the 
differential risk of MI at different proportions of PUFA could not be 
explained by an interaction with smoking. Even if there were such an 
interaction, it would affect the odds ratios in the opposite way, as observed 
for selenium; better adjustment for smoking could only enhance our findings 
for 6-carotene and PUFA. The interaction between a-tocopherol and SFA 
cannot easily be interpreted, since it is not reflected in any interaction with 
PUFA. Adipose tissue SFA in itself have a poor correlation with dietary fat 
intake. 
Levels of 6-carotene, a-tocopherol, selenium and fatty acid composition 
were determined in a central laboratory. Selenium in toenails has been shown 
to be a time-integrated measure of selenium intake22. For adipose tissue 
6-carotene and a-tocopherol, a relationship with intake has been shown, but 
it is not very strong23. However, most of the body's a-tocopherol is stored in 
the adipose tissue24. The fatty acid composition of adipose tissue, especially 
of essential fatty acids21, has been shown to be a reliable indicator of dietary 
intake over a longer period of time. The absence of a relation between 
adipose PUFA and a-tocopherol is surprising, in view of their common food 
sources. 
It should be remarked that the overall findings of an inverse association 
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of 6-carotene with MI, especially at high PUFA levels, need not necessarily 
hold for all the populations contributing to this study. The number of subjects 
in the different centres are too small to allow these calculations for the 
separate centres, but the main conclusions did not change when the centres 
with extreme PUFA and MUFA levels (Israel and Spain) were excluded from 
analysis. 
Experimental studies indicate that the balance between antioxidant 
status, oxidative stress and PUFA as the main substrate for oxidation, may 
determine the amount of damage to cells and tissues and eventually the 
occurrence of disease. The oxidation of LDL is thought to be a major factor 
in atherogenesis, mainly by causing an increased uptake of lipids in the 
macrophages in the arterial wall and by its cytotoxic effects on the 
endothelial cells3. Increasing the amount of vitamin E in the LDL particle by 
oral supplementation increases the resistance against in vitro oxidation4'5. 
However, the initial concentration of vitamin E in the LDL is not related to 
oxidation resistance25'26; this has been attributed to other components of the 
LDL, such as other antioxidants, but also to the fatty acid composition. Long-
term supplementation with |3-carotene resulted in increased 6-carotene levels 
in the LDL, but these enriched LDL particles were not more resistant to in 
vitro oxidation4'5. Oxidation of the LDL results in the formation of 
hydroxylated derivatives of both oleic and linoleic acid27. However, a more 
modest increase in amounts of hydroxy derivatives is seen for oleic acid, as 
compared to linoleic acid27. Moreover, diets rich in oleic acid relative to 
PUFA, reduce the uptake of LDL by macrophages6'7'28. 
There is also a growing body of epidemiological evidence for an inverse 
relationship between antioxidant nutrients and CHD-risk8"11*29'30. However, not 
all studies have found this association12"15. For vitamin E, possibly only very 
high intake through supplementation is associated with decreased risk of 
CHD8. The findings for B-carotene indicate an inverse association at normal 
dietary intake levels. Population-based studies have scarcely addressed the 
combined effect of antioxidants and dietary fatty acids on CHD risk. Kok et 
al. 1 6 observed lower selenium to PUFA ratios in cases with severe versus 
mild coronary atherosclerosis, but these results were not adjusted for smoking 
status. The ratio of a-tocopherol to PUFA did not differ between these 
groups. Riemersma9 reported no significant interaction between adipose 
linoleic acid and plasma vitamin E in the relationship with angina pectoris. 
This is in agreement with our findings for a-tocopherol. The interaction 
between B-carotene and PUFA has not been addressed in other studies, to our 
knowledge. As Reaven et al.5 have remarked, from the fact that 6-carotene 
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does not confer direct protection to the LDL in in vitro experiments, it should 
not be concluded that it has no role as an antioxidant in the prevention of 
coronary heart disease. The oxidation of LDL by different types of cells in 
the artery wall may well be influenced by the B-carotene content of these 
cells. Our finding of an interaction between B-carotene and PUFA supports 
such an alternative role of B-carotene as an antioxidant, whereas the 
protective role of a-tocopherol may be less important at normal dietary intake 
levels in the in vivo situation. 
In conclusion, the association of low B-carotene levels in adipose tissue 
with increased risk of MI is modified by adipose tissue PUFA levels. At high 
PUFA, the risk of MI of low compared to high B-carotene status, is twice as 
high as at low PUFA levels. Since adipose tissue fatty acid composition and 
B-carotene concentration are reported to be indicators of long-term dietary 
intake, it may be concluded that high intake of PUFA may increase the risk 
of MI when 6-carotene intake is inadequate (supposedly to protect the PUFA 
against oxidation). Low B-carotene intake may increase the risk of MI in 
men, particularly when they consume large amounts of PUFA. Increased 
consumption of yellow fruits and green leafy vegetables may improve the 
OLD risk-profile of middle-aged men. In the evaluation of PUFA, relative to 
MUFA and SFA, both the susceptibility to oxidative stress and the 
cholesterol-lowering potential should be taken into account. It is too early to 
make firm recommendations in favour of MUFA over PUFA on the basis of 
available evidence. 
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Relationship between antioxidant vitamins in 
adipose tissue, plasma and diet 
Alwine FM Kardinaal, Pieter van 't Veer, Henny AM Brants, Henk van den 
Berg, Jan van Schoonhoven, Rudolph JJ Hermus 
Abstract 
To evaluate fat-soluble vitamin concentrations in adipose tissue as biomarkers 
of intake, estimates of usual intake of 6-carotene, total vitamin A and 
a-tocopherol assessed by food frequency questionnaire, were compared with 
plasma and adipose tissue B-carotene, retinol and a-tocopherol 
concentrations, respectively. Data were collected in 1992 for 38 male and 47 
female healthy, non-smoking volunteers, aged 50-70. For a-tocopherol a 
significant age- and sex-adjusted partial correlation (r = 0.24, p < 0.05) was 
observed between adipose tissue levels and intake, which was mainly present 
in women (r = 0.30). For B-carotene, the partial r was 0.20 (r = 0.30 in men, 
0.12 in women). Adipose tissue retinol did not reflect intake (partial 
r = 0.08). Correlations of adipose tissue vitamin levels with plasma vitamin 
levels were overall higher (r = 0.34 for a-tocopherol, r = 0.56 for B-carotene, 
r = 0.17 for retinol) than correlations with intake. Plasma concentrations of 
a-tocopherol, B-carotene and retinol were not associated with dietary intake 
(partial r = 0.05, 0.17 and -0.12 respectively). Pearson correlations of 
repeated measurements in adipose tissue (after 4 months) were 0.24 for 
retinol, 0.50 for 6-carotene and 0.78 for a-tocopherol. Adipose tissue 
B-carotene was shown to increase 6-fold after 6 months supplementation with 
30 mg B-carotene daily. Although gender differences may exist, it is 
concluded that, especially in case-control studies, adipose tissue vitamin 
concentrations may be preferable to plasma levels. 
Introduction 
Antioxidant vitamins may have an important role in the prevention of certain 
Submitted 
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types of cancer and cardiovascular disease1'2. In the epidemiological studies, 
antioxidant intake is often assessed by means of a food frequency 
questionnaire. In case-control studies, however, this type of assessment is 
liable to differential recall by cases and controls and therefore may bias the 
outcome of the study; in multi-country studies, important to achieve larger 
ranges in intake, diet questionnaires are difficult to standardize. To overcome 
these problems, biomarkers of intake, e.g. plasma B-carotene, may be used as 
an alternative to diet assessment. However, dietary intake is not the only 
determinant of biomarker status. Antioxidant levels in blood or tissue are 
affected by genetic and lifestyle factors, as well as intake of other nutrients. 
In case-control studies, a useful biomarker of intake should be related to 
intake over a relatively long period of time, as the onset of chronic diseases 
is usually related to long-term exposures. Levels of vitamin E and B-carotene 
in plasma are related to intake, but represent a relatively short time period. 
To assess fatty acid composition of the diet, especially for polyunsaturated 
fats, the composition of adipose tissue has been shown to be a reliable 
indicator3'4. As vitamin E, 6-carotene and retinol are fat-soluble compounds, 
which are stored in subcutaneous adipose tissue, concentrations in adipose 
tissue may be a better indicator of intake than plasma levels are. Information 
on the relationship between intake and adipose tissue levels of these vitamins 
in free-living human populations is very limited5'6. 
Therefore, we studied the relationship between intake, plasma and 
adipose tissue levels of vitamin E, B-carotene and retinol; linoleic acid 
content was included as well, to provide an independent means of comparison 
with other studies. The interrelation of these parameters was studied in a 
cross-sectional design. Moreover, reproducibility was assessed by repeated 
measurement and for B-carotene the tissue response to supplementation was 
examined. 
Materials and methods 
Study population 
Subjects in this study were men and women aged 50-70 years, recruited 
by an advertisement in a local newspaper. All 85 volunteers (38 men and 47 
women) were apparently healthy non-smokers, did not use vitamin 
supplements or prescribed medication, had not lost weight in excess of 5 kg 
and had had stable food habits during the previous year. The protocol was 
approved by an independent medical-ethical review board. 
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Design 
A group of 30 men and 26 women (group 1) was invited to our institute 
for two visits, 4 months apart (in May and September). Both times a fat 
aspirate from the gluteal region and a blood sample were obtained; a food 
frequency questionnaire was taken home and returned by mail. Alcohol intake 
was assessed with a separate questionnaire during the first visit, and 
anthropometric measures were taken. A second group (8 men, 21 women) 
was asked to take two capsules with P-carotene (15 mg each) daily, for a 
period of 6 months (from April to October), before the second visit. The 
same data were collected as in the first group. Data for group 1 were used to 
assess reproducibility of measurements. Results from group 2 informed us on 
the responsiveness of adipose tissue concentrations to dietary intake of 
B-carotene. Data from the first visit of both groups were used to assess 
correlations between dietary intake, plasma and adipose tissue concentrations. 
P-Carotene supplementation 
At their first visit, subjects in group 2 were given instructions in writing, 
to take two P-carotene capsules daily with their main meal. The capsules 
used were commercially available (Lamberts Natural Beta Carotene, supplied 
by Adviesbureau Orthomoleculaire Voeding Den Haag) and contained 15 mg 
P-carotene, encapsulated with gelatine, glycerine, soya bean oil and water. 
Analysis in our lab indicated a mean value of 17.8 mg p-carotene per capsu-
le. Participants received capsules in two-monthly batches and were instructed 
to store them in a cool, dry place and protected from light. 
Fat aspirate and blood collection 
Subcutaneous fat aspirates were obtained by a needle biopsy from the 
lateral buttock, as described by Beynen and Katan7, using a 16-gauge needle, 
attached to a plastic container in which the tissue (mean 39 ± 15 mg) was 
collected by connecting a vacuum tube. The plastic container was 
immediately put on dry ice and stored at -80°C until analysis. 
A venous blood sample was drawn in a 10 ml heparin tube from 
nonfasting participants and refrigerated until plasma was separated. Blood 
was centrifuged (10 min at 1500 g) within 2 hours and plasma was stored at 
-80°C. 
Biochemical analyses 
Samples taken at the first and second visit for each subject were 
determined in the same run. Concentrations of retinol, p-carotene and 
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a-tocopherol in adipose tissue and plasma were determined by reverse-phase 
HPLC8'9 and spectrophotometric detection. Samples were protected from light 
during the analysis. The adipose tissue sample was saponified, and 
quantitatively split for vitamin and fatty acid determination. The coefficients 
of variation for the analysis of retinol, 6-carotene and a-tocopherol in adipose 
tissue were 4.3%, 7.1% and 4.9% (at mean values of 4.66 figlg, 2.36 pglg 
and 85.3 pglg respectively, in the quality control samples). For determination 
in plasma, coefficients of variation were 4.3% for retinol (mean 1.78 /anol/T), 
7.3% for 6-carotene (mean 0.26 /anol/1) and 3.2% for a-tocopherol (mean 
25.4 /miol/T). Vitamin concentrations in adipose tissue were expressed in [xglg 
of total fatty acids (mean fatty acid content of aspirates 14.5 ±9.1 mg). 
Fatty acid content was assessed by GLC in an aliquot of the same 
extract as the vitamins, adding heptadecanoic acid (C17:0) as an internal 
standard to the sample before saponification. Linoleic acid (C18:2) was 
quantitated as the percentage of the peak area of total fatty acids. The 
coefficient of variation for linoleic acid was 3.4%. 
Total plasma cholesterol was enzymatically determined (CHOD-PAP 
method, Boehringer, Mannheim, Germany). 
Food frequency questionnaire 
Usual dietary intake of retinol, 6-carotene and vitamin E during the 
previous year was assessed by a 95-item self-completed semi-quantitative 
food frequency questionnaire (FFQ), adapted from a questionnaire on retinol 
and 6-carotene intake, developed and validated by Stiggelbout et al. 1 0 
Additional items representing vitamin E intake were selected on the basis of 
a high vitamin E content and regular use according to the Dutch National 
Food Consumption Survey 19871 1. Frequency of consumption was reported in 
eight categories, never, seldom, 1 day per month, 1 day per 2-3 weeks, 1-2 
days per week, 3-4 days per week, 5-6 days per week, 7 days per week. 
Portion sizes were quantified by respondents in terms of household measures 
(slices, spoons, cups) to which standard weights were assigned. For some 
foods (e.g., milk and dairy products), individual portion sizes were calculated 
from the number of glasses obtained from one litre. Consumption of a 
number of vegetables and fruits was asked separately for summer and winter. 
The use of fats and oils was specified according to type and brand. 
Questionnaires were entered and processed using an automated 
processing system. Completeness, credibility of reported number of servings 
and consistency in reported consumption frequencies were checked. If 
necessary, participants were contacted for further information. Data on mean 
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daily consumption of food products in grams were converted to nutrient 
intake using the computerized Dutch Food Composition Table for retinol 
equivalents and linoleic acid. Information on vitamin E and 6-carotene 
content was mainly derived from recent analyses of Dutch food products12, 
but did not provide complete coverage of all foods in the questionnaire (75% 
for vitamin E, 97% for 6-carotene). Additional information was obtained 
from the English food composition table. Intake of linoleic acid was calcula-
ted, although the questionnaire was not specifically designed to measure this 
nutrient. However, since the important sources of linoleic acid and vitamin E 
are largely the same foods, the questionnaire is considered to measure linoleic 
acid well enough to obtain adequate ranking of subjects according to intake. 
Statistical analysis 
In the group of 56 non-supplemented subjects, the fat aspirate was 
missing for three persons at the first measurement. For two others the vitamin 
values were outside three standard deviations of the mean; these values were 
considered unreliable because of very little fat tissue in the fat aspirate and 
therefore were excluded. For three subjects, the FFQ was excluded from the 
analysis, because their food pattern largely differed from the usual Dutch 
diet, for which the questionnaire was designed. Three other subjects had 
missing plasma data for the second measurement. In the group of 29 
supplemented subjects, three subjects had missing fat aspirate data for the 
first measurement. For the second measurement, aspirate data were missing 
for two subjects, plasma data for two other subjects, and FFQ data for one 
person. 
Skewed distributions of all dietary, plasma and adipose nutrients, except 
for dietary retinol equivalents and relative intake of linoleic acid (percentage 
of total fat intake), were normalized by natural logarithm. All correlation 
analyses were performed on the loge-transformed data. In tables 1 and 3, 
untransformed mean levels are presented; in table 5, values are re-
transformed from the loge-value, for ease of interpretation. Plasma 
a-tocopherol values were strongly correlated with total plasma cholesterol 
(r = 0.64, p < 0.001), but plasma 6-carotene was not (r = 0.15, p = 0.16). 
Therefore, absolute plasma a-tocopherol values as well as the ratio of 
a-tocopherol to total plasma cholesterol are presented where necessary. 
Mean and standard deviations of vitamin levels were calculated. 
Reproducibility of all three independent measurements (in diet, plasma, 
adipose tissue) was assessed by calculating Pearson correlation coefficients. 
Association between adipose tissue vitamin levels and age, sex, body mass 
102 Chapter 7 
index, waist-hip ratio, alcohol intake and socioeconomic status was tested by 
linear regression analysis. The change in adipose tissue and plasma 
antioxidant concentrations in the suppleted group was adjusted for changes in 
the non-suppleted group with use of linear regression of the second 
measurement on group and first measurement. Simple Pearson and age- and 
sex-adjusted correlations between adipose tissue and plasma levels, and intake 
assessed by FFQ were calculated. To account for variability in the plasma 
and adipose tissue measurements, correlation coefficients were deattenuated, 
using the within- to between-person variance ratios13, calculated with ANOVA 
from the repeated measurements in the non-supplemented group. The 
deattenuated correlation (rt) is calculated from the observed correlation (r0) as 
follows: 
r, = r„ SQRT{(1 + XJ2){\ + V2)}' w n e r e is m e variance ratio, x are plasma 
measurements and y adipose tissue measurements. 
Finally, age- and sex-adjusted mean dietary intake and plasma levels are 
presented across quartiles of adipose tissue concentrations. Tests for trend 
over quartiles were performed by assigning the median value of the quartile 
to each category. Analyses were performed with the BMDP software package. 
Results 
Characteristics of the study population at the start of the study are 
presented in Table 1. Men and women differed with respect to socio-
economic status and waist-hip ratio. Usual intake of vitamin E ranged from 
5.5 to 37.3 mg per day; intake of B-carotene varied from 0.64 to 4.05 mg. 
Plasma levels of a-tocopherol ranged from 20.1 to 55.6 /umo\/] 
(tocopherohcholesterol from 2.8-8.0), B-carotene from 0.09 to 4.7 /rniol/1. 
Adipose tissue concentration of a-tocopherol varied 11-fold, between 87 and 
950 tug/g; the range for B-carotene was about 20-fold, from 0.33 to 6.9 jug/g. 
Pearson correlation coefficients were calculated for repeated 
measurements of vitamin and linoleic acid content in adipose tissue and 
plasma, and intake assessed by FFQ, in the non-supplemented group (Table 
2). The highest reproducibility was found for plasma values. It should be 
noted that the correlation for cholesterol-standardized a-tocopherol is lower 
than for absolute levels of a-tocopherol. For adipose tissue, the 
reproducibility of retinol levels is low (r = 0.24). The highest correlation in 
adipose tissue is observed for a-tocopherol (r = 0.78, p < 0.001). 
Reproducibility of adipose tissue 6-carotene values was considerably better 
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Reproducibility of adipose tissue 6-carotene values was considerably better 
for women than for men (r = 0.62 and 0.39, respectively). The same could be 
said for linoleic acid content (r = 0.91 for women, r = 0.36 for men). In the 
smaller samples, containing below 10 mg fatty acids, the correlation for 
a-tocopherol was 0.69, for B-carotene only 0.21 (p = 0.3) and for linoleic 
acid 0.44 (p = 0.02); corresponding correlation coefficients in samples 
containing over 10 mg fatty acids were 0.90, 0.90 and 0.89, over the same 
range. These data point to larger analytical variation in smaller samples. 
Repeated assessment of intake by FFQ showed somewhat higher correlation 
coefficients for linoleic acid (r = 0.80) as compared to the vitamins. 
Table 1. Characteristics of the study population, mean (± SD) dietary intake, plasma 
and adipose tissue levels of fat-soluble vitamins and linoleic acid among 38 men and 47 
women in the Netherlands, 1992. 
Men (n = 38) 
mean ± SD 
Women (n = 47) 
mean ± SD 
Age 59.5 + 6.3 58.3 ± 5.9 
BMI (kg/m2) 24.4 ± 2.7 24.7 ± 3.3 
Waist/hip ratio 0.90 ± 0.06 0.83 ± 0.10 
Serum cholesterol (mmol/1) 5.9 ± 1.2 5.7 ± 0.9 
Alcohol use (%) 95 94 
Socioeconomic status (%) 
low 32 52 
high 68 48 
Dietary intake 
P-carotene (mg) 1.73 ± 0.66 1.75 + 0.72 
retinol (RE) 0.83 ± 0.23 0.79 ± 0.24 
a-tocopherol (mg) 17.3 ± 6.5 13.1 ± 5.9 
linoleic acid (% of total fat) 19.0 ± 7.0 13.8 ± 7.2 
Plasma 
P-carotene (amol/L) 0.41 ± 0.26 0.63 ± 0.67 
retinol (umol/L) 2.47 ± 0.59 2.11 ± 0.68 
a-tocopherol (rnnol/L) 35.5 ± 8.6 32.6 ± 7.4 
a-tocopherol/cholesterol 6.0 ± 1.0 5.7 ± 1.0 
Adipose tissue 
P-carotene (wg/g) 1.08 + 0.66 1.81 + 1.20 
retinol (ug/g) 2.99 ± 3.08 2.35 ± 1.30 
a-tocopherol (ug/g) 240 ± 106 281 ± 152 
linoleic acid (%) 15.9 ± 4.8 13.0 ± 4.4 
Table 2. Pearson correlations between repeated measurements of vitamin and linoleic acid content in adipose and plasma, and intake 
measured by FFQ: the Netherlands, 1992. 
Adipose Plasma FFQ 
Men Women Overall Men Women Overall Men Women Overall 
n = 26 n = 25 n = 51 n = 28 n = 25 n = 53 n = 29 n = 24 n = 53 
|3-carotene 0.39* 0.62*** 0.50*** 0.90*** 0.95*** 093*** 0.60*** 0.74*** 0.67*** 
retinol 0.24 0.27 0.24 0.53** 079*** 0.74*** 0.38* 0.47* 0.43 
a-tocopherol Q 77*** 0.86*** 0.78*** 0.82*** Q gQ*** 0.86*** 0.68*** 0.55** 0.63*** 
a-tocopherol/cholesterol - - - 0.72*** 0.67*** 0.69*** - - -
linoleic acid (%) 0.36 Q <)j*** 0.58*** - - - 0.81*** 0.76*** 0.80*** 
* p < 0.05; ** p < 0.01; *** p < 0.001. 
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To evaluate whether an increased 6-carotene intake resulted in enhanced 
adipose tissue 6-carotene levels, concentrations of the vitamins in adipose and 
in plasma were compared before and after the 6-month supplementation 
period. The difference was corrected for any changes observed in the non-
supplemented group (Table 3). In adipose tissue a sixfold increase of mean 
6-carotene levels was measured. In plasma we observed an (eightfold) 
increase in 6-carotene as well, on average with 3.28 ^mol/1 (95% CI 
2.75-3.81). For a-tocopherol and retinol, no change was seen. There appeared 
to be no correlation between the increase in plasma 6-carotene and the 
increase in adipose tissue 6-carotene (r = 0.09); however, when two extreme 
values were excluded, a significant correlation was observed (r = 0.56, 
p < 0.005). 
Table 3. Effect of ^-carotene supplemention on ^-carotene, a-tocopherol and retinol 
levels in adipose tissue and plasma: the Netherlands, 1992. 
Vitamin Group Baseline 
mean (SD) 
End 
mean (SD) 
Diff 
mean (SD) 
A Diff (95% CI) 
Adipose («g/g)+ 
P-carotene Suppl 
Ref 
1.47 (0.83) 
1.54 (1.18) 
9.31 (9.74) 
1.84 (2.45) 
7.84 (9.42) 
0.31 (2.43) 
7.56 (4.81 - 10.3) 
a-tocopherol Suppl 
Ref 
278 (134) 
258 (138) 
327 (155) 
286 (184) 
49 (135) 
28 (114) 
22 (-35 - 80) 
retinol Suppl 
Ref 
2.21 (1.25) 
2.81 (2.60) 
3.07 (2.12) 
3.07 (4.23) 
0.86 (2.27) 
0.26 (5.02) 
-0.00 (-1.76 - 1.76) 
Plasma (wmol/r >* 
P-carotene Suppl 
Ref 
0.46 (0.28) 
0.58 (0.65) 
3.77 (2.01) 
0.63 (0.67) 
3.31 (1.95) 
0.04 (0.14) 
3.28 (2.75 - 3.81) 
a-tocopherol Suppl 
Ref 
34.2 (8.6) 
33.1 (7.3) 
35.0 (9.6) 
34.3 (8.3) 
0.8 (6.2) 
1.2 (4.2) 
-0.4 (-2.7 - 1.9) 
retinol Suppl 
Ref 
2.32 (0.79) 
2.21 (0.59) 
2.43 (0.98) 
2.26 (0.50) 
0.11 (0.70) 
0.04 (0.46) 
0.10 (-0.14 - 0.34) 
supplemented group: n = 25; reference group: n = 51. 
supplemented group: n = 27; reference group: n = 53. 
The difference in the supplemented group, after correction, was 7.56 figlg 
(95% CI 4.81-10.3). Adipose tissue a-tocopherol and retinol did not change 
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significantly. 
The association of adipose tissue a-tocopherol and P-carotene with sex, 
age, socioeconomic class, alcohol intake, body mass index and waist-hip ratio 
was tested by linear regression analysis, using the first measurement for all 
subjects. None of these factors were associated with adipose a-tocopherol; 
P-carotene levels were significantly higher in women compared to men, and 
were inversely associated with waist-hip ratio (p = 0.01), but not with body 
mass index (p = 0.25). When sex was taken into account, waist-hip ratio was 
no longer associated with adipose p-carotene. The intake of vitamin E was 
significantly associated with the intake of P-carotene (r = 0.34, p < 0.05); as 
this may be caused by the association of both nutrients with energy intake, 
we also looked at correlation of vitamin-intake, relative to total fat intake. 
The significant association remained: r = 0.45 (p < 0.001). Plasma P-carotene 
and cholesterol-standardized plasma a-tocopherol were not significantly 
associated (r = 0.06), but adipose p-carotene and tocopherol were (r = 0.29, 
p = 0.01). 
Correlations between measurements in adipose, plasma and FFQ are 
displayed in Table 4. Plasma and FFQ measurements of retinol were not 
correlated (r = 0.06). Intake of a-tocopherol was weakly correlated with 
cholesterol-standardized plasma-tocopherol (r = 0.22), but not with absolute 
plasma levels. Overall, adipose tissue levels were stronger correlated to intake 
than plasma levels are; for p-carotene crude correlation was 0.16 (not 
significant), the age- and sex-adjusted partial correlation 0.20 (p = 0.09). For 
a-tocopherol similar correlations were calculated (crude r = 0.19, partial 
r = 0.24, p = 0.05). Linoleic acid content of adipose tissue was significantly 
related to intake (r = 0.44, p < 0.001). Mutual correlations for plasma and 
adipose levels were higher than with intake. Especially for p-carotene, 
correlation was relatively high (partial r = 0.56, p < 0.001). Standardization 
of plasma a-tocopherol to cholesterol did not affect the correlation with 
adipose a-tocopherol. For men a higher correlation between plasma and 
adipose a-tocopherol was observed than for women (crude r = 0.53 and 0.21, 
respectively). 
From the repeated measurements in the non-supplemented group, the 
within- to between-person variance ratio was calculated. The ratio varied 
between 0.08 for P-carotene and 0.41 for cholesterol-standardized a-toco-
pherol in plasma, and between 0.31 for a-tocopherol and 1.7 for retinol in 
adipose tissue. Crude correlation coefficients for the interrelations of intake, 
plasma and adipose tissue levels were deattenuated for this variance ratio 
(Table 4), which did not change the results substantially. 
Table 4. Pearson correlation between vitamin and linoleic acid levels in adipose, plasma and FFQ: the Netherlands, 1992. 
Overall Adipose vs Plasma ( n = 77) Adipose vs FFQ (n = 74) Plasma vs FFQ (n = 82) 
crude age-
and sex 
adjusted 
deattenuatedT crude age- and 
sex 
adjusted 
deattenuatedf crude age-
and sex 
adjusted 
deattenuated+ 
ct-tocopherol 
men 
women 
0.31** 
0.53** 
0.21 
0.34** 0.34** 0.19 
0.16 
0.30* 
0.24* 0.20 0.11 
0.18 
-0.06 
0.05 0.11 
P-carotene 
men 
women 
0.62*** 
0.53** 
0.59*** 
0.56*** 0.77*** 0.16 
0.30 
0.12 
0.20 0.20 0.15 
-0.07 
0.33* 
0.17 0.15 
retinol 
men 
women 
0.21 
0.25 
0.16 
0.17 0.31** 0.12 
0.14 
0.08 
0.08 0.14 0.06 
-0.02 
-0.12 
-0.12 0.07 
linoleic acid 
men 
women 
0.44*** 
0.40* 
0.40* 
0.42*** 0.51*** ~ ~ ~ 
a-tocopherol/ 
cholesterol 
men 
women 
0.30** 
0.60*** 
0.18 
0.34*** 0.35** 
- - -
0.22* 
0.33* 
0.09 
0.19 0.24* 
For within- to between person variance ratio, 
p s 0.05; ** p < 0.01; *** p < 0.001. 
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Table 5 shows the age- and sex-adjusted mean plasma values and intake 
for B-carotene, vitamin E and linoleic acid, by quartile of adipose tissue 
concentration. Mean intake of B-carotene changed little across adipose 
quintiles. Intake of vitamin E was 27% higher in the highest adipose quartile 
than in the lowest quartile. For relative intake of linoleic acid the difference 
was 42%. Mean plasma levels of B-carotene in the highest adipose quartile 
(0.63 /miol/1) were more than twice as high as in the lowest quartile (0.30 
/anol/1). For absolute plasma tocopherol, the difference between quartiles was 
not significant (p = 0.11); for the tocopherol:cholesterol ratio, there was a 
15% increase over adipose quartiles and a significant trend (p < 0.05). 
Table 5. Age- and sex-adjusted mean vitamin and linoleic acid concentrations in plasma 
and intake assessed by FFQ, by quartiles of adipose tissue concentration, among 38 
men and 47 women, the Netherlands, 1992. 
Adipose quartiles* 
2 3 p-trend 
Plasma 
(3-carotene («raol/l) 0.30 0.32 0.51 0.63 < 0.01 
a-tocopherol (umol/1) 30.3 33.5 33.6 34.6 0.11 
a-tocopherol:cholesterol 5.27 5.89 5.90 6.08 < 0.05 
FFQ 
p-carotene (mg) 
vitamin E (mg) 
linoleic acid (g) 
0.90 
13.1 
13.8 
0.89 
12.5 
15.0 
0.98 
12.7 
16.4 
1.00 
16.6 
19.6 
0.35 
< 0.05 
0.01 
Quartile outpoints for P-carotene: 0.83, 1.14, 2.01 ug/g; a-tocopherol: 180, 238, 309 fig/g; 
linoleic acid: 11.7, 13.1, 16.4 %. 
Discussion 
Aim of the present study was to evaluate the use of fat-soluble vitamins 
in adipose tissue as biomarker of dietary intake in epidemiological studies. 
Comparison of dietary intake of B-carotene and a-tocopherol with plasma and 
adipose levels among 85 healthy men and women has shown a moderate 
correlation of adipose tissue levels with intake assessed by FFQ, only 
somewhat higher than the correlation observed between plasma levels and 
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intake. This is consistent with the notion that adipose tissue better reflects 
long-term intake and is less subject to short-term fluctuations. However, 
within-person variability of adipose tissue levels was higher than of plasma 
levels. Adipose tissue 6-carotene was shown to respond to prolonged oral 
supplementation. 
Strength of correlations partly depend on analytical and intra-individual 
variation of measurements. We were able to adjust for those, because 
repeated measurements were available. Repeated measures of adipose tissue 
levels showed relatively larger differences than plasma levels, although less 
fluctuation was expected. A possible explanation is the less homogeneous 
texture of the adipose tissue compared to plasma, which may cause an 
uneven distribution of the vitamins in the tissue, or the larger analytical 
variation observed in smaller samples, rather than biological variation. 
Overall analytical variation was within acceptable ranges. However, unlike 
plasma levels, adipose tissue values were expressed as fxg per gram fatty 
acids. This means that the analytical variation of both the vitamin and the 
fatty acid analysis contribute to the error in the vitamin concentration. 
Intake of a-tocopherol in the present study is similar to intake assessed 
in other studies, using different food consumption methods5 ,14"16; several other 
studies have reported lower intakes17"20. Mean intake of a-tocopherol in a 
Dutch total diet study among 18-year old men was 13.9 mg 2 1. 6-Carotene 
intake, however, is considerably lower than in other studies 1 6 ' 1 8 , 2 2 ' 2 3. This may 
be due to the method of calculation of intake: in our study, as well as in that 
of Albanes et al. 2 2 (with a mean intake of 2.1 mg/day closest to our results), 
recently analyzed food composition data were used. Other studies determined 
6-carotene values by partitioning total vitamin A activity into 6-carotene, 
retinol and other carotenoids. Perhaps this latter method leads to an 
overestimation of intake of 6-carotene. Our results agree with those of a total 
diet study in the Netherlands21, in which a mean daily intake of 1.3 mg/day 
for 6-carotene was found for male adolescents. Relative intake of linoleic 
acid was similar to reports of the Dutch Food Consumption Survey11. 
Vitamin E content of adipose tissue has been reported by few 
authors5 , 8'2 4"2 7; mean a-tocopherol levels vary from 141 to 402 pglg 
triglycerides. Parker8 indicates a range of 61-811 pg/g adipose tissue. 
Concentrations cannot simply be compared between studies, because of the 
different ways to express these concentrations. In all studies relatively large 
between-person variation has been observed; in the present study levels 
varied 11-fold for a-tocopherol and 20-fold for 6-carotene. Mean 6-carotene 
content of adipose tissue in our study was of the same order as reported 
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by Parker8. 
The correlation of levels of B-carotene in adipose and plasma is much 
higher than the correlation of a-tocopherol levels. This may be explained in 
part by the larger range of adipose tissue B-carotene as compared to 
a-tocopherol. On the other hand, it might indicate a quicker response of 
adipose tissue B-carotene to fluctuations in plasma levels; if so, this would 
disagree with the notion that adipose tissue B-carotene levels reflect long-
term intake. 
Correlation between intake and biomarkers is always weakened by inter-
individual differences in absorption and metabolism, and the effect of other, 
mostly unknown determinants of the biomarker levels. For B-carotene the 
sensitivity of plasma concentrations to intake has been shown previously22'28. 
Plasma vitamin E concentration as such is a questionable index of intake, as 
it is strongly correlated with plasma lipid concentration. Therefore, the use of 
tocopherol/lipid ratios is recommended29 as indicator of nutritional status. In 
our study, plasma a-tocopherol (relative to plasma cholesterol) is weakly 
correlated with intake; of the other plasma parameters that were assessed, 
only B-carotene concentration was significantly associated with intake, among 
women. Others have found similar low correlations between intake of vitamin 
E and plasma a-tocopherol, among non-supplement-users17'19. Some other 
studies 1 5 ' 1 8 ' 2 0 have observed significant correlations a little over 0.3. 
Correlation between intake of carotenoids and plasma or serum B-carotene 
varies between 0.21 1 4 , 2 3 and 0.4919, among non-supplement-users. In the 
present study, for women we observed a similar correlation (0.33), but for 
men there was no correlation between intake and plasma levels at all. These 
findings may be due to some extent to the larger range of intake among 
women. However, metabolic differences between men and women may also 
play a part. 
As yet, little information is available on the relationship between intake 
and adipose tissue levels. Kayden et al. 2 5 reported increased adipose tissue 
tocopherol levels in two subjects taking supplemental vitamin E for more 
than a year; in one of them, who discontinued the supplement 20 months 
prior to the study, plasma tocopherol levels had returned to normal, but the 
adipose tissue level remained elevated. The only human study, to our 
knowledge, in which the effect of vitamin E supplementation on adipose 
tissue levels has been studied systematically, dates from some time ago 3 0. 
Two week supplementation with 1 g of vitamin E daily resulted in a doubling 
of adipose tissue levels. Experimental studies in animals have shown that 
concentrations in adipose tissue reflect the intake over a period of time31"33. 
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Accumulation of B-carotene in adipose tissue was observed 5 days after 
a single dose of 120 mg B-carotene34. In the present study an increased level 
of adipose tissue B-carotene in response to long-term supplementation has 
been observed. Since only one measurement was performed, six months after 
supplementation, no information can be derived on the time it takes before 
adipose levels start to increase, whether a steady state has been reached after 
six months, or the time required to return to normal levels, after the end of 
supplementation. The increase in adipose tissue appears to be correlated with 
the increase in plasma levels, suggesting that an equilibrium had been 
reached; both show large differences between individuals. 
For linoleic acid, the correlation between intake and adipose tissue 
levels was in the same range as reported by others3'35. Aro et al.6 recently 
reported a correlation of 0.46 (p = 0.015) between B-carotene intake assessed 
by five-day food records and 6-carotene levels in adipose tissue, sampled 
immediately thereafter. A lower correlation (r = 0.33) was found between 
three days double portions and a biopsy 6 months later. The conclusion that 
adipose tissue levels reflect recent dietary intake may be valid, but it could 
also be attributed to this particular population which may have had relatively 
stable dietary habits. In our study, adipose tissue cc-tocopherol correlated 
better with intake than plasma levels and intake, among women; for 
B-carotene, adipose tissue concentrations correlated well with intake among 
men, but not among women. An explanation is hard to give on the basis of 
these findings. However, it seems possible that metabolism and the 
distribution of fat-soluble vitamins over different body compartments may 
differ between men and women; this suggestion is supported by the finding 
that concentrations of 6-carotene in plasma and in adipose tissue in women 
are substantially higher than in men, although intake is similar. 
Overall, adipose tissue levels of linoleic acid enable us to rank subjects 
adequately according to intake, and high adipose tissue ct-tocopherol was 
related to relatively high dietary intake. Adipose tissue fi-carotene seemed to 
provide a less direct indication of intake as assessed by FFQ. Whether this is 
caused by a larger dependence on plasma concentrations, and thus recent 
dietary intake, or perhaps an insufficient ability of our FFQ to rank subjects 
according to intake adequately, for the limited range observed in this 
population, remains to be clarified. 
In conclusion, adipose tissue concentrations of B-carotene in men and 
a-tocopherol in women, respectively, seem to be feasible biomarkers of usual 
dietary intake. Overall, the association with intake is somewhat, but not much 
better than of plasma levels with intake. The advantage of biomarkers in 
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adipose tissue over plasma is evident in case-control studies; in persons who 
may have changed their diet recently, or who have endured the effects of an 
acute event, such as a myocardial infarction, plasma levels will be affected, 
whereas adipose tissue levels will most likely be constant for a longer period 
of time. In prospective studies, the choice of biomarker may be determined 
by factors such as feasibility and cost; in most cases, plasma levels will then 
be preferable. Finally, even if these biomarkers are not perfect indicators of 
dietary intake, they may still be relevant predictors of disease risk, as they 
account for the individual differences of absorption and metabolism that 
affect nutritional status. 
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Comparison of biomarkers and dietary intake of 
antioxidants in relation to myocardial infarction 
Alwine FM Kardinaal, Pieter van 't Veer, Henny AM Brants, Dick ACM 
Kruijssen, Rudolph JJ Hermus, Frans J Kok 
Abstract 
In theory, antioxidant biomarkers may be more relevant predictors of disease 
risk than dietary intake assessment, which disregards individual variation in 
absorption and metabolism. 
Concentrations of ct-tocopherol and B-carotene in adipose tissue were 
compared with usual dietary intake, in 66 patients with first acute myocardial 
infarction (MI) and 58 population controls. Adipose tissue B-carotene was 
lower in cases (0.49 jxglg ± 0.37) than in controls (0.67 fUg/g ± 0.45, 
p = 0.08), whereas dietary intake was similar. No significant differences were 
observed for cc-tocopherol in adipose tissue or in diet. There was a weak 
positive correlation between intake and adipose tissue levels among controls 
(r = 0.10 for cc-tocopherol; r = 0.24, p = 0.08 for B-carotene). An inverse 
correlation was observed among cases (r = -0.27, p < 0.05 for a-tocopherol; 
r = -0.16 for B-carotene). Other determinants of adipose tissue antioxidant 
levels were smoking status, body mass index and serum HDL cholesterol. 
The adjusted odds ratio (OR) of MI in the lowest tertile of adipose tissue 
B-carotene was 2.5 (95% CI 1.0-6.6). There was no significant association 
with dietary intake of B-carotene. For adipose tissue a-tocopherol also no 
association with MI was observed (OR in lowest tertile 0.7, 95% CI 0.3-1.7); 
dietary intake of a-tocopherol was inversely associated with MI (OR 1.8, 
95% CI 0.8-4.2), though not statistically significant. 
Adipose tissue antioxidants do not reflect dietary intake in the same 
way for MI patients and control subjects. This may indicate different 
absorption and metabolism, or a relation of the biomarkers with the disease 
status. 
Submitted 
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Introduction 
Dietary antioxidants may play a role in the prevention of coronary heart 
disease (CHD)1 , 2. Observational studies in humans have shown inverse 
associations between vitamin E, B-carotene and CHD 3 ' 4 , 5. The use of dietary 
intake assessment in case-control studies on antioxidants and CHD may 
introduce recall bias and disregards metabolic variation between individuals. 
Therefore, antioxidant biomarkers may be more relevant predictors of disease 
risk, as they account for individual differences of absorption and metabolism6. 
It is, however, necessary to know the relationship between intake and 
biomarker, for a better interpretation of diet studies and the support of dietary 
recommendations. 
We have studied the exposure to the antioxidants a-tocopherol and 
B-carotene in male patients with acute myocardial infarction and population 
controls, by assessing usual dietary intake and by determining the level of 
these antioxidants in adipose tissue. Moreover, the proportion of linoleic acid 
in adipose tissue, which has been shown to be a good marker of intake7 ,8, and 
in diet was determined for purpose of comparison. The relationship of the 
biomarkers with dietary intake and other determinants was investigated in 
patients and controls. Subsequently, to evaluate the two different approaches, 
the association of both exposure measures and risk of myocardial infarction 
was examined. 
Methods 
Study population 
This study was conducted as part of the multi-centre EURAMIC Study on 
antioxidants and myocardial infarction9. Eligible subjects were men under 70 
years of age, without previously reported myocardial infarction, with stable 
dietary patterns and body weight in the past year. Cases were subjects 
diagnosed with a first acute myocardial infarction (MI) (ICD-code 410) 
-confirmed by specific abnormalities on the ECG and elevated enzyme 
levels- and admitted within 24 hours of manifesting symptoms. They were 
recruited from the coronary care unit of participating hospitals. Of the 94 
eligible subjects that were invited, 83 consented to participate. 
Subjects without a history of myocardial infarction were eligible as 
controls. For each patient, four control subjects were randomly selected from 
his general practitioner's patient registry, according to a standard protocol, 
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within a 5-year age interval. They were sent a questionnaire addressing the 
exclusion criteria and, if eligible, were invited to participate. During the study 
it became apparent that this method of control recruitment resulted in a 
underrepresentation of the age category of 45-60 years. Therefore, another 
random sample was obtained from the municipalities in which the patients in 
this age category lived; these persons were invited in exactly the same way 
as the controls recruited via the general practitioner. Overall, 117 control 
subjects were invited to the study, of whom 99 returned the questionnaire. 
Five subjects were excluded because of previous MI, weight loss over 5 kg, 
age over 70 and alcohol abuse. 75 Subject could be enrolled in the study. 
Biochemical analyses 
Subcutaneous adipose tissue was taken from the buttock by needle 
aspiration10. In cases, the adipose sample was taken within seven days of 
hospital admission. Samples were stored at -70°C; handling of the samples 
has been described previously9. Concentrations of a-tocopherol and 
P-carotene in adipose tissue were determined by reverse-phase HPLC 1 1 and 
spectrophotometric detection. The coefficient of variation for the analysis of 
6-carotene and a-tocopherol was 7% (at mean values of 2.1 /xglg and 84 jug/g 
in the quality control samples, respectively). Detection limits were 0.02 tug/g 
for 6-carotene and 2 fxglg for a-tocopherol, at mean sample weight (29 mg). 
Vitamin concentration was expressed in pig/g of total fatty acids. 
Fatty acid composition of the samples was assessed by GLC 1 2 in an 
aliquot of the same extract as the vitamins, at the National Public Health 
Institute in Helsinki (Finland). The saponified sample was acidified with HC1 
and the free fatty acids were extracted with hexane and methylated with 
acidic methanol. Fatty acid composition was determined by a gas 
chromatograph (HNU Nordion Oy, Finland, HRCG 412) with a 60 m long 
SP-2380 column, I.D. 0.32 mm, phase layer 0.20 /an with split injector and 
helium as carrier gas. Fatty acid peaks were identified by an SC-workstation 
(Sunicom Oy, Finland) in a temperature-programmed run. Linoleic acid 
(C18:2) was expressed as proportion of total fatty acids. 
Non-fasting blood samples were to be drawn as soon as possible after 
admission, and not later than 24 hours after the manifestation of symptoms 
for cases. Serum total and HDL cholesterol levels were determined 
enzymatically (Boehringer Mannheim Kit) at the National Public Health 
Institute in Helsinki (Finland). 
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Dietary questionnaire 
Usual dietary intake of P-carotene and vitamin E during the previous year 
was assessed by a 95-item self-completed semi-quantitative food frequency 
questionnaire (FFQ)1 3. Frequency of consumption was reported in eight 
categories, never, seldom, 1 day per month, 1 day per 2-3 weeks, 1-2 days 
per week, 3-4 days per week, 5-6 days per week, 7 days per week. Portion 
sizes were quantified by respondents in terms of household measures (slices, 
spoons, cups) to which standard weights were assigned. 
Completeness, credibility of reported number of servings and 
consistency in reported consumption frequencies were checked. Information 
on vitamin E and p-carotene content was mainly derived from recent analyses 
of Dutch food products14, but did not provide complete coverage of all foods 
in the questionnaire (75% for vitamin E, 97% for p-carotene). Additional 
information was obtained from the English food composition table. Intake of 
linoleic acid was calculated, although the questionnaire was not specifically 
designed to measure this nutrient. However, since the important sources of 
linoleic acid and vitamin E are largely the same foods, the questionnaire is 
considered to measure linoleic acid well enough to obtain adequate ranking 
of subjects according to intake. 
Data analysis 
From 72 out of 83 patients and 61 out of 75 control subjects a fat aspirate 
could be obtained. Vitamin and fatty acid results from 6 patients and 3 
controls were excluded from data analysis, because of too little sample 
material, resulting in unreliable measurements. Dietary intake data were 
available for 64 patients and 68 controls. 
Crude means for major risk factors and potential confounders, as well 
as mean levels of the antioxidants and fatty acid composition, in adipose 
tissue and from the diet, among cases and controls were calculated. Signifi-
cance testing of the difference in means was performed with Student's t-test 
and chi-square analyses. The distributions of a-tocopherol and P-carotene, 
both in adipose tissue and from the diet, were positively skewed; values were 
log-transformed for testing procedures. The relationship between the anti-
oxidants and fatty acids from the diet and in adipose tissue was assessed by 
calculating Pearson correlation coefficients. Determinants of concentrations in 
adipose tissue were evaluated by linear regression analysis. The association 
between risk of MI and antioxidants and fatty acids, both from the diet and in 
adipose tissue, was estimated with logistic regression analysis. Odds ratios 
were calculated for the lowest tertile compared to the highest, based on the 
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distribution among controls. Linear trend of the association was tested by 
including the tertiles as a continuous variable in the model. 
Results 
The prevalence of risk factors for coronary heart disease among patients and 
controls is shown in Table 1. 
Table 1. Prevalence of risk factors for coronary heart disease among cases and 
controls. 
Cases (n = 66) Controls (n = 58) 
Age (yr) 53.0 ± 9.9 52.3 ± 9.8 
Total cholesterol (mmol/L) 5.7 ± 0.9 5.6 ± 1.0 
LDL cholesterol (mmol/L) 3.9 ± 0.8 3.6 ± 0.9 
HDL cholesterol (mmol/L) 1.0 ± 0.3 1.1 ± 0.3** 
Current smokers (%) 55 46 
Number of cigarettes 27 ± 16 18 ± 12* 
Hypertension (%) 15 10 
Family history of CHD (%) 49 29* 
Diabetes (%) 4.6 3.4 
Angina pectoris (%) 11 7 
Low socioeconomic status (%) 50 43 
Alcohol use (%) 91 90 
BMI (kg/m2) 25.9 ± 3.6 25.4 ± 2.8 
* p < 0.05; ** p < 0.01. 
Serum HDL cholesterol, smoking habits and a family history of CHD were 
significantly different between patients and controls. Since HDL 
concentration was dependent on the time-lag between the infarction and the 
blood sampling (r = -0.34, p = 0.02) in cases, this variable could be 
evaluated only in the control group. Table 2 presents the mean values (± SD) 
for the concentrations of a-tocopherol, B-carotene and linoleic acid in adipose 
tissue, as well as their mean daily intake, as assessed by the food frequency 
questionnaire. Adipose tissue B-carotene levels were lower in cases (0.49 
/xglg ± 0.37) than in controls (0.67 [tg/g ± 0.45, p = 0.08). Dietary intake of 
B-carotene was similar for cases and controls; vitamin E intake tended to be 
higher in controls, although the difference is not significant (p = 0.11). 
The crude correlation between dietary intake and the adipose tissue 
biomarkers among cases and controls was assessed. 
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Table 2. Mean (± SD) concentration of a-tocopherol, ^-carotene and linoleic acid in 
adipose tissue and mean dietary intake among cases and controls. 
Antioxidant vitamins Cases Controls p-value+ 
Biomarkers n = 66 n = 58 
a-tocopherol (ag/g) 225 + 98 221 + 131 0.26 
P-carotene (ag/g) 0.49 + 0.37 0.67 + 0.45 0.08 
linoleic acid (% of total fatty acids) 14.6 + 3.4 15.3 + 3.7 0.36 
Dietary intake n = 64 n = 68 
a-tocopherol (mg/day) 15.3 + 8.1 18.1 + 11.7 0.11 
P-carotene (mg/day) 0.86 + 0.41 0.90 + 0.42 0.54 
linoleic acid (% of total fat) 15.9 + 7.1 16.5 + 6.3 0.42 
student's t-test performed with log,,-transformed values where necessary. 
For a-tocopherol, a correlation of 0.10 was found among controls, but an 
inverse correlation (Pearson r = -0.27, p < 0.05) among patients. For 
6-carotene the crude correlation was 0.24 (p = 0.08) among controls and 
-0.16 among cases. A higher correlation was observed for linoleic acid in 
adipose tissue and from the diet: 0.49 among controls and 0.48 among 
patients. Other determinants of the biomarker concentrations were evaluated 
by univariate linear regression analysis (Table 3), separately for cases and 
controls. Smoking status, body mass index (BMI) and serum HDL cholesterol 
appeared to be relevant predictors of the antioxidant biomarkers. These 
variables were included in a multivariate model, together with dietary intake 
(Table 4; HDL only in controls). The resulting regression equations were 
significantly different for patients and control (p < 0.05). BMI was inversely 
associated with adipose tissue a-tocopherol and 6-carotene in controls, but 
not in patients. The effect of smoking was similar in patients and control 
subjects. HDL was an important predictor of a-tocopherol and 6-carotene in 
controls, which, in the multivariate model, slightly lowered the coefficients 
for dietary intake. Dietary intake of linoleic acid was the main predictor of 
the proportion of linoleic acid in adipose tissue (among controls 6 = 0.295, 
SE = 0.072). None of the other variables measured in this study significantly 
improved the fit of the linear model (data not shown). 
Next, we investigated the association between the biomarkers and the 
risk of MI on the one hand, and the association of dietary intake and risk of 
MI on the other (Table 5). 
Table 3. Simple regression coefficients for predictors of adipose tissue a-tocopherol and ^-carotene. 
a-tocopherol ß-carotene 
Predictors patients controls patients controls 
ß ± SE ß ± SE ß ± SE ß ± SE 
Dietary intake -0.256 ± 0.110 * 0.170 ±0.169 -0.170 ± 0.194 0.339 ± 0.199 
Age 0.006 ± 0.006 0.001 ± 0.008 -0.002 ± 0.008 0.006 ± 0.008 
Total cholesterol 0.050 ± 0.069 -0.006 ± 0.091 0.183 ± 0.099 -0.097 ± 0.083 
LDL cholesterol 0.131 ± 0.080 0.031 ± 0.104 0.145 ± 0.121 -0.150 ± 0.094 
HDL cholesterol -0.371 ± 0.226 1.121 ± 0.369 " 0.139 ± 0.345 1.468 ± 0.306 " 
Smoking -0.246 ± 0.110 * -0.214 ± 0.163 -0.267 ± 0.158 -0.429 ± 0.147 '* 
Hypertension 0.196 ± 0.157 0.039 ± 0.268 -0.111 ± 0.224 0.159 ± 0.254 
Family history 0.128 ± 0.113 -0.313 ± 0.175 -0.270 ± 0.157 -0.046 ± 0.171 
Diabetes -0.304 ± 0.263 -0.155 ± 0.447 -0.580 ± 0.382 -0.113 ± 0.426 
Angina 0.044 ± 0.185 -0.186 ± 0.322 0.117 ± 0.261 -0.329 ± 0.304 
Low SES -0.082 ±0.113 -0.100 ± 0.164 0.083 ± 0.160 -0.036 ± 0.157 
Alcohol use -0.074 ± 0.198 -0.012 ± 0.268 0.290 ± 0.277 0.101 ± 0.255 
BMI 0.602 ± 0.428 -1.699 ± 0.714 * 0.172 ± 0.622 -1.305 ± 0.690 
* p < 0.05; ** p rs 0.01. 
t Serum HDL in patients probably affected by acute MI. 
Table 4. Multivariate linear regression coefficients for predictors of a-tocopherol and ^-carotene in adipose tissue among MI cases and 
control subjects. 
Linear model 
Biomarker disease status dietary intake 
P ± SE 
BMI 
p ± S E 
smoking status 
P ± SE 
HDL 
P ± SE 
a-tocopherol patient (n = 52) 
control (n = 51) 
control (n = 42) 
-0.246 ±0.118 
0.126 ± 0.166 
0.092 ±0.180 
0.351 ± 0.439 
-1.942 ± 0.805 
-1.904 ±0.903 
-0.182 ±0.120 
-0.289 ± 0.183 
-0.151 ± 0.201 0.876 ± 0.423 
P-carotene patient (n = 52) 
control (n = 51) 
control (n = 42) 
-0.077 ± 0.203 
0.261 ± 0.185 
0.256 ± 0.169 
0.124 ± 0.675 
-1.810 ± 0.682 
-1.555 ± 0.657 
-0.400 ± 0.188 
-0.377 ± 0.154 
-0.276 ± 0.147 1.172 ± 0.302 
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The crude odds ratio of MI for subjects in the lowest tertile of the adipose 
tissue 6-carotene distribution was 2.7 (95% CI 1.1-6.6). Adjustment for 
smoking (in five categories) and BMI lowered the odds ratios (OR 2.5 in 
lowest tertile, 95% CI 1.0-6.6). Both the crude and adjusted odds ratios 
showed a linear trend over tertiles. There was a slight tendency for a positive 
association of adipose tissue cc-tocopherol and MI, and an inverse association 
of linoleic acid and MI, but both were not significant, nor was the trend over 
tertiles. Adjustment for BMI and smoking did not substantially affect the 
estimated odds ratio for a-tocopherol. Because of the apparent effect of the 
infarction on serum HDL levels, adequate adjustment for confounding was 
not possible. However, inclusion of HDL in the logistic regression model 
decreased the estimated odds ratio by 29% for a-tocopherol and 36% for 
6-carotene. Part of this effect is due to the artefactual low HDL among cases. 
With respect to dietary intake, the results for a-tocopherol were 
suggestive of an inverse association with MI, but the odds ratios did not 
differ significantly from unity (OR 1.8, 95% CI: 0.8-4.2). For intake of 
6-carotene and linoleic acid no association with MI was observed. 
Table 5. Odds ratios of MI in tertiles of the biomarker distribution and dietary intake 
among controls. 
Antioxidant Assessment tertile 1-low tertile 2 tertile 3-high p for 
method OR (95% CI) OR (95% CI) OR (95% CI) trend 
a-tocopherol biomarkers a 0.7 (0.3-1.7) 0.9 (0.4-2.2) 1.0 0.42 
diet" 1.8 (0.8-4.2) 1.4 (0.6-3.4) 1.0 0.18 
P-carotene biomarkers c 2.7 (1.1-6.6) 0.8 (0.3-2.3) 1.0 0.02 
diet d 1.2 (0.5-2.8) 0.8 (0.4-2.0) 1.0 0.59 
linoleic acid biomarkers c 1.6 (0.7-3.8) 1.4 (0.6-3.6) 1.0 0.30 
diet 1 1.2 (0.5-2.7) 1.3 (0.5- 2.9) 1.0 0.75 
Tertile outpoints: " 143, 240 ^g/g; " 12.9, 19.0 mg; c 0.44, 0.63 pig/g; d 0.68, 0.93 mg; 
c 13.6%, 16.4%; r 12.2%, 17.9%. 
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Discussion 
The relationship between dietary intake and biomarkers of ct-tocopherol and 
6-carotene was found to be different for patients with acute myocardial 
infarction as compared to population controls, whereas for linoleic acid, there 
was a similar association for patients and controls. In controls, we observed a 
weak positive correlation between intake and adipose tissue levels of both 
a-tocopherol and 6-carotene. In cases, there was no correlation between both 
assessments for 6-carotene and an inverse correlation for a-tocopherol. This 
was reflected in the finding of different risk estimates for MI, for low adipose 
tissue antioxidants as compared to low dietary intake. These results suggest 
that the use of dietary intake data in the study of antioxidants and coronary 
heart disease may yield different conclusions than the use of biomarkers, in 
the same population. 
Of course, in view of the relatively small numbers of patients (n = 66) 
and controls (n = 58) in our study, it cannot be excluded that some of our 
observations are due to chance variation. However, the associations observed 
between the antioxidant biomarkers and risk of MI were very similar to the 
results of a pooled data analysis in a larger study population, of which the 
present study was a part9. 
Only a modest correlation between intake and biomarkers may be 
expected, because of inter-individual differences in absorption and 
metabolism, and the effect of other, mostly unknown determinants of the 
biomarker levels. Moreover, intra-individual variation and independent 
random errors in both assessment methods13 weaken the correlation. The 
questionnaire used in this study has recently been validated in a non-smoking, 
but otherwise comparable population13. The correlation between intake and 
adipose tissue concentration was 0.30 for 6-carotene, 0.16 for a-tocopherol 
and 0.40 for linoleic acid, comparable to what we observed in the present 
study in controls. 
Absence of correlation between intake and adipose tissue levels may be 
explained in different ways. The use of a questionnaire to assess dietary 
exposure in a case-control study is liable to differential recall by cases and 
controls, introducing recall bias. It is conceivable that cases have reported 
higher intakes of fruits and vegetables in retrospect, as compared to true 
long-term intake, which could have diminished the correlation with adipose 
tissue levels in cases and underestimated a possible association between 
6-carotene intake and risk of MI. If we, however, assume that the 
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measurement of dietary intake was adequate, the different correlations with 
the biomarkers for patients and controls might be attributed to an effect of 
the disease, which relates to the validity of the biomarker. It is possible, 
although not supported by clinical evidence, that the level of p-carotene is 
affected by the process of atherosclerosis. This may indicate an increased 
requirement of P-carotene as a consequence of atherosclerosis. It does not 
exclude a possible role of p-carotene in the prevention of progression of 
atherosclerosis or an effect on hemostasis and thrombosis. Another possible 
explanation of the lower association between 6-carotene intake and adipose 
tissue levels in patients is a restricted absorption capacity for p-carotene in 
patients, leading to the low tissue levels, associated with MI. To examine a 
potential acute effect of MI on adipose tissue levels in cases, we looked at 
the correlation between the number of days after the infarction, when the fat 
aspirate was obtained, and the concentration of p-carotene and a-tocopherol. 
We found no correlation at all (r = 0.06 for p-carotene, r = -0.02 for 
a-tocopherol). Comparison of vitamin concentrations in adipose tissue 
sampled immediately after hospitalization and after four days, in the same 
patients, did also not show a decrease (data not published). 
An inverse correlation, as observed for a-tocopherol, is hard to explain 
by any biological mechanism and therefore may be attributed to chance. For 
a-tocopherol, patients tend to have higher adipose tissue concentrations than 
controls, whereas their dietary intake appears to be lower. Apart from the 
performance of the dietary questionnaire, this may also be due to differences 
in absorption (but this time higher in patients) or to a different distribution 
over body compartments. The latter is supported by the finding that BMI is a 
predictor of adipose tissue vitamins in controls, but not in cases. The fact that 
serum HDL is an important predictor of adipose tissue vitamin levels 
suggests a relation with lipid metabolism. 
The determinants of adipose tissue p-carotene in our study (smoking and 
BMI) are also the main determinants of plasma P-carotene15,16,17 apart from 
gender. No consistent determinants of plasma vitamin E have been identified, 
apart from supplement use 1 5 , 1 8 . The inverse association with BMI which we 
observed for adipose tissue a-tocopherol in controls was not reported by 
others. 
Biomarkers of dietary antioxidants, taking into account the individual 
differences of absorption and metabolism, may be more relevant predictors of 
disease risk than dietary intake in itself. However, it is important to know 
how the disease may affect the biomarker levels, to evaluate what is cause 
and what is consequence. Moreover, an understanding of the relationship 
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between dietary intake and biomarker levels, and of the influence of lifestyle 
factors on this relationship, is necessary to support dietary recommendations. 
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General discussion 
The purpose of the EURAMIC Study, as described in Chapter 3, was to provide 
evidence for the potential role of diet-derived antioxidants in the prevention 
of coronary heart disease. It was designed as a multi-centre case-control study 
of the association of a-tocopherol and 6-carotene in adipose tissue, and 
selenium in toenails, with risk of myocardial infarction (MI). 
Table 1. Results of the EURAMIC Study in relation to the antioxidant hypothesis. 
Type of 
evidence 
Antioxidant Observation Chapter 
Supportive P-carotene inverse association with MI 
strongest in smokers 
and at high PUFA-level 
4 
4 
6 
selenium inverse association 
strongest at low a-tocopherol level 
5 
5 
Non-supportive a-tocopherol no association with MI 
association not dependent on PUFA level 
4 
6 
Inconsistent a-tocopherol inverse association with MI at lowest 
selenium quintile; trend towards positive 
association at all other levels of selenium 5 
P-carotene strongest inverse association at high 
a-tocopherol level 4 
selenium inverse association at low but not at high 
PUFA level 6 
First, the advantages and limitations of the study design will be 
summarized. Next, the findings, which are summarized in Table 1, will be 
evaluated in the light of results from recent experimental and epidemiological 
studies. Finally, the public health implications of our findings and those of 
others will be discussed. 
Methodological considerations 
Disease end-point 
Ischaemic heart disease is the major cause of death among men in affluent 
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societies; in the Netherlands it accounts for about 20% of total mortality1. 
The most important diagnosis in this category of diseases is acute myocardial 
infarction. Atherosclerotic lesions in the coronary arteries form the underlying 
cause. In acute myocardial infarction, a rupture or fissure of the endothelium, 
covering a lipid-rich plaque, takes place, followed by haemorrhage into the 
plaque, acutely increasing stenosis. Additionally, a clot may develop, leading 
to total or partial occlusion of the vessel2. 
First-time acute myocardial infarction was a suitable end-point for the 
EURAMIC Study because of its high incidence, relatively straightforward 
diagnosis and acuteness. The latter is important, because a history of cardiac 
complaints may lead to a change of dietary habits, thereby biasing the 
exposure information obtained in a retrospective study. Subjects with a 
history of angina pectoris, who may have done just that, were not excluded 
from the EURAMIC Study, but they were present among cases as well as 
controls, and a possible confounding effect was evaluated in the data 
analysis. 
A large proportion of persons suffering from acute MI die before 
reaching the hospital. These victims of 'sudden death' form a subgroup, 
whose pathology may be different. In the EURAMIC Study, only survivors of 
MI were enrolled. Theoretically, survival may depend on antioxidant status, 
and therefore any observed association with MI may be different in 'sudden 
death' cases. However, there is no reason to assume that these fatal cases 
have higher antioxidant levels than survivors. Moreover, current knowledge 
indicates that antioxidants may restrict the damage inflicted by free radicals 
in ischaemia and reoxygenation. Therefore, it is possible that patients with a 
relatively high antioxidant status are more likely to survive. This may have 
weakened the observed associations between the antioxidants and MI, leading 
to a conservative risk estimate. 
Furthermore, it should be realized that the pathogenesis of MI is not 
identical to that of atherosclerosis, since thrombosis may play a crucial role 
as well. The choice of MI as end-point does not permit any conclusions about 
the specific mechanism in which antioxidants may play a part. Although the 
antioxidant levels in adipose tissue may not fluctuate as much as plasma 
levels, it is not likely that they reflect the antioxidant status at the time when 
atherosclerosis started, which is already at a very early age. Therefore, any 
association we have found with MI may tell us something about a relatively 
short-term mechanism, possibly related to thrombosis, or to progression of 
atherosclerosis. On the other hand, it cannot be excluded that the process of 
atherosclerosis, prior to the myocardial infarction end-point, has influenced 
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antioxidant levels, although we do not know theories with regard to this 
effect. 
Study population 
The use of different methods of control recruitment in the different 
centres is discussed in Chapters 4 to 6, as it is likely to be a point of 
criticism. The main criterion in selecting controls is that they should represent 
the population from which the cases are recruited (the study base principle), 
with respect to exposure distribution3. It can be argued that the best way to 
do this may vary among countries, depending on the determinants of hospital 
admission, completeness of case ascertainment, non-response or inadequacies 
of the sampling frame. It is not by definition true that population controls are 
preferable over hospital controls or controls from a medical practice4. Internal 
validity within a centre was considered more important than a common 
method of recruitment. 
The EURAMIC Study population was confined to men. It is likely that the 
antioxidants have a similar biological function in men and women. However, 
the metabolism of fat-soluble antioxidants may well be different for men and 
women. In our additional study on the relationship between diet, plasma and 
adipose tissue levels of antioxidants, more than half of the study group were 
female. Women had higher antioxidant concentrations in both plasma and 
adipose tissue, at similar levels of intake. Considering the larger fat mass of 
women, lower levels in adipose tissue would have been easier to explain. 
Higher levels in adipose tissue were also observed in the female study 
population of the breast cancer part of the EURAMIC Study5 (Chapter 3). 
Moreover, the relationship between dietary intake and tissue levels was not 
consistent for men and women (Chapter 7). It is possible that the association 
between a-tocopherol and |3~carotene and MI is dependent on these 
differences. Therefore, our results may need to be confirmed in a female 
population. 
Multi-centre design 
The multi-centre approach was chosen for several reasons. The first, 
pragmatic, reason was that involvement of more than one centre would 
facilitate the recruitment of the required number of subjects within a limited 
period of time. This argument appeared to be valid; although most centres did 
not attain the aimed number of 100 cases and 100 controls within a period of 
2 year, the power of the pooled study was adequate to detect the expected 
associations. 
132 Chapter 9 
Second, the variation in exposure to antioxidant vitamins within a 
country is limited because of more or less homogeneous consumption 
patterns. The use of populations with larger variations in exposure would 
theoretically increase the chance of finding an existing association between 
exposure and disease. In the individual countries, the 10th and 90th 
percentiles differed on average by a factor of 3.7 for a-tocopherol, 6.3 for 
B-carotene and 1.6 for selenium. The overall variation between the 10th and 
90th percentiles were 3.7, 7.5 and 2.0, respectively. To calculate the odds 
ratio of MI for low versus high levels of the antioxidants, categories were 
based on this overall distribution of antioxidants in the control population. 
However, it was considered necessary to adjust for centre in all data analyses, 
thereby again limiting exposure variation. We did this for two reasons: 
because controls were frequency-matched for centre and because the 
inclusion of many different centres adds not only to the heterogeneity of the 
exposure, but also to variation in potential confounders. Of course, the study 
design involved standardized measurement of potential confounders as well 
as exposure. However, lack of cross-culturally validated methods did not 
permit the use of a standard questionnaire for all variables. In theory, 
adequate adjustment for confounders may render additional centre-adjustment 
superfluous, but we have chosen for consistent centre-adjustment in our 
analysis strategy. 
A third advantage of a multi-centre approach is the possibility to 
calculate centre-specific odds ratios which can be interpreted as replications 
of the study under different circumstances. Consistency of the results among 
the different centres provides arguments for the generalizability of the 
outcomes. In the BURAMIC Study, odds ratios were not consistent among 
countries, but, since the numbers in each centre were quite small and the 
variation was not statistically significant, this may be attributed to chance. 
Biomarkers versus dietary intake 
In general, biomarkers may be defined as "cellular, biochemical or 
molecular alterations that are measurable in biological media, such as human 
tissues, cells, or fluids"6. If an exogenous compound, such as a nutrient, is 
identified in body tissues or fluids through a laboratory assay, it becomes a 
marker of internal dose6, an indication of the amount absorbed in the gut. 
This marker may better represent concentrations in the biological relevant 
target tissues than dietary intake assessment may. In the EURAMIC Study, the 
exposure to antioxidants was assessed by determining their concentration in 
adipose tissue and toenails. 
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Another advantage of the use of biomarkers in general is the 
comparability among countries, in case of centralized laboratory analysis. 
Even more important are the objectivity and comparability of the information 
obtained from cases and controls, provided that sample collection and 
handling takes place under similar conditions and samples from cases and 
controls are equally divided over analytical runs. 
Although the use of biomarkers was preferred for the reasons mentioned 
above, it is relevant to have information about their relationship with dietary 
intake. The concentration of selenium in toenails has been shown to correlate 
well with dietary intake over a period of about 6-12 months7. Concentrations 
of ct-tocopherol and 6-carotene in adipose tissue and toenails were preferred 
to concentrations in plasma, for several reasons. First, plasma levels are 
affected by the event of an acute MI, precluding a valid case-control 
comparison. Second, a regulatory mechanism for a-tocopherol in plasma has 
recently been postulated8, which probably limits the range of plasma values 
and hence its use as an indicator of intake. Third, concentrations in adipose 
tissue were believed to provide a more time-integrated measure of dietary 
exposure, as has been shown for the proportions of essential fatty acids in 
adipose tissue9. However, at the start very little information was available 
about the relation of adipose tissue levels to dietary intake. Our own 
comparisons of dietary intake, plasma and adipose tissue levels (Chapters 7 
and 8) have shown that there is at most a very modest linear correlation 
between intake and biomarkers. This is partly due to the limitations of dietary 
assessment methods. Moreover, differences in absorption, regulation of 
plasma levels and influences of other dietary or life-style factors affect this 
correlation. Perhaps there is even a non-linear relationship. Surprising was the 
finding that B-carotene levels in Spain and Israel were the lowest among all 
centres, whereas comparative data on consumption of fruit and vegetables10 
show a relatively high use in these countries. It may be speculated that the 
intake of retinol (vitamin A) from animal sources in Spain and Israel is 
relatively low, causing an efficient conversion of B-carotene into retinol. In 
summary, the results, based on the "internal dose" of a-tocopherol and 
B-carotene in adipose tissue, cannot be easily extrapolated to conclusions 
about dietary intake, except in general terms. 
Adipose tissue sampling 
The EURAMIC Study was the first to use the a-tocopherol and B-carotene 
concentration in adipose tissue as biomarker. In practice, we had to face a 
number of technical difficulties, related to the amount of material obtained. It 
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is difficult to assess the amount during the biopsy procedure, because tissue 
other than fat may be part of the biopsy. Moreover, in some subjects the 
procedure was not successful and no material could be obtained at all. Due to 
small amounts of adipose tissue, no reliable vitamin concentrations could be 
assessed for about 6% of our population, although a biopsy was taken. Other 
procedures may yield more sample material, but may not be performed 
without applying local anaesthetics, which also has drawbacks. 
Absolutely as well as relatively small amounts of fat tissue in the biopsy 
adversely affect the precision of vitamin concentrations: absolute amounts, 
because a minimum amount of tissue is necessary to determine especially 
0-carotene, which is present in a much lower concentration than 
ct-tocopherol; relative amounts, or the proportion of fat tissue in the biopsy, 
because a correction for this proportion needs to be made in the calculation 
of the vitamin concentration. In a biopsy in which only 40% of the tissue is 
fat, the concentration of fat-soluble vitamins per mg biopsy is multiplied by 
2.5 to obtain the concentration per mg fat. Any random error in vitamin 
assessment (which will be larger in small samples) is thus multiplied by the 
random error in the fatty acid assessment. However, it is necessary to 
perform this correction, because the biopsies show a large variation in 
proportion of fat tissue, cases having on average higher proportions of fat in 
their biopsies than controls. This measurement error, which results in a 
certain amount of random "misclassification" of exposure status and therefore 
may weaken the association with disease, may be limited by obtaining larger 
samples, washing the samples before weighing and standardizing the biopsy 
procedure as much as possible. 
E U R A M I C Study results in the light of recent studies 
Recent publications on antioxidants and cardiovascular disease can be 
divided into four mainstreams: animal experiments on the prevention of 
atherosclerosis by antioxidants; observational studies on antioxidants and 
cardiovascular disease end-points in human subjects; ex vivo studies on the 
susceptibility of LDL to oxidation; investigations into the relationship 
between LDL oxidation and coronary heart disease (CHD). It is not the 
intention of this chapter to provide a complete review of all these studies, but 
to highlight some important studies that are relevant to the interpretation of 
our own results. A review of the literature available until 1991 is given in 
Chapter 2. 
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Animal studies 
Until recently, almost no data were available on the effectiveness of 
dietary antioxidants in the prevention of experimental atherosclerosis in 
animal models1 1. Studies had only been performed with antioxidant drugs, 
such as probucol12. Now, two studies in rabbits have been reported in which 
vitamin E suppletion resulted in less atherosclerotic plaque formation, either 
with1 3 or without14 lowered blood cholesterol levels. Another study also 
reports lowered plasma total and LDL cholesterol in vitamin E-fed rabbits, 
although no inhibition of plaque formation was observed15. Wojcicki et al. 1 6 
report an additive protective effect of selenium and vitamin E on 
atherosclerosis. Convincing evidence comes from a study17 in which primates 
were supplemented with 79 mg vitamin E daily, resulting in prevention of 
experimental atherosclerosis compared with a control group receiving only 
the atherogenic diet; in another group, which already had developed 
atherosclerosis, vitamin E suppletion caused a significant regression. To our 
knowledge, no such experiments have been reported for |3-carotene. 
Epidemiological studies 
Vitamin E has also received most attention in epidemiological studies. 
The preliminary results of the first long-term, randomized primary-prevention 
trial were reported only recently18. Among male smokers receiving 50 mg 
a-tocopherol daily for 5 to 8 years, there were fewer, but not significantly 
less, deaths caused by ischaemic heart disease than in the control group. 
Overall mortality did not differ significantly between the a-tocopherol and 
control groups, although more deaths from haemorrhagic stroke were 
observed among the men who received the supplement. Rimm et al. 1 9 have 
reported an inverse association of vitamin E intake with risk of CHD in a 
prospective cohort study among US health professionals. The association was 
restricted to supplement users and was not observed at normal dietary intake 
levels; a similar result was reported for women2 0. Of course, dietary intake 
assessment has major limitations and the use of supplements is probably 
much easier to recall than the habitual use of specific foods. Moreover, exact 
information on the vitamin E content of supplements is readily available, 
whereas the vitamin E content of foods may vary and the calculations of 
intake by means of a food composition table can only provide a best estimate 
at a particular moment. Together with the smaller contrast in the normal 
range, this may partly explain the lack of association with dietary intake21. 
Limitations of the study design include the impossibility to adjust for blood 
cholesterol, the potential residual confounding by general health-related 
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behaviour and the possible confounding of the association between vitamin E 
and CHD by other vitamins. However, the study by Rimm et al. is certainly 
suggestive of a beneficial role for vitamin E in the prevention of CHD. 
Analysis of the effect of the number of years of supplement use showed 
hardly an association in subjects using vitamin E for less than 2 years, but a 
significant inverse association in those using supplements for 2-4 years. 
Rimm et al. 1 9 argue that this indicates a role in the atherogenic process, and 
not primarily in the acute events leading to sudden death or infarction; 
Byers2 1 uses the same data to arrive at the opposite conclusion. Two recent 
prospective studies using serum vitamin E showed no association with MI 2 2 
and CHD 2 3, supposedly because vitamin E status was above a presumed 
critical threshold level. In a German study22, the relative risk estimate in the 
lowest textile of serum vitamin E, when subjects with CHD at baseline were 
excluded, was 0.54 (90% CI 0.21-1.38). The association was not dependent 
on fatality of MI. So far the only observational study (apart from ecological 
comparisons) that has shown an inverse association of plasma vitamin E with 
cardiovascular disease was reported from Scotland24, in patients with 
previously undiagnosed angina. (In Scotland, vitamin E status is relatively 
low. In the EURAMIC Study, mean adipose tissue a-tocopherol among cases in 
Edinburgh was 25% lower than among controls (p < 0.01).) 
For 8-carotene, epidemiological studies have provided more support for 
a protective role in cardiovascular disease. In the US Health Professionals 
Follow-up Study19, a significant inverse association between 6-carotene and 
risk of CHD was observed among former and current smokers, but not 
among men who had never smoked. Another prospective study, among a 
cohort of elderly men and women, also showed a significant inverse 
association between dietary intake of 6-carotene and cardiovascular death25. 
Preliminary results have been reported of an inverse association between 
serum and plasma carotenoids and CHD events26 or progression of carotid 
atherosclerosis27. In contrast with these findings are the preliminary results of 
the Finnish Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study18, in 
which more deaths due to ischaemic heart disease were found among 
participants who had received 20 mg B-carotene a day for 5 to 8 years (77.1 
per 10,000 person-years) than in the control group (68.9 per 10,000 person-
years). These results provide certainly no evidence for a beneficial effect of 
B-carotene, at least at the dosis used. Therefore, it cannot be excluded that 
the inverse associations found in observational studies only indicate that 
6-carotene is marker for other dietary factors or for a life-style that is 
preventive of CHD. 
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In comparison with vitamin E and 6-carotene, the role of selenium in 
atherogenesis has received little attention in the past few years, in contrast 
with the earlier burst of studies. In Denmark, a 3-year follow-up of a cohort 
of over 3000 men showed a 55% increased risk of ischaemic heart disease 
among subjects with serum selenium levels below 1 jumol/l, approximately 
the lowest tertile, after adjustment for cholesterol, social class, smoking and 
age 2 8. 
Biological mechanism 
The current major hypothesis linking antioxidants to coronary heart 
disease focuses on the lipid peroxidation of the LDL cholesterol particle, 
enhancing its uptake by macrophages in the arterial wall and the formation of 
fatty streaks, an early stage of atherosclerosis. Moreover, oxidized LDL may 
be a key component in endothelial injury29, playing a role in later stages. 
Another hypothesis supposes an effect of antioxidants, in particular vitamin 
E, on platelet aggregation30 or adhesion31. Observational and experimental 
studies have accumulated evidence for the role of oxidative modification of 
LDL in human atherosclerosis. Salonen et al. 3 2 have found the titre of 
autoantibodies against malondialdehyde-modified LDL to be an independent 
predictor of the progression of carotid atherosclerosis in men. Regnstrom et 
al. 3 3 found the susceptibility of LDL to oxidation to be associated with 
severity of coronary atherosclerosis in survivors of myocardial infarction. The 
in vitro oxidizability of LDL was shown to be dependent on vitamin E 
content34"37, and on fatty acid composition: replacement of linoleic acid with 
oleic acid reduces the oxidation rate and inhibits the uptake by 
macrophages38"45. Supplementation with 6-carotene does not result in 
protection of LDL against oxidation in vitro 3 5 ' 3 7. In how far the method of 
copper- or cell-mediated oxidation of LDL in vitro reflects any of the actual 
processes going on in the atherosclerotic vessel remains unclear. 
EURAMIC Study 
The a priori hypothesis was that antioxidant status would be lower in MI 
cases than in controls. Furthermore, we postulated that an inverse association 
between B-carotene and MI would be most pronounced in smokers; selenium 
would interact with vitamin E in the association with MI. 
^.-Tocopherol 
The findings of the EURAMIC Study do not suggest an important role of 
a-tocopherol, in the physiological range, in the protection of myocardial 
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infarction. We found no overall significant association of cc-tocopherol with 
ML At the lowest selenium quintile, there may be a trend towards an inverse 
association, but at all other levels of selenium status the direction of the 
association is even positive. There is no effect modification by level of PUFA 
in the adipose tissue. This lack of association is in agreement with most 
studies using plasma or serum vitamin E levels to examine the association 
with CHD. Moreover, normal dietary intake of vitamin E in other studies was 
also not associated with CHD risk. However, intake of vitamin E supplements 
was found to be inversely associated with risk of CHD, in line with 
supplementation studies in animals. This apparent inconsistency may be 
related to the different ranges of intake. The recent suggestion that plasma 
a-tocopherol levels may be regulated within a certain range under normal 
circumstances supports the notion that normal intake levels are not related to 
CHD risk. Only at a very high or low vitamin E status2 4 a linear inverse 
association with CHD risk could become apparent. The biological mechanism 
need not be the same in such extreme situations; the pharmacological effect 
can be different from an antioxidant effect. Under specific circumstances, 
a-tocopherol may even act as a pro-oxidant46. Thus, in contrast to in vitro 
and animal experiments, the EURAMIC Study has not confirmed the hypothesis 
that a-tocopherol in particular may provide protection against CHD. 
^-Carotene 
The EURAMIC results support the hypothesis that 6 -carotene may play a 
role in the protection of polyunsaturated fatty acids against oxidation and 
thereby prevent myocardial infarction. The inverse association of 6-carotene 
with risk of MI might be attributed to a lower intake in patients. The 
association is strongest in smokers and in subjects with a high PUFA status. 
These form the groups with relatively high oxidative stress and high 
susceptibility to lipid peroxidation. These findings are in line with those from 
dietary intake studies1 9'4 7, although a possible interaction with PUFA intake 
has not yet been examined to our knowledge. The results of the Finnish 
prevention study18, however, do not support a causal role of 6-carotene 
suppletion in the prevention of CHD. Although further reports from this study 
are to be awaited, this may indicate that 6-carotene is merely a marker of a 
protective dietary pattern or life-style. On the other hand, as for a-tocopherol, 
different biological mechanisms may prevail at different ranges of exposure. 
Selenium 
The observed association of toenail selenium with MI was only weak 
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and not statistically significant. In the lowest selenium quintile the risk of MI 
was 55% higher than in the highest quintile. The finding that a significant 
association between selenium and MI existed at low vitamin E levels 
(although the interaction term was not significant), suggests that selenium 
may act as an antioxidant somewhere in the process of atherogenesis or 
thrombogenesis. However, the observed interaction with PUFA was not in 
line with the antioxidant hypothesis. At low PUFA, we observed an inverse 
association, but not at medium or high PUFA levels. Of course, as this 
modifying effect of PUFA status on the risk estimates for selenium was not 
significant, it may well be explained by chance. It was not due to a low 
vitamin E status in the low-PUFA group, because there was no overall 
association between vitamin E and PUFA in our population. It is possible that 
the interaction between selenium and PUFA may be explained by some 
residual confounding by smoking: the largest proportion of smokers was 
found at the lowest PUFA level. The biological role of selenium in the body 
has been shown to be primarily its function as an antioxidant48 and a 
nutritional interaction with vitamin E was established in studies on animal 
diseases, decades ago. Our results are in line with animal experiments 
showing a combined effect of vitamin E and selenium on atherosclerosis16 
and platelet function49. To our knowledge, no human (experimental or 
observational) studies have been performed to investigate a possible 
interaction of selenium and vitamin E in atherogenesis. 
Public health consequences 
Our conclusions about the possible role of selenium, ct-tocopherol and 
|3-carotene in the prevention of myocardial infarction are based on biomarker 
status. Comparison of biomarker status with dietary intake indicates that 
extrapolation to conclusions about dietary intake can only be made very 
cautiously. 
General recommendations of antioxidant supplements are not warranted 
before large, long-term prevention trials have established a clear benefit50 
- not only because the effectiveness of a preventive or therapeutic measure 
should be known, but also because it is not completely sure that the long-
term intake of very large doses of antioxidant nutrients will be harmless. The 
preliminary results of the first large primary-prevention trial justify such 
reservations18. More data from metabolic studies in healthy subjects as well 
as CHD patients are needed to clarify the biological mechanism, the impact 
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of dosage and the relationship with diet, including the role of different food 
sources and dietary patterns, before dietary antioxidants may be optimally 
used in primary and secondary prevention of CHD. However, there are 
certainly no objections to a generous intake of antioxidants through a normal 
dietary pattern. 
A recent evaluation of vitamin E intake in the Netherlands, based on the 
first National Food Consumption Survey, indicated an adequate level of 
intake for the population51: median intake in all age-categories was above the 
0.67 cc-tocopherol equivalents (a-TE) per gram PUFA, defined as the intake 
that covers minimum requirements for 97.5% of the population. Indeed, only 
1-2% of the adult population had an intake of less than that minimum 
requirement (0.4 a-TE/gram PUFA). Considering the adequate provision with 
vitamin E, our results indicate that selenium status is not likely to be an 
important factor in the prevention of CHD in the Netherlands. However, it is 
evident from the comparison among the EURAMIC centres that the selenium 
status in the Netherlands is among the lowest in Europe. In the lowest range 
of selenium status, it may be important to avoid a simultaneous low vitamin 
E status. As yet, on the basis of our study and other available evidence in 
human populations, there is no reason to raise the recommendations for 
dietary vitamin E intake, neither absolutely nor relative to polyunsaturated 
fatty acids. 
Fruits and vegetables, the main sources of 6-carotene, and partly good 
sources of vitamin E as well, also contain other health-promoting 
compounds52. Moreover, there is accumulating evidence that fruit and 
vegetables may protect against specific forms of cancer5 3'5 4. In the light of 
this notion, it is worrying that the consumption of fruits and vegetables has 
decreased between 1987 and 1992 in the Netherlands, by almost 10% 5 5. The 
average consumption of fruit is limited to one portion, and the mean 
consumption of vegetables is only 128 g per day, which is 50-100 g less than 
what is desirable according to the Netherlands Bureau for Nutrition 
Education56, and certainly less than the recommendation of 5 daily servings 
issued by the American National Research Council57. An active policy to 
increase the consumption of fruit and vegetables in the Netherlands, 
especially among younger age groups, may be warranted. 
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Summary 
The epidemiologic study presented in this thesis aimed to find evidence in 
support of the hypothesis that antioxidant nutrients may protect against 
coronary heart disease. 
Coronary heart disease is the major cause of death among men in most 
European countries. The underlying process, atherosclerosis, involves the 
accumulation of cholesterol and other lipids in the arterial wall. In an 
advanced stage of atherosclerosis, the lumen of the vessel may become 
completely obstructed by the resulting fibrous plaque, or by the formation of 
a blood clot. If that happens in the coronary arteries, the blood flow to the 
heart is interrupted, causing a myocardial infarction. One of the main risk 
factors for atherosclerosis is a high serum cholesterol level, in particular 
cholesterol transported in low-density lipoproteins (LDL). Recent 
experimental studies suggest that LDL in itself is not atherogenic, but 
becomes so when modified by oxidation processes naturally occurring in the 
body. Especially the polyunsaturated fatty acids in the LDL particle are 
susceptible to oxidation. Oxidation processes in the body are restrained by an 
antioxidant defense mechanism. This defense consists of several enzymes, 
including the selenium-containing glutathione peroxidase, and diet-derived 
compounds such as vitamin E and (3-carotene (pro-vitamin A). It is 
conceivable that the beginning and progress of atherosclerosis is dependent 
on the balance between oxidative stress by internal and external factors, the 
susceptibility to oxidation of fatty acids and other biomolecules, and the 
availability of antioxidants acting to prevent oxidation (Chapter 2). 
The EURopean study on Antioxidants, Myocardial Infarction and 
Cancer of the breast, in short the EURAMIC Study, was designed to examine 
the association between antioxidants and the risk of coronary heart disease. 
The levels of ct-tocopherol (vitamin E) and B-carotene in adipose tissue and 
of selenium in toenails were compared between patients with a first acute 
myocardial infarction (MI) and control subjects without a history of MI. We 
hypothesized that these levels would be lower in patients than in controls. 
Moreover, the relative intake of polyunsaturated fatty acids was estimated by 
assessing the fatty acid composition of the adipose tissue. Patients were 
recruited from coronary care units of hospitals in 8 European countries and 
Israel. Control subjects were, in most countries, population controls, but in 
some countries hospital controls were a more feasible comparison group. 
Patients as well as controls were below 70 years of age, had had stable 
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dietary habits (including supplement use) and a stable body weight in the 
previous 12 months. The antioxidant levels in the samples were analyzed in a 
central laboratory, to ensure comparability among centers. The data from all 
centers were pooled to calculate the risk of MI at low versus high antioxidant 
levels (Chapter 3). 
In 683 patients and 727 controls, we examined the association between 
adipose tissue a-tocopherol, 6-carotene and risk of MI. The mean 6-carotene 
concentration was significantly lower in patients than in controls. Persons in 
the lowest fifth of the B-carotene distribution had a 80% higher risk than 
persons in the highest fifth. This was particularly due to an increased risk in 
former and current cigarette smokers. The risk of MI was not associated with 
the level of a-tocopherol in adipose tissue (Chapter 4). 
Mean toenail selenium concentration was 4% lower in cases than in 
controls. The risk of MI was 55% higher at low than at high selenium levels, 
but this difference was not statistically significant. However, in subjects with 
low vitamin E levels, low toenail selenium was associated with a 2.5-fold 
increased risk of MI compared with high selenium. Among persons with high 
vitamin E levels, the risk of MI was not dependent on selenium levels. These 
findings suggest an interaction of selenium and vitamin E in the etiology of 
MI, possibly through their antioxidant functions (Chapter 5). 
As mentioned above, the potential protective effect of antioxidants may 
also depend on the intake of polyunsaturated fatty acids (PUFA) that are 
susceptible to lipid peroxidation. The intake of PUFA is reflected in the 
adipose tissue. The inverse association between 6-carotene and MI described 
in Chapter 4 was indeed dependent on the level of PUFA. At high PUFA 
levels, low 6-carotene status was associated with a more than three-fold 
increased risk of MI. At lower PUFA levels, there was still an increased risk 
at low 6-carotene status, but less than at high PUFA levels. For a-tocopherol, 
no interaction with PUFA levels was observed. For selenium, the opposite 
was found: at low PUFA, but not at high PUFA, there was an inverse 
association between selenium and MI. This is not in line with our hypothesis; 
possibly this finding may be explained by the larger number of smokers in 
the low-PUFA group, because smoking strongly affects selenium levels 
(Chapter 6). 
In the EURAMIC Study, biomarkers of a-tocopherol, 6 -carotene and 
selenium were used, assuming that these would reflect dietary intake over a 
longer period of time. To examine this assumption for a-tocopherol and 
6-carotene, we compared the levels in plasma and in adipose tissue with 
dietary intake, as measured by a food frequency questionnaire, in an 
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additional study. The study was performed among healthy, non-smoking 
volunteers (38 men and 47 women), aged 50-70. Supplementation with 30 
mg P-carotene daily for 6 months resulted in 6-fold increased levels in 
adipose tissue. However, the association between adipose tissue levels and 
usual dietary intake was only modest (r = 0.24 for a-tocopherol and r = 0.20 
for B-carotene), but stronger than the association of plasma levels with intake 
(Chapter 7). 
In the Dutch contribution to the EURAMIC Study, in addition to the 
adipose tissue samples, we collected information on dietary intake of 
a-tocopherol and p-carotene by means of a food frequency questionnaire. For 
the biomarkers, the associations with MI were similar to those for the pooled 
data. For dietary intake, the association between p-carotene and MI was weak 
and not significant; for a-tocopherol intake, there was a tendency towards an 
inverse association with MI, which was more or less opposite to the 
biomarker data. The limited number of subjects does not allow to draw firm 
conclusions. However, it appears that the biomarkers do not reflect dietary 
intake very well, as we had seen before; moreover, the relationship between 
intake and biomarkers differs between MI patients and population controls. 
This may indicate a different recall of food consumption for patients and 
controls, but it may also reflect differences in metabolism, either as a cause 
or a consequence of the disease (Chapter 8). 
Chapter 9 gives an account of some of the strengths and weaknesses in 
the study design and conduct. The results of the EURAMIC Study are 
discussed in the light of recent findings. We conclude that variations within 
the normal range of intake of vitamin E are not associated with MI and 
therefore cannot be considered to protect against coronary heart disease. This 
does not exclude the possibility that large doses of vitamin E may have a 
beneficial effect. Dietary selenium may have a modest protective effect on 
coronary heart disease, in particular in persons with a low vitamin E status. 
Low p-carotene status is associated with increased risk of myocardial 
infarction, especially in persons who smoke cigarettes or have done so in the 
past. Randomized controlled trials with varying doses and combinations of 
antioxidant nutrients should clarify whether the observed associations are 
causal. Until then, supplement use is not recommended, but a generous 
consumption of fruits and vegetables may be encouraged. 
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Samenvatting 
Het doel van het epidemiologisch onderzoek dat in dit proefschrift wordt 
beschreven, was het onderbouwen van de hypothèse dat antioxidanten uit de 
voeding bescherming kunnen bieden tegen coronaire hartziekten. 
Coronaire hartziekten vormen de belangrijkste doodsoorzaak voor 
mannen in de meeste landen van Europa. Hieraan ten grondslag ligt het 
procès van athérosclérose, waarbij cholesterol en andere vetten in de 
vaatwand worden opgeslagen. In een gevorderd stadium van athérosclérose 
kan de doorgang van het bloedvat worden geblokkeerd door de gevormde 
fibreuze plaque, of door de vorming van een bloedstolsel. Als dat gebeurt in 
de kransslagaders van het hart wordt de doorbloeding van het hart belemmerd 
en ontstaat er een hartinfarct. Een van de voornaamste risicofactoren voor 
athérosclérose is een hoog serum-cholesterolgehalte, met name het cholesterol 
dat in het bloed getransporteerd wordt in het lage-dichtheids-lipoproteïne 
(LDL). Volgens récente experimentele studies zou LDL zelf niet atherogeen 
zijn, maar dat pas worden wanneer het gemodificeerd wordt door 
oxidatiereacties, die van nature in het lichaam plaatsvinden. Vooral de 
meervoudig onverzadigde vetzuren in het LDL-deeltje zijn gevoelig voor 
oxidatie. Oxidatieprocessen in het lichaam worden binnen de perken 
gehouden door de beschermende werking van antioxidanten. Deze 
bescherming wordt gegeven door verschallende enzymen, waaronder het 
selenium-bevattende glutathion-peroxidase, en door uit de voeding afkomstige 
Stoffen zoals vitamine E en ß-caroteen (pro-vitamine A). Het is denkbaar dat 
het ontstaan en het voortschrijden van athérosclérose afhangt van de balans 
tussen oxidatieve stress door interne en externe factoren, de gevoeligheid van 
vetzuren voor oxidatie en de aanwezigheid van antioxidanten (Hoofdstuk 2). 
De EURAMlC-studie (EURopean study on Antioxidants, Myocardial 
Infarction and Cancer of the Breast) is opgezet om het verband tussen 
antioxidanten en coronaire hartziekten te onderzoeken. De gehalten van 
a-tocoferol (vitamine E) en ß-caroteen in onderhuids vetweefsel en van 
selenium in teennagels zijn vergeleken tussen patiënten met een eerste acuut 
hartinfarct en controlepersonen die nooit een hartinfarct hadden gehad. De 
vooronderstelling was dat deze gehalten lager zouden zijn in patiënten dan in 
controlepersonen. Verder is gekeken naar de vetzuursamenstelling van het 
vetweefsel; die geeft een indruk van de relatieve inneming van meervoudig 
onverzadigde vetzuren via de voeding. Patiënten waren afkomstig van de 
hartbewakingsafdelingen van ziekenhuizen in 8 landen in Europa en Israel. 
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De controlegroep werd in de meeste landen gevormd door een steekproef uit 
de bevolking, maar in sommige landen vormden ziekenhuiscontroles een 
geschiktere vergelijkingsgroep. Patienten en controlepersonen waren jonger 
dan 70, hadden stabiele voedingsgewoonten en een stabiel lichaamsgewicht in 
de voorafgaande 12 maanden. Het antioxidantgehalte is in de 
vetweefselmonsters bepaald in een centraal laboratorium, om de resultaten 
van de verschillende centra goed te kunnen vergelijken. De data van aile 
centra zijn bij elkaar genomen om het risico op een hartinfarct te kunnen 
berekenen voor mensen met een laag antioxidantgehalte ten opzichte van 
mensen met een hoog gehalte (Hoofdstuk 3). 
Bij 683 patiënten en 727 controlepersonen is het verband tussen 
a-tocoferol en ß-caroteen in vetweefsel en het risico op een hartinfarct 
bestudeerd. De gemiddelde ß-caroteenconcentratie was significant lager bij 
patiënten. Personen in de laagste 20% van de ß-caroteen-verdeling hadden 
een 80% hoger risico op een infarct dan personen in de hoogste 20% van de 
verdeling. Dit was vooral te wijten aan een verhoogd risico bij rokers en ex-
rokers. Het risico op een hartinfarct hield geen verband met het a-tocoferol-
gehalte in vetweefsel (Hoofdstuk 4). 
De gemiddelde concentratie van selenium in teennagels was 4% lager 
bij patiënten dan bij contrôles. Het risico op een infarct bij een laag 
seleniumgehalte was 55% hoger dan bij een hoog seleniumgehalte; dit 
verschil was echter niet statistisch significant. Voor personen met een läge 
vitamine E-status was er echter wel een significant verband tussen een laag 
seleniumgehalte en het infarctrisico: het risico bij laag seleniumgehalte was 
dan 2,5 maal zo hoog als bij hoog selenium. Bij personen met een hoge 
vitamine E status was er geen verband tussen het risico op een infarct en het 
seleniumgehalte. Deze resultaten wijzen op een mogelijke interactie tussen 
selenium en vitamine E in de etiologie van het hartinfarct, hetgeen mogelijk 
verband houdt met de antioxidantfunctie van beide Stoffen (Hoofdstuk 5). 
Zoals eerder aangegeven wordt de balans tussen oxidatie en 
antioxidanten mede bepaald door de inneming van meervoudig onverzadigde 
vetzuren (MOV), die relatief gemakkelijk geoxideerd worden. De inneming 
van MOV wordt weerspiegeld in de samenstelling van het onderhuids 
vetweefsel. De sterkte van het inverse verband tussen ß-caroteen en het risico 
op een hartinfarct dat in Hoofdstuk 4 is beschreven, bleek inderdaad af te 
hangen van het niveau van MOV. Bij een hoge MOV-status was een laag 
ß-caroteen-gehalte geassocieerd met een meer dan drievoudig verhoogd risico 
op een hartinfarct. Bij een läge MOV-status was er ook een verhoogd risico 
bij een laag ß-caroteengehalte, maar minder hoog dan bij een hoge MOV-
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status. Voor a-tocoferol is geen interactie met MOV gevonden. Voor 
selenium vonden we, in tegenspraak met de vooronderstelling, wel een invers 
verband tussen selenium en hartinfarct bij een läge MOV-status, maar niet bij 
een hoge MOV-status. Deze onverwachte bevinding kan mogelijk verklaard 
worden door het grotere aantal rokers in de groep met een läge PUFA-status, 
omdat roken het seleniumgehalte sterk bei'nvloedt (Hoofdstuk 6). 
In de EURAMlC-studie zijn biomerkers voor a-tocoferol, ß-caroteen en 
selenium gebruikt, in de veronderstelling dat deze een weerspiegeling zouden 
vormen van de inneming via de voeding over een längere période. Om deze 
aanname voor a-tocoferol en ß-caroteen te onderzoeken, zijn de gehalten in 
plasma en in vetweefsel vergeleken met de inneming via de voeding, gemeten 
met een voedselfrequentie-vragenlijst, in een aanvullende Studie. Dit 
onderzoek is uitgevoerd bij gezonde, niet-rokende vrijwilligers (38 mannen en 
47 vrouwen) van 50-70 jaar. Suppletie met 30 mg ß-caroteen gedurende 6 
maanden resulteerde in gemiddeld 6-voudig verhoogde concentraties in 
vetweefsel. Het verband tussen concentraties in vetweefsel en de 
gebruikelijke inneming via de voeding was echter vrij zwak (r = 0.24 voor 
a-tocoferol en r = 0.20 voor ß-caroteen), maar sterker dan het verband tussen 
concentraties in plasma en de inneming (Hoofdstuk 7). 
In de Nederlandse bijdrage aan de EURAMIC-studie is, naast vetweefsel, 
ook informatie verzameld over de inneming van a-tocoferol en ß-caroteen via 
de voeding, met behulp van dezelfde voedselfrequentie-vragenlijst. Voor de 
antioxidanten in vetweefsel vonden we vergelijkbare resultaten als in de 
internationale dataset. De resultaten voor antioxidanten uit de voeding waren 
min of meer tegenovergesteld: voor ß-caroteen was er geen verband met het 
risico op een hartinfarct en voor a-tocoferol was er een tendens naar een 
invers verband. Dit is onder andere het gevolg van het feit dat de gebruikte 
biomerkers de inneming via de voeding niet bijzonder goed weer lijken te 
geven, zoais we in de aanvullende studie al hadden gezien. Verder is de 
relatie tussen inneming en biomerkers verschillend voor infarctpatiënten en de 
controlepersonen. Door de beperkte omvang van de populatie in deze 
deelstudie is het niet mogelijk hier harde conclusies aan te verbinden. Het 
kan een aanwijzing zijn dat de vragen over de voeding verschillend worden 
beantwoord door patiënten en contrôles, maar het kan ook betekenen dat er 
verschillen in métabolisme zijn tussen patiënten en contrôles, hetzij als 
oorzaak hetzij als gevolg van de ziekte (Hoofdstuk 8). 
In Hoofdstuk 9 worden enkele aspecten van de onderzoeksopzet en 
-uitvoering uitvoeriger besproken. De resultaten van de EURAMIC-studie 
worden belicht in het kader van récente resultaten van andere studies. De 
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conclusie is dat normale inneming van vitamine E geen bescherming lijkt te 
bieden tegen coronaire hartziekten, hoewel dit niet uitsluit dat grote 
hoeveelheden vitamine E mogelijk wel een gunstig effect hebben. Sélénium 
beschermt misschien enigszins tegen coronaire hartziekten, vooral bij 
personen met een läge vitamine E-status. Een läge ß-caroteen-status is 
geassocieerd met een verhoogd risico op een hartinfarct, vooral bij personen 
die roken of hebben gerookt. Gecontroleerde interventiestudies met 
verschillende doses antioxidanten moeten in de toekomst opheldering geven 
over de mogelijke causaliteit van de verbanden die we hebben waargenomen. 
Tot die tijd is er geen goede reden om suppletie met antioxidanten aan te 
bevelen; de consumptie van ruime hoeveelheden groenten en fruit kan echter 
zeker geen kwaad. 
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alle "principal investigators" en hun collega's in de verschillende landen. Ik 
heb mijn deel daar aan bij mögen dragen, maar het zal duidelijk zijn dat dit 
proefschrift mede te danken is aan heel veel anderen. Het allermeest heb ik te 
danken aan Prof. Frans Kok en Dr. Pieter van 't Veer. Frans en Pieter, zonder 
jullie had EURAMic niet bestaan en mijn proefschrift ook niet. Jullie niet-
aflatend enthousiasme, plus de nodige tactische en technische kwaliteiten, 
hebben gezorgd voor een succesvolle onderneming. Ik heb veel van jullie 
geleerd; bovendien waren we een prima team, als coördinerend centrum - we 
hebben net zoveel gelachen als gestressed. De nachtelijke wandelingen in 
Malaga en Davos hebben ongetwijfeld bijgedragen aan het geheel. Ik heb wel 
even moeten slikken bij jullie beider vertrek naar Wageningen, maar het 
uiteindelijk resultaat heeft er zeker niet onder geleden. 
Verder wil ik Prof. Ruud Hermus noemen; Ruud, bedankt voor je steun en 
je betrokkenheid bij de inhoudelijke discussies. Aan Theo Ockhuizen heb ik 
te danken dat ik bij TNO terecht ben gekomen. Theo, je zag wel iets in de 
allergenen-databank en ik zat bij de deal inbegrepen, al zei ik direct dat ik 
liever onderzoek wilde gaan doen. Door jouw steun is het daar inderdaad van 
gekomen: bedankt voor het vertrouwen dat je in me Steide. 
I'd like to express my gratitude to the principal investigators of the 
EURAMIC Study, for their invaluable contributions to the study, their 
enthusiasm and support, and for their friendship: Antti Aro, Miguel Delgado, 
Jorge Gomez, Jussi Huttunen, Jeremy Kark, Lenore Kohlmeier, Blaise 
Martin, José Martin-Moreno, Vladimir Mazaev, Rudolph Riemersma, Jetmund 
Ringstad, Sean Strain, Michael Thamm. I have good memories of the 
meetings we had in Zeist, in Malaga, in Berlin, Davos and Coleraine and I 
certainly hope we will work together again in the future. I haven't forgotten 
all the other people involved in the conduct of the study, I just can't mention 
them all here, but I certainly realize and appreciate that their work has made 
this thesis possible. 
Dankzij de medewerking van cardiologen en arts-assistenten in 
verschillende ziekenhuizen konden we ook in Nederland een bijdrage aan 
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belangrijk. Verder ben ik dank verschuldigd aan dr. C.A.P.L. Ascoop, dr. R. 
van Mechelen, dr. J. May, dr. G.A.J. Jessurun, dr. M.P. Freericks en dr. J.P. 
Kerker en hun medewerkers op de hartbewakingsafdelingen en op de labs. 
Het Nederlands Huisartsen Genootschap ben ik erkentelijk voor de adviezen 
over de controlewerving; ook de vele huisartsen die deel hadden in de 
werving van controlepersonen wil ik bedanken. Maar zonder de medewerking 
van de patienten en de controlepersonen in EURAMIC en de vrijwilligers in de 
'Biomerker-studie' had dit resultaat er natuurlijk nooit gelegen. 
De werving van deelnemers en het verzamelen van de monsters is voor mij 
gedaan door Annelies Legters en Rob Gerritse. Annelies, Rob, jullie hebben 
het fantastisch gedaan en het was niet altijd makkelijk. Uit eigen ervaring 
weet ik dat jullie uitstekend een vetbiopt kunnen nemen. 
De mensen van het lab bij TNO, Jan van Schoonhoven, Frank van Schaik, 
Hetty van de Pol, Berry Wezendonk en iedereen die zieh verder ooit verdiept 
heeft in de samenstelling van een vetbiopt - bedankt, ik ben erg blij dat ik dit 
deel met een gerust hart aan jullie kon overlaten. Het Interfacultair Reactor 
Instituut dank ik voor de analyse van selenium in de teennagels. 
Flora de Vrijer heeft ons met raad en daad bijgestaan bij het organiseren 
van de Workshops. Dirk van der Heij heeft zijn licht laten schijnen over het 
Engels taalgebruik, met name in de hoofdstukken waar ik het zonder de hulp 
van 'native Speakers' als co-auteur moest doen. Anneloes Meijer, het rapport 
dat jij voor je afstudeerstage hebt geschreven is erg goed van pas gekomen. 
Verschillende collega's hebben een duidelijke bijdrage aan dit boekje 
geleverd. Soms heel herkenbaar: Geert van Poppel, Henny Brants en Henk 
van den Berg als co-auteur, Arthur van Aken voor de figuren, Hanny Leezer 
de perfecte vormgeving en Monica Stam de prachtige omslag. Of wat meer 
impliciet: Willy van Dijk, door alle voedingsvragenlijsten in te voeren, Marco 
Bouman, voor de conversie van de uiteenlopende data naar hetzelfde format, 
anderen door belangstelling, adviezen en zo nu en dan een schouderklopje als 
dat nodig was. Ellen, het was op het laatst wel eens lastig (vooral voor de 
(co)promotoren) dat we zo synchroon liepen, maar ik vond het erg opbeurend 
om iemand in de buurt te hebben die ook in paniek kon raken bij het idee dat 
de nullen en enen misschien verwisseld waren. 
Mijn ouders wil ik bedanken voor het altijd vanzelfsprekende vertrouwen 
in mij. Jullie hebben mij altijd mijn eigen keuzes laten maken en op allerlei 
manieren gesteund. Richard, jij hebt ervoor gewaakt dat ik in de weekeinden 
mijn tijd aan andere dingen bleef besteden - ook daardoor kan ik nu zeggen: 
het viel achteraf best mee. 
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